Stereoselective reactions of alkenes mediated by

chiral hypervalent iodine reagents by Farid, Umar
 Stereoselective Reactions of Alkenes Mediated by 
Chiral Hypervalent Iodine Reagents 
 
 
 
 
 
 
 
 
 
A Thesis Submitted to Cardiff University 
in Fulfilment of the Requirements for the Degree of 
Doctor of Philosophy 
by Umar Farid 
 
 
 
 
 
 
 
 
PhD Thesis October 2013 
Cardiff University 
i 
 
DECLARATION 
This work has not been submitted in substance for any other degree or award at this or 
any other university or place of learning, nor is being submitted concurrently in candidature 
for any degree or other award. 
 
Signed ………………………………………… (Umar Farid)       Date ………………………… 
 
STATEMENT 1 
This thesis is being submitted in partial fulfillment of the requirements for the degree of 
…………………………(insert MCh, MD, MPhil, PhD etc, as appropriate) 
 
Signed ………………………………………… (Umar Farid)       Date ………………………… 
 
STATEMENT 2 
This thesis is the result of my own independent work/investigation, except where otherwise 
stated. 
Other sources are acknowledged by explicit references.  The views expressed are my 
own. 
 
Signed ………………………………………… (Umar Farid)       Date ………………………… 
 
STATEMENT 3 
I hereby give consent for my thesis, if accepted, to be available for photocopying and for 
inter-library loan, and for the title and summary to be made available to outside 
organisations. 
 
Signed ………………………………………… (Umar Farid)       Date ………………………… 
 
 
 
ii 
 
CANDIDATE’S LAST NAME FARID 
CANDIDATE’S FIRST NAME(S) UMAR 
CANDIDATE’S ID NUMBER 0931936 
SCHOOL CHEMISTRY 
TITLE OF DEGREE 
Please circle appropriate degree title 
EdD, EngD, DSW, DClinPsy, DHS, MCh, MD, MPhil, MScD 
by Research, PhD 
FULL TITLE OF THESIS 
 
 
 
 
 
 
 
Stereoselective Reactions of Alkenes Mediated by Chiral 
Hypervalent Iodine Reagents 
 
 
 
 
 
 
 
IS THIS A RESUBMISSION? YES / NO 
THESIS SUBMITTED FOR 
EXAMINATION IN 
Permanent  Binding         
Temporary binding           
CANDIDATE SIGNATURE DATE 
 
 
iii 
 
Acknowledgements 
 
I am indebted to many people for their long-lasting support and encouragement which was 
invaluable for the successful completion of this research work. In the following lines some 
of them are gratefully acknowledged. However, I am aware of the fact that there are many 
more and these words cannot express the gratitude and respect I feel for all of them. 
Firstly, I would like to thank my supervisor Professor Thomas Wirth who gave me the 
opportunity to come to the Cardiff and explore the chemistry of hypervalent iodine 
reagents. He offered me a warm welcome in his group and always generously offered 
advice, especially when I, every now and then, stumbled upon odd results. Thanks Sir! 
My sincere gratitude goes to my colleagues for scientific discussions, advice and 
continuous support, among them Dr. Sascha, Dr. Sohail, Dr. Zulfiqar, Dr. Omar, Dr. 
Munawwer, Dr. Fateh, Dr. Pushpak, Dr. Mike, Dr. Nida, Dr. Ravi, Dr. Diana, Dr. Kenta, 
Richard, Baker, Kevin, Guillaume, Simon, Elisabetha, Elena, Christina, Terreca, Fabian, 
Martin, Ana, Marcelo, Sandra, Lena, Rosalia, Erika, Mohammad and Michele for many 
valuable ideas and suggestions. I am very much grateful to Mathew and Florence for 
reading my thesis and making it readable. I am really thankful to Dr. Liwei who introduced 
me to the methods of research and helped me when I was struggling in the start. 
Many thanks go to the visiting students, Olivier, Gregory, Pierre-Henri, Romain and my 
colleague Florence who helped me out and contributed towards my research.  
I am really thankful to my friends, Avess, Usman, Hafiz Usman, Taimoor, Sohrab, Uzair, 
Noman, Vania, Adeeba, Ragini, Ziafat, Qaisar, Vittoria and Zahid for their moral support 
and good gestures. You guys made it really easy for me!  
I would like to acknowledge Prof. Olofsson and her research team who gave me the 
opportunity to visit Stockholm and learn their chemistry. Thanks to my mentor and 
examiner Dr. Mark Elliott and Prof. Keith Smith for their encouragement and suggestions 
during my viva exams. 
My acknowledgements would remain incomplete if I do not mention the support of 
technical and non-technical staff at the School of Chemistry, especially, Dr. Rob Jenkins 
and Sham Ali. I also want to thank the EPSRC National Mass Spectrometry Service Centre 
(Swansea) for mass spectrometric data and Dr. B. Kariuki (Cardiff University) for the X-
iv 
 
Ray analysis. Finally, I am grateful to Cardiff University, RSC and Charles Wallace Trust 
for the generous financial support, without which this thesis would not have been possible. 
Last but by no means least, I would like to thank my family especially my parents, 
grandparents, brothers Farrukh, Khurram, Ali, my sister, my aunts and my sister in laws for 
the opportunity to start and pursue a career in science. I am particularly indebted to my 
father Mr. Pervaiz, my mother, Miss Tabassum, my uncles Kamran and Tahir for their 
never-ending encouragement and ongoing support!  
 
Umar Farid 
 
Research is the name of patience and hardwork! (Umar Farid) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
 
 
 
 
 
 
 
 
 
Dedicated to the Nation of Pakistan, Wishing them Success and Progress in the 
Field of Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
List of Abbreviations 
°C  Degree Celsius 
Å   Angstrøm 
Ac   Acetyl 
Ar   Aryl 
BuOH   Butanol 
d.e.   Diastereomeric excess 
d.r.   Diastereomeric ratio 
DMF   N,N-Dimethylformamide 
e.e.   Enantiomeric excess 
e.r.   Enantiomeric ratio 
Et   Ethyl 
EtOH   Ethanol 
h   Hour/hours 
HPLC   High pressure liquid chromatography 
HRMS  High resolution mass spectrometry 
Hz   Hertz 
HFIP  Hexafluoroisopropanol 
i-Pr   i-Propyl 
LDA   Lithium diisopropylamide 
M   Molarity (mol/l) 
m-CPBA  3-Chloroperoxybenzoic acid 
Me   Methyl 
MeOH  Methanol 
MHz   Megahertz 
min   Minute 
mL  Millilitre 
mmol   Millimol 
m.p.   Melting point 
m/z   Mass over charge ratio 
n-BuLi  n-Butyllithium 
vii 
 
NMR   Nuclear magnetic resonance 
on  overnight 
ppm   Parts per million 
Ph   Phenyl 
Pr   Propyl 
PrOH   Propanol 
rt   Room temperature 
t-Bu   t-Butyl 
t-BuOH  t-Butanol 
THF   Tetrahydrofuran 
TBDMSOTf Tertiarybutyldimethyl silyl triflate 
Ts  Tosyl (4-toluenesulfonic) 
p-TsCl  4-Toluenesulfonyl chloride 
TsOH  p-Toluenesulfonic acid 
TLC   Thin layer chromatography 
TFE  2,2,2-Trifluoroethanol 
TMSOTf  Trimethylsilyl triflate 
TfOH  Triflic acid 
TEMPO (2,2,6,6-Tetramethylpiperidin-1-yl)oxy 
TMOF  Trimethyl orthoformate 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
Abstract 
Chiral hypervalent iodine compounds are used as environmentally friendly, mild, and 
selective oxidants for many organic transformations.  
In this thesis, enantiomerically pure chiral hypervalent iodine reagents have been 
synthesized and used in the functionalization of different types of alkenes. A highly 
enantioselective oxyamination of alkenes with N-sulfonyl ureas employing chiral lactic 
acid-based hypervalent iodine reagents giving a facile synthesis of enantiomerically pure 2-
arylproline derivatives is described. This is the first example of stereoselective 
oxyamination reactions under metal-free conditions. 
 
Then oxidative rearrangement of aryl-substituted ketones induced by lactate acid-based 
chiral hypervalent iodine reagents via 1,2 migration of the aryl moiety in the presence of 
alcohol nucleophiles is described leading to the α-arylated and β-oxygenated carbonyl 
compounds in enantiomerically pure form. This is the first stereoselective rearrangement 
reaction mediated by chiral hypervalent iodine reagents.  
 
Finally, all experimental details and characterization of the compounds are described. 
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Introduction to Chiral Hypervalent Iodine 
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1.1   Iodine 
Iodine is a chemical element with the symbol I and atomic number 53. The lustrous, 
purple-black metallic sheen of crystalline iodine was firstly observed by the French 
chemist B. Courtois in 1811. The name is from the Greek word,  ἰωδής meaning violet 
or purple which reflects its most characteristic property. In human biology iodine is a 
constituent of thyroid hormone named Thyroxine 1. If the necessary iodine input is 
insufficient the thyroid gland enlarges in an attempt to acquire more iodine: addition of 
0.01% sodium iodide to table salt prevents the condition.  
 
In addition to its use in medicine, iodine and its compounds have been widely exploited 
in volumetric analysis (iodometry and iodimetry). Organoiodine compounds have also 
played a notable part in the development of synthetic organic chemistry like in the A. 
W. von Hoffman's alkylation of amines, Williamson's synthesis of ethers, Wurtz's 
coupling reaction, hypervalent iodine reagents for oxidation reactions and Grignard's 
reagents.[1] 
1.2   Introduction to Hypervalent Iodine Reagents 
The first organic hypervalent iodine reagent dichloroiodobenzene, PhICl2 was prepared 
by the German chemist C. Willgerodt in 1886.[2] A growing interest in this field was 
observed 60 years later. In the mean time a huge expansion occurred in the field of 
hypervalent iodine chemistry, especially during the last 15 years.  Since then 
hypervalent iodine reagents have been extensively used in organic synthesis as mild and 
selective oxidants replacing toxic and heavy transition metals.  
1.3   Bonding and Structure in Hypervalent Iodine Reagents 
Molecules containing elements of Group V-VIII bearing more electrons than the octet in 
their valence shell are regarded as hypervalent molecules.[3] The term iodane refers to 
hydrogen iodide (HI). According to IUPAC rules, compounds with nonstandard 
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bonding numbers are shown by lambda notion; thus H3I is called λ3-iodane and H5I λ5-
iodane. The most common ArIL2 (L: heteroatom ligands) with decet structure is named 
aryl- λ3-iodane. The geometry of aryl-λ3-iodanes (ArIL2) is a pseudotrigonal bipyramid. 
Commonly, a less electronegative group with an aryl group is bonded to the iodine by a 
normal covalent bond, lying in the equatorial position of a trigonal bipyramid. The two 
heteroatom ligands (L) are in the axial positions and each are attached to one of the 
lobes, of one doubly occupied 5p orbital of the iodine. This is a hypervalent three-center 
four-electron bond (3c-4e bond) with two electrons from the doubly occupied 5p orbital 
on iodine and one electron from each of the ligands (L). Molecules of this kind are T-
shaped; the electronic structure for a typical member, (dichloroiodo)benzene, is 
described below. 
 
Fig 1.1: The electronic structure of dichloroiodobenzene 
Hypervalent iodine compounds show a partial positive charge on the iodine and a partial 
negative charge on the axial heteroatom ligands. This can be explained by the 
organisation in the molecular orbitals. The two lower energy molecular orbitals of the 
three produced for the hypervalent 3c-4e-bond are occupied (Fig. 1.2). They are 
bonding and non-bonding orbitals. The non-bonding molecular orbital has a node at the 
central iodine whereby the partial charges are induced. So this highly polarized 
3c-4e-bond leads to an electrophilic character of aryl-λ3-iodanes and the preferred 
orientation of more electronegative ligands in the axial position. Consequently the 
presence of more electropositive central atoms is energetically favorable for a 
hypervalent species. Hence, λ3-iodanes in general are more stable than analogous 
λ
3
-bromanes and λ3-chloranes.[4,5] 
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Fig 1.2: Pseudotrigonal bipyramidal structure and molecular orbital of the 3c-4e-bond 
1.4   General Reactivities of Hypervalent Iodine Reagents 
Traditionally hypervalent iodine reagents were mainly recognized as highly selective 
oxidants but many other useful synthetic reactions for the construction of carbon-
carbon bonds, carbon-heteroatom bonds and rearrangement reactions etc., have also 
been  developed extensively. A brief summary of these reactions and the use of 
different hypervalent iodine reagents is described below. 
1.4.1   Oxidation 
The oxidation of alcohols to the corresponding carbonyl compounds under mild 
reaction conditions is one the prominent feature of hypervalent iodine reagents.[6] 
Simple oxidation of 2-iodobenzoic acid with oxone gives a quite popular iodine(V) 
reagent, ortho-iodoxybenzoic acid (IBX; 2).[7] To overcome solubility issues associated 
with IBX, Dess-Martin periodinane (DMP; 3) is used in organic syntheses.[8] Other 
established hypervalent iodine(III) oxidants include (diacetoxyiodo)benzene 4, 
[bis(trifluoroacetoxy)iodo]benzene 5 and (hydroxytosyloxyiodo)benzene also known 
as Koser's reagent 6 (Fig. 1.3). 
 
Fig 1.3: Commonly used hypervalent iodine reagents 
Benzylic, allylic and propargylic alcohols 7 can be oxidised to the corresponding 
aldehydes in the presence of stabilized Wittig ylides to generate α,β-unsaturated esters 8 
in a one pot procedure by using IBX 2. This is a useful reaction especially when the 
intermediate aldehydes are unstable and are difficult to isolate.[9] The dearomatization of 
phenols 9 with hypervalent iodine reagents has been also used frequently. In the 
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presence of internal nucleophiles, cyclized products are obtained to give quinone 
derivatives 10 (Scheme 1.1).[10]  
 
 
Scheme 1.1: Oxidation of alcohols and phenols with hypervalent iodine reagents 
1.4.2   Formation of Carbon-Carbon Bonds 
Reactions leading to the formation of carbon-carbon bonds are an important area of 
practical applications of hypervalent iodine reagents. These reactions proceed either 
through generation of carbon-centered reactive intermediates such as free radicals, 
carbocations etc., or by ligand coupling-reactions mediated by tricoordinate iodine 
intermediates which can be generated by the addition of a carbon nucleophile to an 
iodonium salt.[11]  
Kita and co-workers have efficiently reported oxidative phenol derivative 11 for carbon-
carbon coupling reaction to give 12 as a key step in the synthesis of complex natural 
product mediated by [bis(trifluoroacetoxy)iodo]benzene 5  and MK10 as a solid acid 
additive.[12] Malonic acid derivatives can be employed to synthesize cyclopropane 
derivatives 14 from alkenes 13 by in situ  generation of iodonium ylides from diacetoxy 
iodobenzene 4 and a carbene precursor (Scheme 1.2).[13] 
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Scheme 1.2: Carbon-carbon bond forming reactions via phenol dearomatization and 
cyclopropanation of alkenes mediated by hypervalent iodine reagents 
1.4.3   Formation of Carbon-Heteroatom Bonds 
The use of hypervalent iodine reagents in carbon-heteroatom bond formation is well 
established and been used successfully for a wide range of substrates. One of the most 
common example is the halogenation of carbonyl compounds. α-Fluoro sulfides or 
selenides 16  can be obtained with (difluoroiodo)toluene 17 through a Fluoro-Pummerer 
reaction in which fluoride is incorporated into the sulfur-containing molecule 15  
allowing the synthesis of mono- and difluorides.[14] The treatment of N-carbonyl 
pyrrolidine derivatives 18 with iodosobenzene 20 and trimethylsilyl azide leads to 
azidonation of the ring 19 with upto 82% yields (Scheme 1.3).[15] 
 
Scheme 1.3: Carbon-heteroatom bond forming reactions via Fluoro-Pummerer reaction and 
azidonation reaction 
1.4.4   Rearrangements 
The nature of hypervalent iodine(III) compounds to react as electrophiles and then 
behave as excellent leaving groups make them highly suitable reagents for generating 
cationic intermediates which can either directly react with nucleophiles or lead to 
rearranged products. Treatment of aryl substituted alkenes 21 and 23 with hypervalent 
iodine(III) reagents 4 and 6  gave rise to the cyclized product 22[16] when internal 
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nucleophiles were involved or to the ketones 24 [17] when external nucleophiles were 
present (Scheme 1.4). 
                                               
 
Scheme 1.4: Rearrangement reactions of alkenes mediated by iodine(III) reagents. 
1.5   Introduction to Chiral Hypervalent Iodine Reagents 
Hypervalent iodine compounds have found broad applications in organic chemistry. 
They have been frequently used as mild and chemoselective oxidation and oxygenation 
reagents, replacing toxic and heavy metal containing reagents, thus providing more 
environmentally friendly reaction conditions. In this context, the use of chiral 
hypervalent iodine reagents for asymmetric transformations has emerged as an 
interesting area of research in recent years. Developments and highlights of this 
chemistry are summarized below, more comprehensive reviews have also appeared in 
the literature.[18] 
Different principles can be used for the synthesis of chiral hypervalent iodine 
compounds. Iodine(III) derivatives can either have one (25) or two (26) aryl or alkenyl 
substituents. Either these substituents or the heteroatom ligands L in these compounds 
can bear a stereogenic moiety. The same is true for iodine(V) compounds (27), although 
compounds with a stereogenic iodine atom should also be possible. To our knowledge, 
such compounds have not yet been characterized or employed in asymmetric synthesis. 
Hypervalent iodate anions can be coordinated to chiral cations allowing the formation of 
reactive ion-pairs 28 as reagents (Fig. 1.4). Iodine(VII) compounds have not been 
reported yet for asymmetric synthesis. 
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Fig. 1.4: Different types of hypervalent iodine reagents 
1.6   General Reactivities of Chiral Hypervalent Iodine Reagents 
The use of enantiomerically pure hypervalent iodine reagents in many organic 
transformations such as the oxidation of sulfides to sulfoxides, α-arylation of carbonyl 
compounds, the dearomatization of phenols, the dioxygenation, diamination and 
aminofluorination of alkenes is summarized below.  
1.6.1   Oxidation of Sulfides to Sulfoxides 
The first optically active hypervalent iodine compound was described in 1907 resulting 
from the reaction between diphenyliodonium hydroxide and tartaric acid.[19] Similar 
complexes, although structually not characterized and probably containing oligomeric 
structures, have been used by Imamoto 31[20] and later by Koser 32[21] who performed 
the oxidation of prochiral sulfides 29 to optically active sulfoxides 30 with selectivities 
of up to 53% ee (Scheme 1.5). The selective sulfide-to-sulfoxide conversion remained 
for a long time the only reaction to test novel chiral hypervalent iodine compounds. 
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Scheme 1.5: Oxidation of sulfide to sulfoxides by chiral hypervalent iodine reagents 
Kita used 10 mol% of a chiral diacyltartaric acid derivative together with 
iodoxybenzene (PhIO2) and performed the oxidation of sulfides to sulfoxides 30 in the 
presence of surfactants in excellent yields and enantioselectivities of up to 72% ee.[22] 
Other studies of enantioselective oxidation of sulfides have also been performed by 
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using camphor-type ligands as stereoselective moieties in iodine(III) compounds of type 
25 which resulted in lower selectivities.[23] 
1.6.2   Functionaliation of Alkenes and Carbonyl Compounds 
In 1997, Wirth reported the first asymmetric functionalizations of alkenes and ketones 
using chiral iodine(III) dervatives of type 33. Such compounds 33 (R' = H) were used in 
the enantioselective oxytosylation of propiophenone 34 and the dioxytosylation of 
styrene 36, leading to the selectivities of up to 15% ee in 35 and 21% ee in 37 
respectively.[24] Optimized reagents with second ortho-substituents (33, R' = Et, OMe) 
improved these selectivities to up to 65% ee in product 37 (Scheme 1.6).[25]  
 
Scheme 1.6: Functionalization of propiophenone and styrene mediated by chiral hypervalent 
iodine  
The development of reactions using hypervalent iodine derivatives in catalytic 
amounts[26] was the basis for the first enantioselective catalytic reactions involving 
chiral hypervalent iodine reagents by Wirth.[27] Catalytic reaction involves the 
utilization of iodine containing molecules together with a stoichiometric oxidant. The 
oxidant generates the hypervalent iodine reagent in situ and after the oxidative 
transformation mediated by the hypervalent iodine compound; the reduced iodine-
containing molecule is re-oxidized (Fig. 1.5).[28]  
*Ar I
X
X
*Ar I
+ Substrate
+ Oxidized Product
Oxidant
 
Fig. 1.5: Catalytic cycle for the synthesis of hypervalent iodine reagent. 
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A range of chiral iodides were investigated together with m-CPBA as stoichiometric 
oxidant in the α-oxytosylation of propiophenone with just 10 mol% chiral aryl iodide 
and and para-toluenesulfonic acid (TsOH) giving the product 35 in selectivities of up to 
39% ee. When chiral sulfonic acids such as camphorsulfonic acid were used the 
selectivity was increased to  44% ee (Scheme 1.6).[29]  
Higher selectivities have been obtained in cyclization reactions. Lactic acid-derived 
chiral λ3-iodanes such as 38 were prepared by Fujita and employed in the 
tetrahydrofuranylation of acyloxybutenes 39 leading to products 40 in up to 64% ee.[30] 
Fujita et al. also reported the tosyloxylactonization of 2-ethenylbenzoic acid using 
stoichiometric amounts of chiral hypervalent iodine reagents of type 38 in the presence 
of para-toluenesulfonic acid (TsOH) or acetic acid. Selectivities of up to 98% ee have 
been obtained which is demonstrated in the synthesis of the natural product 41 (Scheme 
1.7).[31]  
 
Scheme 1.7: Lactate-based hypervalent iodine reagents in cyclization reactions 
In these reactions syn additions to the alkene were observed, this has been already 
established by previous investigations. A catalytic variant of the oxylactonization was 
also obtained by using chiral iodine reagent 42 as an organocatalyst along with m-
CPBA as an oxidant to give dihydrofuran-fused isochromanone 43 with up to 91% 
ee.
[32] 
 The same research group also reported enantioselective Prévost and Woodward 
reactions with lactate derived λ3-iodanes 38 leading to reaction products with similarly 
high selectivities (Scheme 1.7).[33] 
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Hypervalent iodine reagents derived from the lactate-based iodoarene 44 have also been 
successfully used for the derivatization of alkenes. As shown below, enantioselective 
diaminations of styrene derivatives 45 have been reported by Muñiz et al.[34] These 
reactions are leading to almost enantiopure diamine 46 (up to 95% ee). The utilization 
of new dinuclear binaphthyl iodine(III) reagent 47 in the similar reaction gave up to 
32% ee.[35] Nevado et al. reported the highly regioselective aminofluorination of alkenes 
48 giving the 6-endo- cyclized product 49 in 88% ee and 79% yield by employing 50 in 
stoichiometric amounts. The methodology was expanded to give 7-membered β-
fluorinated azepane scaffolds by employing 50 along with a gold complex in catalytic 
amounts to give 51 in 77% ee and 64% yield (Scheme 1.8).[36]    
 
Scheme 1.8: Lactate-based hypervalent iodine reagents in diamination and aminofluorination 
reactions 
1.6.3   Dearomatization of Phenols and α-Arylation of Ketones 
Kita et al. introduced hypervalent iodine compounds such as 52 in the enantioselective 
oxidative spirolactonizations to 53 with selectivities of up to 86% ee and 86% yield 
(92% ee and 96% yield in the catalytic reaction  by employing 54).[37,38] Ishihara et al. 
reported a C2-symmetric chiral iodoarene 55 as a catalyst for spirocyclizations with 
selectivities of up to 92% ee and 94% yields (Scheme 1.9).[39] By using an excess of m-
CPBA in these reactions (5 equivalents), the product 53 can also be epoxidized. 
Intramolecular bonding interactions between the amide protons and the iodine ligands 
11 
 
or between the carbonyl oxygen atom and the iodine atom are suggested to directly 
affect the asymmetric reaction. 
        
Scheme 1.9: Oxidative spirolactonizations of phenols by chiral hypervalent iodine reagents. 
Harned et al. synthesized the tricylic chiral iodide 56 derived from 8-iodotetralone and 
tartaric acid and used them to obtain para-quinol derivatives 58 from phenols 57 in up 
to 60% ee and 79% yield (Scheme 1.10).[40] 
                                
Scheme 1.10: Tricyclic chiral iodide for p-quinol derivatives synthesis 
Ochiai et al. reported the first iodinanes with a binaphthyl structure.[41] Later his 
research group used diaryliodonium salts 59 for the phenylation of β-keto esters in the 
presence of a base to give products 60 with yields of up to 69% and selectivities of up to 
53% ee.[42] Other chiral iodoarenes based on a binaphthyl system such as 61 have been 
reported by Quideau et al. and used in the asymmetric hydroxylative dearomatization of 
phenol derivatives. The α-hydroxylated product 62 was obtained with 50% ee and in 
83% yield (Scheme 1.11).[43] 
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Scheme 1.11: Utilization of chiral binaphthyl iodoarenes in α-arylation and dearomitization 
reactions 
1.6.4   Stereoselective Oxidation Reactions Mediated by Iodine(V) Reagents  
Only very few chiral λ5-iodanes have been synthesized and used in asymmetric 
synthesis. Zhdankin et al. prepared the series of benziodazoles of type 63 from naturally 
occurring amino acids and used them for the oxidation of sulfides obtaining sulfoxides 
30 in up to 16% ee.[44] The same research group also prepared proline containing λ5-
iodanes 64 and investigated their use as stereoselective oxidizing agents for meso-diols 
obtaining selectivities in the products 65 of up to 33% ee.[45] Zhdankin et al. also 
prepared different amino acid-based chiral λ3-iodanes, either with the amino acids as a 
chiral moiety attached to the iodoarene or as a ligand on the iodine(III) atom.[46] Birman 
et al. introduced a class of chiral iodine(V) aryliodooxazolines such as 66 derived from 
amino alcohols. They investigated their use for the oxidation of phenols in an oxidative 
dearomatization followed by a [4+2] dimerization to products 67 with 
enantioselectivities of up to 77% (Scheme 1.12).[47] Later Wirth and co-workers 
reported another series of chiral hypervalent iodine(V) compounds as stoichiometric 
oxidants.[48] 
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Scheme 1.12: Iodine(V) reagents in oxidation reactions 
1.6.5   Cycloetherification of Phenols 
Ishihara et al. investigated the enantioselective oxidative cycloetherification of 
ketophenols to 2-acyl-2,3-dihydrobenzofuran derivatives catalyzed by in situ generated 
chiral quaternary ammonium iodide catalysts 68 with hydrogen peroxide as a 
stoichiometric oxidant. This is a very vital example of asymmetric catalysis using chiral 
cations paired with inorganic iodine derived oxo acids. In this protocol, the C2-
symmetric chiral binaphthyl-based quaternary ammonium (hypo)iodite reagent was 
generated in situ by reaction with hydrogen peroxide. It was found that ammonium 
cations bearing bulky and electron deficient substituents gave the best results giving 
selectivities in 69 of up to 96% ee with 99% yield (Scheme 1.13).[49] 
 
Scheme 1.13: Cycloetherification by in situ generated chiral quaternary ammonium iodide  
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1.7   Conclusion 
In conclusion, hypervalent iodine reagents have been developed for mild and 
environmentally friendly reaction protocols leading to synthetically attractive organic 
molecules. They have been used not only as selective oxidants but also as powerful 
electrophiles for the activation of carbon-carbon double bonds. The developments and 
recent advances in the field of chiral hypervalent iodine reagents have led to the 
synthesis of many biologically important molecules in optically active form. 
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2.1   Introduction to Aminohydroxylations of Alkenes 
The functionalization of an alkene is one of the most popular reaction among synthetic 
chemists because of their wide occurrence. Many novel methodologies have been 
developed involving alkenes leading to the synthetically attractive and biologically 
important molecules. Particularly, the 1,2-difunctionalization of alkenes has always 
been a challenging target in synthetic chemistry because of regio- and stereochemical 
issues.[1] The occurrence of 1,2-difunctionalized compounds in natural products and 
biologically active compounds in the form of 1,2-amino alcohols, 1,2-diamines and 1,2-
diols illustrate the importance of the products of such transformations. Given their 
prominent significance in organic chemistry, it is no surprise that many synthetic routes 
have been developed to overcome the challenges of their synthesis.  
1,2-Amino alcohols are the key functional groups in many bioactive compounds, natural 
products and chiral reagents for stereoselective synthesis. One of the most common 
naturally occurring amino alcohols are the hydroxy amino acids like serine and 
threonine. Other biologically important compounds containing amino alcohol moieties 
include anisomysin[2] which is a potent inhibitor of protein biosynthesis and have anti 
cancer activity and bestatin[3] with applications in cancer chemotherapy (Fig. 2.1). 
 
Fig. 2.1: Bioactive compounds with amino alcohol moieties 
Vicinal amino alcohol-based chiral reagents have found broad applications in 
asymmetric synthesis. Most of these amino alcohols are present in cyclic systems for 
example, Evans' reagents 70.[4] These enantiopure chiral auxiliaries are used in aldol 
condensation, alkylation and Diels-Alder reactions. Oxazaborolidine 71 are proline-
based systems used in the highly selective catalytic asymmetric reduction of carbonyl 
compounds.[5] Acyclic amino alcohols are also used in many asymmetric 
transformations; ephedrine derivative 72 has been used in asymmetric alkylation of 
amides (Fig. 2.2).[6] 
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Fig. 2.2: Commonly used chiral amino alcohol reagents in asymmetric transformations 
Transition metal-catalyzed oxidative amination reactions are established methods for the 
synthesis of new carbon-nitrogen and carbon-oxygen bonds through the 
functionalization of alkenes.[1] Other metal-free protocols are also reported in the 
literature to overcome the toxicity and cost issues associated with the metal-catalyzed 
reactions. A brief summary on the background of such reactions is described below. 
2.2   Transition Metal-Catalyzed Aminohydroxylations 
In 1996, Sharpless et al. developed the first asymmetric aminohydroxylation (AA) of 
alkenes. The reaction involves direct enantioselective synthesis of vicinal amino 
alcohols 74 from the alkenes 73 by loading catalytic amounts of potassium osmate, in 
the presence of stoichiometric nitrogen source that also acts as a re-oxidant and 
cinchona alkaloids; hydroquinine 1,4-phthalazinediyl diether (DHQ)2PHAL to control 
regio- and stereo-chemistry of the products (Scheme 2.1).[7]  
 
Scheme 2.1: Sharpless asymmetric aminohydroxlation (AA) of alkenes  
The Sharpless AA protocol has also been applied in the synthesis of many natural 
products such as γ-amino-β-hydroxybutyric acid (GABOB)[8] and (+)-caprazol.[9] In 
2005 Muñiz et al. reported the first osmium catalyzed substrate-controlled 
aminohydroxylation of acrylamides 75  with moderate to excellent yields and 
diastereoselectivites of amino alcohols 76 (Scheme 2.2).[10] 
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Scheme 2.2: Natural products synthesized from Sharpless AA and reagent-controlled 
aminohydroxylations 
Despite the recent advances in osmium catalyzed aminohydroxylations of alkenes, these 
reactions are highly dependent on the nature of the substrate and have regiochemical 
issues. To address these problems, Donohoe et al. developed a novel strategy in which 
the nitrogen source was tethered to the alkene substrates 77 and 78 giving 79 with 
complete regioselectivity. However, no enantioselectivity was observed when these 
substrates were exposed to the reaction conditions in the presence of cinchona ligands 
(Scheme 2.3).[11,12] 
 
 
Scheme 2.3: Osmium catalyzed tethered aminohydroxylations 
Donohoe et al. also reported an osmium catalyzed intramolecular aminohydroxylation 
of N-protected amino alcohols 80 onto tethered alkenes to give corresponding 
pyrrolidine rings 81 with up to 98% yields. It was proposed that the reaction proceeds 
via chelation of Os(VI) species and the amino alcohol moiety, followed by the acid 
promoted syn-addition to the alkene 82. Then the resulting Os(IV) is re-oxidized by 
using pyridine-N-oxide (PNO).[13] By employing similar strategy led to the formation of 
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a highly substituted tetrahydrofuran derivative as a single diastereomer 84 from the 
diene 83 (Scheme 2.4).[14]  
 
 Scheme 2.4: Osmium catalyzed cyclization reactions 
Rhodium(II) catalysts along with hypervalent iodine(III) reagents as stoichiometric 
oxidants have also been used in the oxyamination of electron rich alkenes. Evidence 
suggested that the reaction proceeds through the formation of aziridine intermediate via 
the addition of metallonitrene to the alkene 85 and 86, followed by the attack of 
different oxygen nucleophile to give amino alcohol derivatives 87 and 88 in high yields 
and as single diastereomers (Scheme 2.5).[15,16] 
 
          
Scheme 2.5: Rhodium(II)-catalyzed intra- and intermolecular oxyamination of alkenes 
The direct oxyamination of terminal and internal alkenes was developed by Bäckvall et 
al. in 1975. Stoichiometric amounts of Pd(II) were necessary for the reaction, limiting 
its scope for further manipulations.[17] However, in 2005 Sorensen et al. reported that a 
catalytic source of Pd(II) in the presence of an iodine(III) re-oxidant could be applied to 
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the olefin 89 to give oxyaminated product 90 in moderate yields and high 
diastereoselectivities. The reaction proceeded with anti-addition of heteroatoms across 
the double bonds.[18] An analogous catalytic system was developed further for 
oxyamination of wide range of alkenes 91 and 92 to give products 93 and 94 with 
complete regioselectivity and high diastereoselectivity (Scheme 2.6).[19,20] 
 
Scheme 2.6: Palladium(II) catalyzed oxyamination of alkenes using iodine(III) reagents as 
oxidants 
Muñiz et al. also showed that platinum can also act as a catalyst for intramolecular 
oxyamination of alkenes in the presence of copper dibromide as co-catalyst. However 
the reaction was limited to the systems bearing the terminal alkenes 95 to give 5-6 fused 
ring system 96. It was observed that the reaction proceeded with high chemo- and 
diastereoselectivity when a stereocentre was present on the carbon backbone (Scheme 
2.7).[21] 
 
Scheme 2.7: Platinum catalyzed oxyaminations. 
In 2002, Göttlich and Naock reported a copper-catalyzed oxyamintion of alkenes in the 
presence of Lewis acids. The authors suggested that in this reaction, N-benzoyl 
hydroxylamines 97 with pendant olefins underwent a radical type mechanism followed 
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by 5-exo-trig cyclization onto the tethered alkene to deliver 98 as a major oxyaminated 
product.[22] The similar strategy was then applied for intermolecular addition of N-O 
bond of an N-sulfonyl oxaziridine 99 across a range of alkenes to give a mixture of cis 
and trans aminooxygenated products 100 (Scheme 2.8).[23] 
 
Scheme 2.8: Copper catalyzed oxyamination of alkenes 
The use of chiral bisoxazoline copper(II) complexes for enantioselective intermolecular 
oxyamination of alkenes make them a useful complementary transformation to the 
Sharpless AA reaction. The reaction proceeded with high regio- and enantioselectivity 
but the lack of stereospecificity; as illustrated by the formation of mixture of products 
101, was a major drawback.[24] Chemler et al. developed the first intramolecular 
enantioselective oxyamination reaction with high enantio- and regioselectivity by using 
catalytic amounts of copper in the presence of (2,2,6,6-tetramethylpiperidin-1-yl)-oxyl 
(TEMPO) which served both as stoichiometric oxidant and the oxygen source. In the 
presence of asymmetric bisoxazoline ligands of type 102, chiral indolines and 
pyrrolidines 103 were obtained. Further kinetic studies indicated that the reaction is first 
order both in the substrate and the copper complex and zero order in TEMPO (Scheme 
2.9).[25,26] 
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Scheme 2.9: Copper catalyzed enantioselective aminooxygenation of alkenes 
First row transition metal catalysts like Fe(III) continue to contribute towards effective  
intermolecular addition of N-O by using N-sulfonyl oxaziridine 104 across the range of 
alkenes giving the oxyaminated products in high yields and selectivities.[27] It is 
noteworthy that the regioselectivity obtained in Fe(III) catalyzed reaction product 105 is 
inverted as to that observed with Cu(II) catalyzed product 100 (Scheme 2.8). Iron(III) 
catalysts have also been used for asymmetric oxyamination reaction of alkenes by using 
chiral ligands of type 102 to give enantioenriched oxazolidine products 106 that can be 
easily manipulated to give free amino alcohols (Scheme 2.10).[28]  
 
Scheme 2.10: Iron(III) catalyzed oxyamination of alkenes 
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2.3   Metal-Free Oxyamination Protocols 
Transition-metal catalysis though provides an easy access to the broad range of 
oxyamination products from the wide range of alkenes, however there are several 
drawbacks of these reagents. As they are expensive, toxic, air sensitive and often 
difficult to remove in final pharmaceutical products on large scale. As a result, many 
researchers have been interested to develop metal-free reaction conditions to obtain 
amino alcohols from alkenes. These are useful synthetic methodologies because of their 
mild, non-toxic and environmentally friendly reaction conditions.                                                                                                         
Stoker et al. reported the iodine(0) mediated one-pot oxyamination of alkenes. In this 
paper bishomoallylic amines 107 were cyclized to form hydroxypyrrolidines 108 with 
high regio- and diastereoselectivity. The reaction proceeded with the activation of the 
double bond by iodine followed by 5-exo-tet cyclization of the primary amine. The 
resulting haloamine intermediate was substituted by carbon dioxide generated in situ 
from sodium bicarbonate (NaHCO3).[29] N-δ-alkenyl-N'-sulfonyl ureas 109 were also 
cyclized to give bicyclic isoureas 110 by using N-iodosuccinimide (NIS) along with 
catalytic amounts of silver triflate (AgOTf) (Scheme 2.11).[30] 
 
Scheme 2.11: Iodine(0) mediated oxyamination of alkenes 
The use of iodine(III) reagents in oxyamination reactions of alkenes was firstly 
developed by Dominguez's group. They used [bis(trifluoroacetoxy)iodo]benzene for 
direct intramolecular oxyamination of terminal alkenes. In the reaction protocol, N-
para-methoxyphenyl amides 111 were transformed into pyrrolidinones 112. The authors 
proposed the oxidation of amide group by the PIFA followed by intramolecular addition 
reaction to the olefin to generate aziridinium cation, as the key step in the reaction. 
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However, the reaction was limited just to the terminal alkenes and to amides bearing the 
para-methoxyphenyl (PMP) protecting group (Scheme 2.12).[31]  
 
Scheme 2.12: PIFA mediated oxyamination of termial alkenes 
The similar oxidative approach for diastereoselective formation of hydroxylactams 114 
from amides 113 which are directly activated by the methoxy group was developed by 
Wardrop's research group in 2010. This methodology enabled the synthesis of five-eight 
membered rings in moderate to excellent yields. The main limitation of this protocol 
was  the moderate regioselectivity and the stoichiometric loadings of transition-metal 
reagents for deprotection of the nitrogen moiety (Scheme 2.13).[32] 
 
Scheme 2.13: PIFA mediated oxyamidation of alkenes 
Michael et al. broadened the scope of iodine(III) reagents for intramolecular 
oxyamination of bis-homoallylic sulfonyl ureas 115. When these substrates were 
exposed to iodosyl benzene (PhIO) in the presence of trimethylsilyl triflate (TMSOTf), 
bicyclic isoureas 116 were obtained in  up to 86% yield. An ionic mechanism for this 
transformation was proposed by the authors which involved the in situ generation of  a 
new iodine(III) reagent 117 derived from the PhIO and TMSOTf through ligand 
exchange reaction on the iodine followed by the activation of the  alkene. The resultant 
cationic intermediate underwent 5-exo-tet-cyclization through the attack of the nitrogen. 
Subsequent attack of urea oxygen delivered the isourea 116 with high syn selectivity.[33] 
The same research group also reported the first direct oxyamination of homoallylic 
amines 118  exhibiting 6-endo selectivity to deliver cyclized oxyamination products 119 
in the presence of trifluoroacetic acid (TFA) (Scheme 2.14).[34] 
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Scheme 2.14: Iodine(III) mediated oxyamination of alkenes 
Johnston et al. reported the addition of alkyl azides to α,β-unsaturated amides 120 under 
acidic conditions to give β-amino products 121 in good yields and with anti 
selectivity.[35] This method represents a useful alternative approach to the osmium 
catalyzed syn selective aminohydroxylation reaction (Scheme 2.15). The oxyamination 
of dienes was reported by Weinreb.[36] In this approach a hetero-Diels-Alder reaction 
between N-sulfinyl carbamate 122 and a range of dienes were used to obtain allylic 
sulfoxides  123 which underwent a stereospecific [2,3] sigmatropic rearrangement on 
exposure to phenyl magnesium bromide to deliver the oxyaminated product 124. 
However, the limited substrate scope of this methodology has restricted its use in 
modern synthetic chemistry (Scheme 2.15).  
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Scheme 2.15: Other metal-free oxyaminations of alkenes 
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An electrochemical protocol for the synthesis of protected hydroxy-pyrrolidines 126 by 
the oxidative electrolysis of N-sulfonyl amines 125 bearing electron rich alkenes using 
reticulated vitreous carbon anode (RVC) and platinum wire cathode has been reported 
by Moeller et al. The authors proposed that the reaction proceeds via a radical process 
in the presence of a nucleophile such as methanol to deliver the oxyamination product 
in good yield (Scheme 2.16).[37]  
 
Scheme 2.16: Electrochemical oxyamination of electron rich alkenes 
Togo et al. reported th Bronsted acid-catalyzed intramolecular aminohydroxylation of 
N-alkenylsulfonamides 127 in the presence of oxone (2KHSO5·KHSO4·K2SO4) to give 
prolinol derivatives 128 in high yields. The reaction proceeded with an activation of 
oxone with p-toluenesulfonic acid (TsOH) to give a peroxymonosulfate intermediate 
which reacted with the alkene to give an epoxide. The exo-selective intramolecular 
amination of the epoxide gave rise to the prolinol derivatives (Scheme 2.17).[38] 
 
Scheme 2.17: Acid-catalyzed oxyaminations of alkenes 
2.4   Summary 
During the past decade, many developments have been made in the field of 
aminohydroxylation reactions. Metal-catalyzed oxyamination reactions remain the most 
reliable methods for stereoselective synthesis of amino alcohols. However, not any of 
these methods are able to offer a complete regio- and stereocontrol aminohydroxylation 
reaction with all types of olefins. It is also notable that none of the above mentioned 
metal-free protocols provide an enantioselective route to amino alcohols. Therefore, 
further advancement in this area of research is necessary to overcome these problems. 
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Chapter 3 
Results and Discussion of 
Aminohydroxylation Reactions 
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3.1   Objectives 
The main objective of this work is to develop a stereoselective metal-free protocol for 
the intramolecular oxyamination of alkenes (Fig. 3.1). Besides the long history of the 
aminohydroxylation chemistry, it is notable that there is not even a single report of such 
a reaction under metal-free conditions. In this context, the use of chiral hypervalent 
iodine reagents for asymmetric transformations can be a suitable replacement because 
of their environmentally friendly and mild reaction conditions. This avoids the issues of 
toxicity or the complicated ligands related to many transition metal-based systems. 
Utilization of chiral hypervalent iodine compounds as electrophilic reagents for alkene 
functionalization is also a well established research field, as illustrated by the 
dioxygenation,[1] diamination[2] and aminofluorination[3] reactions of alkenes.  
 
Fig. 3.1: Metal-free aminohydroxylation of alkenes leading to free amino alcohol moiety 
3.2   Project Approach 
The project approach starts with the synthesis of sulfonyl-substituted homoallylic urea 
derivatives of type 129. The use of such bifunctional nucleophiles together with 
stoichiometric amounts of hypervalent iodine reagents in the addition to alkenes can be 
used for intramolecular oxyamination reactions. In the reaction protocol, after the 
activation of the double bond with the hypervalent iodine reagent the first nucleophile 
reacts to give intermediate 130. The hypervalent iodine moiety is then attached to a sp3-
hybridized carbon atom and therefore is an excellent leaving group, several orders of 
magnitude more reactive than triflates or tosylates.[4] The subsequent substitution 
reaction directly yields bicyclic compounds 131. It has already been shown in the 
literature that the strong acidic conditions lead to isoureas 131a and weak acidic 
conditions lead  to the formation of diamination products 131b (Scheme 3.1).[5] The 
deprotection of the nitrogen followed by the cleavage reaction can give rise to the free 
amino alcohol or diamines derivatives. 
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Scheme 3.1: Cyclization of urea bisnucleophiles with alkenes using hypervalent iodine reagents 
(Ar-IL2) for the synthesis of isoureas 131a (path a) or of cyclic ureas 131b (path b) 
Based on the reactions mentioned above, we shall also extend this concept towards the 
enantioselective synthesis of protected amino alcohols from alkenes. As we generate a 
new stereogenic centre in the reaction, use of chiral hypervalent iodine reagents for 
stereochemical induction can be interesting which will lead towards the 
enantiomerically pure amino alcohols. In this perspective, many lactate-based chiral 
hypervalent iodine reagents of type 132 reported in the literature can be examined (Fig. 
3.2).[6,7] The results obtained in these reactions are described below. 
 
Fig. 3.2: Lactate-based chiral hypervalent iodine reagent 
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3.3   Initial Oxyamination Cyclizations 
We have investigated sulfonyl-substituted homoallylic urea derivative 136 for the 
intramolecular oxyamination reaction by using different hypervalent iodine reagent. 
Substrate 136 was synthesized by a known literature procedure starting from the 
abstraction of a proton from diphenylacetonitrile 133 by using sodium hydride followed 
by its reaction with allyl bromide to give 2,2-diphenylpent-4-enenitrile 134 as an oil and 
then the reduction reaction with LiAlH4 to give  2,2-diphenylpent-4-en-1-amine 135.[8] 
The final step was the treatment of 135 with p-toluene sulfonylisocyanate (TsNCO) 
which resulted into the corresponding (2,2-diphenylpent-4-enyl)-3-tosylurea compound 
136 as a white solid (Scheme 3.2). 
 
136
78%
CH2Cl2
S
NCO
O
O 135
HN
O
HN S
Ph
Ph OO
 
Scheme 3.2: Synthesis of starting material 136 for oxyamination reactions 
In the initial experiments for cyclizations, when substrate 136 was exposed to 
[bis(trifluoroacetoxy)iodo]benzene, a mixture of oxyamination 137a and diamination 
137b products in almost equimolar ratio with a  very slow reaction was observed (Table 
3.1, entry 1). The use of catalytic amounts of diphenyl diselenide, a catalyst which was 
successful in a series of other cyclization-elimination sequences, along with a 
stoichiometric amounts of hypervalent iodine oxidant did not have a substantial 
improvement as the reaction time was still long (Table 3.1, entry 2).[9] When tert-
butyldimethylsilyl triflate (TBDMSOTf, Table 3.1, entries 3 and 4)  was added to the 
reaction mixture along with the hypervalent iodine reagent, complete conversion of the 
starting material was observed giving the isourea 137a as a major product. The addition 
of tert-butyldimethylsilyl triflate (TBDMSOTf, Table 3.1, entries 3 and 4) or 
trimethylsilyl triflate (TMSOTf) to (diacetoxyiodo)benzene generates, as evidenced by 
NMR investigations (p. 94), in situ the more reactive PhI(OTf)2.[10] This led to a mixture 
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of 137a and 137b (approx. 2:1) in a much faster reaction with improved combined 
yields of 72% (Table 3.1, entry 4).  
 
Table 3.1: Different hypervalent iodine reagents for the cyclization of 136 
Entry Reagents Solvent, Conditions 137a Yield 
[%] 
137b Yield 
[%] 
1 PhI(OCOCF3)2 (1.2 equiv) CH2Cl2, rt, 120 h 26 28 
2 PhI(OCOCF3)2 (1.05 equiv), 5 mol% 
(PhSe)2 
CH2Cl2, rt, 72 h 62 6 
3 PhI(OAc)2 (1.2 equiv), TBDMSOTf (1.2 
equiv) 
CH2Cl2, –78 ºC to 
rt, 8 h 
48 20 
4 PhI(OCOCF3)2 (1.2 equiv), TBDMSOTf 
(1.2 equiv) 
CH2Cl2, –78 ºC to 
rt, 3 h 
50 22 
3.4   Synthesis of Chiral Hypervalent Iodine Reagents 
As the products 137a and 137b contain stereogenic centres, stereoselective synthesis of 
these cyclized products by using chiral hypervalent iodine reagents was the next step. In 
this context, many chiral hypervalent iodine reagents were synthesized. Lactate-based 
hypervalent iodine compounds have been synthesized by Fujita et al. and reagent 141 
has been introduced by Ishihara et al. for a highly enantioselective 
spirolactonizations.[6,7] These reagents were synthesized by modifying known literature 
procedures starting from a Mitsunobu reaction between 2-iodoresorcinol 138 and (–)-
lactic acid ethyl ester in the presence of diisopropyl azodicarboxylate (DIAD) and 
triphenyl phophine (PPh3) to give the ester 139 as a colourless oil. Then the ester 139 
was hydrolyzed by NaOH to give the chiral C2-symmetric acid 140 in quantitative 
yields. The chiral acid 140 was then converted into the acid chloride in situ by using 
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SOCl2 followed by the addition of  excess amount of mesityl amine (Mes-NH2) to     
give rise to amide product 141 as a white solid. Now the compound 141 was     oxidised          
by     1-(chloromethyl)-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 
[Selectfluor®] to give the corresponding bisfluoride product in situ giving rise to the 
diacetate hypervalent iodine reagent 142 in the presence of acetic acid (Scheme 3.3).  
  
 
Scheme 3.3: Synthesis of chiral hypervalent iodine reagent 142 
Other oxidation protocols such as stirring 141 with the mixture of acetic acid in 
peracetic acid at room temperature[11] or heating a mixture of NaBO3.4H2O with acetic 
acid[12] along with 141 at 40 oC to oxidize 141 to 142, resulted in either partial oxidation 
or decompositions. Only the oxidation conditions of Selectfluor® with acetic acid were 
found to be reliable and reproducible.  
Hypervalent iodine reagents are known to coordinate with heteroatoms. Therefore, it is 
quite common to have nitrogen or oxygen in the chiral side chain in many of these 
reagents. Especially in the reagent 142, the amide bond in the chiral side chain can 
coordinate to the iodine centre probably by intramolecular bonding interactions between 
the carbonyl oxygen atom and the iodine atom 142a or between the amide protons and 
the iodine ligands 142b. These bonding interactions could be responsible to directly 
affect the asymmetric reaction (Fig. 3.3).[7] Recently, these possible interactions were 
confirmed by single crystal X-ray diffraction analysis in the chiral hypervalent iodine 
reagent 143 in which the two intramolecular hydrogen-bonding interactions between the 
acidic amido protons and the ligands were clearly observed.[13] 
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Fig. 3.3: Possible bonding interactions in the chiral hypervalent iodine reagent   
Therefore, the reagent 142 was further modified by varying either the chiral auxiliary in 
the side; mandelate-derived (146 and 151) or  by changing the functional groups; esters 
(144) and ethers (149) to see the effects on the enantioselectivities. 
To avoid long synthetic steps involved in the preparation of reagent 142, ester 139 was 
also oxidized by the mixture of Selectfluor® and acetic acid in acetonitrile to give the 
oxidized  product 144 (Scheme 3.4). 
 
Scheme 3.4: Oxidation of C2-symmetric chiral ester to give hypervalent iodine(III) reagent 144 
The use of (R)-(–)-mandelic acid ethylester in a Mitsunobu reaction with 2-iodophenol 
led to the synthesis of compound 145 in 87% yield. Oxidation of 145 in the presence of 
Selectfluor® and acetic acid in acetonitrile gave rise to the chiral hypervalent iodine 
reagent 146. Interestingly, corresponding iodoso type iodine(III) oxidized product was 
obtained rather than bisacetate iodine(III) product. It is noteworthy that the desired 
chiral iodine(III) reagent 146 was obtained just over two steps, therefore its use in the 
asymmetric reaction could be interesting (Scheme 3.5). 
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Scheme 3.5: Synthesis of mandelic acid ethyl ester derived hypervalent iodine(III) reagent 146 
Our research group recently reported the use of C2-symmetric chiral diselenide 149a in 
the methoxyselenylation of styrene derivatives with high selectivities.[14] Therefore, its 
hypervalent iodine(III) analogue was synthesized and was planned to use in 
oxyamination cyclization reactions. The synthesis started from the lithiation reaction of 
147 which was synthesized from the literature procedure[14] in the presence of n-BuLi at 
0 ºC followed by slow addition of I2 to give 148 in 93% yield. The iodine(I) reagent 148 
was then oxidized by standard reaction conditions as described above to give the 
product 149 (Scheme 3.6).  
 
 
Scheme 3.6:  Synthesis of chiral reagent 149 with ether functionality  in the side chain 
The treatment of chiral C2-symmetric acid 140 under Mitsunobu  reaction conditions 
with (R)-(–)-mandelic acid ethylester led to the synthesis of compound 150 with an 
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additional chiral center in the novel iodine(I) reagent in 72% yield. The compound 150 
was then oxidized to give the desired chiral iodine(III) reagent 151 (Scheme 3.7).  
 
 
  Scheme 3.7: Synthesis of hypervalent iodine(III) reagent 151 
3.5   Stereoselective Oxyamination Reactions 
The chiral hypervalent iodine(III) reagents synthesized above were used in the 
cyclization of substrate 136. Under various reaction conditions, only isourea compound 
137a was obtained with all chiral hypervalent iodine reagents (Fig. 3.4) and the cyclic 
urea derivative 137b could not be detected suggesting that these chiral hypervalent 
iodine reagents are sterically demanding reagents, therefore in the second cyclization we 
only observed the smaller oxygen nucleophile reacting to give the bicyclic isourea 
derivative 137a.  
 
Fig. 3.4: Enantiomerically pure lactate and mandelate-derived hypervalent iodine reagents 
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Table 3.2: Conditions for the stereoselective cyclization to 137a 
Entry Reagents[a] Solvent 137a Yield [%] 137a ee [%] 
1 142, TBDMSOTf CH2Cl2 50 40 
2 142, TfOH CH2Cl2 58 40 
3 142, TMSOTf CH2Cl2 48 61 
4 142, TMSOTf CH2Cl2 61 57[b] 
5 142, TMSOTf toluene 0 - 
6 142, TMSOTf THF 34 10 
7 144, TMSOTf CH2Cl2 30 12 
8 149, TMSOTf CH2Cl2 50 0 
[a] reaction temperature –78 ºC, reaction time 14 h. [b] reaction temperature –78 ºC to rt. 
As shown in Table 3.2, the hypervalent iodine reagent 142 has been investigated 
together with different acids for its activation (Table 3.2, entries 1-3). The highest 
selectivities have been obtained with trimethylsilyl triflate (TMSOTf) leading to the 
reaction product 137a with an enantiomeric excess (ee) of 61% (Table 3.2, entry 3). 
Slightly higher reaction temperatures led to lower selectivities (Table 3.2, entry 4), as 
did other solvents (Table 3.2, entries 5 and 6). The hypervalent iodine compounds 144 
and 149, which are also derived from lactic acid, were less efficient in the 
stereoselective cyclization of 137a (Table 3.2, entries 7 and 8). In these experiments, 
stoichiometric amounts of the hypervalent iodine reagents have been used. About 80-
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85% of the reduced aryl iodides are recovered after the reaction without any loss of 
optical purity and were reused by oxidation.  
To minimize the chances of racemization and the possibility of generating a chiral 
quaternary carbon centre led to the development of substrate 156 derived from styrene. 
Previous research by our group using selenium electrophiles revealed that styrene 
derivatives are potential substrates for cyclizations with high selectivities.[15] We 
therefore prepared compound 156 from (3-bromoprop-1-en-2-yl)benzene 152 which 
was synthesized from α-methylstyrene according to literature procedure[16] and reacted 
with lithiated acetonitrile 153.[17] The lithiation reaction was carried out at –78 ºC in the 
presence of n-BuLi for two hours followed by slow addition of 152 and then warming to 
room temperature to give 4-cyano-2-phenyl-1-butene 154. Further reduction of 154 with 
lithium aluminum hydride gave rise to 5-amino-2-phenyl-1-pentene 155. Amine 155 
was reacted with tosyl isocyanate to yield product 156 along with some traces of tosyl 
amide as a side reaction product which was inseparable by column chromatography 
(Scheme 3.8). 
 
 
Scheme 3.8: Synthesis of styrene derived substrate 156 
Stereoselective cyclizations of 156 led to isourea 157 containing a stereogenic 
tetrasubstituted carbon atom by using different chiral hypervalent iodine reagents. The 
results are summarized in Table 3.3. 
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Table 3.3: Stereoselective cyclization of 156 to isourea derivative 157 
Entry Reagents[a] Solvent 157 Yield 
[%] 
157 ee [%][b] 
1 142, 1.5 eq. TMSOTf CH2Cl2 40 78 
2 144, 1.5 eq. TMSOTf CH2Cl2 35 69 
3 146, 1.5 eq. TMSOTf CH2Cl2 34 50 
4 149, 1.5 eq. TMSOTf CH2Cl2 20 50 
5 151, 1.5 eq. TMSOTf CH2Cl2 40 75 
6 142, 1.5 eq. TMSOTf CH2Cl2:CF3CH2OH (1:1) 43 81 
7[c,d] 142, 2 eq. TMSOTf CH2Cl2:Et2O (3:1) 48 88 
8[c] 142, 2 eq. TMSOTf, 0.5 eq. TsNH2 CH2Cl2:Et2O (1:3) 76 90 
9[c,e] 142, 2 eq. TMSOTf, 0.5 eq. TsNH2 CH2Cl2:Et2O (1:3) 60-71 92-96 
10[c,e,f] 142, 3 eq. TMSOTf, 0.5 eq. TsNH2 CH2Cl2:Et2O (1:3) - >99 
[a] 156 with traces of tosyl amide, reaction temperature –78 ºC, reaction time 14–18 h. [b] major 
enantiomer has (S)-configuration.  [c] reaction time 3 h. [d] reaction temperature –100 ºC. [e] 
addition of 156 after reaction of 142 with TMSOTf. [f] reaction performed on analytical scale. 
All chiral hypervalent iodine reagents shown in Fig. 3.4 have been used for the 
cyclization of compound 157 (Table 3.3, entries 1–5). Highest selectivities have been 
obtained with reagent 142. Reagent 151 consisting of lactic acid and mandelic acid 
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moieties, led to a good selectivity in product 157 as well (Table 3.3, entry 5). The 
addition of 2,2,2-trifluoroethanol, which can strongly influence reactions with 
hypervalent iodine compounds, did not have a pronounced effect in this case (Table 3.3, 
entry 6).[18] The use of other solvent mixtures increased selectivities and yields. 
Experiments with 156 containing small amounts of para-toluenesulfonamide (TsNH2) 
due to the preparation procedure resulted in variable results. Therefore, tosyl amide free 
starting material was prepared by using small amounts (0.95 equiv) of p-
tolueneisocyanate (TsNCO). Then the addition of TsNH2 to the reagent 142 together 
with an excess of TMSOTf, led to  reproducible results and to synthetically very 
attractive selectivities, especially if 142 is allowed to react first with TMSOTf (Table 
3.3, entries 9 and 10). To check the role of para-toluenesulfonamide (TsNH2) in the 
reaction and its possible interactions with the electrophilic iodine centre, a NMR 
experiment was conducted. Due to large signal broadening and decomposition above –
40 ºC, the structure of 142 with added TMSOTf and TsNH2 could not be examined 
using NMR spectroscopy. Compound 157 was obtained enantiomerically pure (>99% 
ee) on an analytical scale reaction (Table 3.3, entry 10) while the selectivity dropped 
slightly on a larger scale (Table 3.3, entry 9). The absolute configuration of the major 
isomer of 157 was found to be S by anomalous dispersion scattering and the refined 
Flack parameter[19] was 0.11(11) as determined by X-ray crystallography (Fig. 3.5).[20]  
N
O
N S
O
O
157
 
Fig. 3.5: X-ray structure of the compound 157 
To check the effects of electronically versatile starting materials with different 
substitutents at the para-position of the phenyl ring led to the synthesis of compounds 
162 a and b. These compounds were prepared by the abstraction of proton from 
isobutyronitrile 158 by uing freshly prepared lithium diisopropylamide (LDA)[21] 
followed by the addition of corresponding styrene derivatives 159 to give the first 
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product 160. Reduction of the nitrile group 160 followed by the reaction with p-
toluenesulphonylisocyanate (TsNCO) led to the products 162 (Scheme 3.9). 
 
 
Scheme 3.9: Synthesis of electronically diverse aryl-substituted alkenes for oxyamination 
reactions 
Electronically withdrawing substituents on the aryl moiety in 162a (R = F) led to the 
expected aminooxygenated product 163a with good yields and moderate seletivities. 
The absolute configuration for the product 163a was assigned in an analogy to the 
product 157. The electron rich derivative 162b (R = OMe) underwent, after cyclization, 
further oxidation and rearrangement to give 163b probably through a reaction between 
the hypervalent iodine reagent and the methoxy-substituted aryl moiety but the structure 
of the product based on its NMR data could not be confirmed at this point (Scheme 
3.10). 
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Scheme 3.10: Effects of substitution on the aryl moiety for oxyamination of alkenes 
Different protecting groups for the urea moiety have also been tried to see the effects on 
the yields and enantioselectivities. These substrates were synthesized by reacting the 
amines 135 and 155 with different protected isocyanates to give products 164, 165 and 
166 in high yields (Scheme 3.11).  
 
 
 
Scheme 3.11: Synthesis of substrate with versatile protecting groups 
It was found that the variation of protecting groups on the urea moiety led to altered 
nucleophilicities of the nitrogen moiety. A phenyl substituent substrate 164 resulted in 
generally lower reactivities as evident through the lower yields in these reactions. Also 
the solvents used in the reactions had to be adjusted to ensure the solubility of the 
starting materials. With substrate 164, the use of PhI(OTf)2 as an achiral reagent led to 
the expected isourea derivative 167a, whereas the chiral reagent 142 yielded the cyclic 
urea 167b as the product of a diamination reaction (Scheme 3.12). This reaction 
indicates that the chiral hypervalent iodine reagent 142 is reasonably sterically 
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demanding. Therefore, it allowed the attack of smaller nitrogen nucleophile with phenyl 
ring protection in the second cyclization to give diamination product. However, when 
the relatively bigger tosyl-protected nitrogen nucleophile was reacted under similar 
conditions, oxyamination was the main reaction pathway as shown above (Table 3.3). 
N
O
NPh
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Ph
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167a: 31% yield
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Scheme 3.12: Reactivity alteration by changing protection on the urea moiety 
Further variation of the tosyl substituent on the urea moiety gave similarly changed 
results. A trifluoromethylphenyl substituent on 165 and 166 resulted in oxyaminated 
products 168 and 169 with generally lower reactivity and selectivities under similar 
reaction conditions of their analogue products 137a (48%, 61% ee) and 157 (40%, 78% 
ee) (Scheme 3.13). 
 
 
Scheme 3.13: Variation of tosyl-protection on urea moiety for oxyamination reaction 
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To accomplish results for C2-symmetric oxyaminated product 173, substrate 172 was 
designed. It was synthesized by deprotonation of malononitrile in the excess amount of 
NaH followed by the addition of allyl bromide to give 2,2-diallylmalononitrile 170 as a 
yellow oil. Subsequent reduction of 170 gave the corresponding amine[22] 171 which 
was subjected to tosylisocyanate (TsNCO) to give the product 172 in 74% yield 
(Scheme 3.14). 
 
 
Scheme 3.14: Synthesis of substrate 172 for enantioselective aminohydorxylations 
 The optimized reaction conditions were then applied to the substrate 172. The reaction 
proceeded with the mixture of products. Interestingly, products 173a and 173b were 
isolated as single diastereomers as judged from their NMR spectra but with low 
selectivities (Scheme 3.15). As lower enantioselectivities were obtained in this reaction 
along with mixture of products, therefore further investigations on the stereochemistry 
of these products were not carried out. However, this extension of the methodology with 
substrates 172 demonstrated that other compounds are also accessible by employing 
these reaction conditions. 
 
Scheme 3.15: Stereoselective oxyaminations other alkenes 
Hypervalent iodine mediated first regioselective aminotrifluoroacetoxylation of alkenes 
135 was developed by Michael et al.[23] We investigated an enantioselective version of a 
similar reaction by using acetic acid as a nucleophile. The substrate 174 and 175 
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required for such transformation were synthesized by the amines 135 and 155 (Scheme 
3.16). 
 
 
Scheme 3.16: Synthesis of starting materials for aminoacetoxylation of alkenes 
By employing optimized reaction conditions described above, the cyclization of 
tosylamide 174 resulted in a 6-endo cyclized product 176 with the acetate added as an 
external nucleophile. In this reaction, the use of 142 as a chiral reagent led to an 
enantiomeric excess of only 27%. It is noteworthy that similar reactions have already 
been described using gold catalysis.[24] However, the cyclization of tosylamide 
derivative 175 did not result in the expected oxyaminated product but in the formation 
of achiral six-membered ring systems with elimination. While the direction of 
elimination was found to be dependent on the Lewis acid used in the reaction. The 
addition of TBDMSOTf led to the elimination product 177a while with BF3·OEt2 
enamine 177b was isolated (Scheme 3.17).  
 
 
Scheme 3.17: Hypervalent iodine mediated aminoacetoxylation of alkenes 
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3.6   Synthesis of α-Aryl Quaternary Proline Derivatives  
The deprotection of the oxyaminated product 157 may lead to the α-aryl quaternary 
proline derivative. Despite the importance of proline-based catalysts in organocatalysis, 
2-phenylprolinol has not yet been prepared enantiomerically pure because α-aryl 
proline derivatives are very difficult to synthesize in optically pure form. These 
reactions require stoichiometric amounts of the chiral proline sulfonamides 178 to give 
the α-aryl quaternary prolines 179 via rearrangement with partial racemization under 
anhydrous basic conditions using dimethylacetamide (DMA) as a solvent.[25] This 
methodology is limited only to electronically withdrawing groups at the 4-position of 
the aryl ring. (Scheme 3.18).  
 
Scheme 3.18: Rearrangement of proline sulfonamides 178   
The oxyaminated product 157 was exposed to the strong deprotection  reaction 
conditions. This allowed the rapid synthesis of (S)-2-phenylprolinol 181 by acidic 
cleavage of the tosylated derivative 157 to the isourea compound 180 followed by basic 
cleavage to the amino alcohol 181 (Scheme 3.19). Probably, due to the tetrasubstituted 
carbon atom in 157 and the related difficult accessibility, all other deprotection attempts 
were unsuccessful (Table 3.4).  
 
Scheme 3.19: Facile route to (S)-2-Phenylprolinol 181   
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Table 3.4: Deprotection attempts for substrate 157 leading to free amino alcohol moiety 
Entry Reagents for deprotection Result 
1 conc. H2SO4:H2O (1:1) 
microwave irradiation, 150 ºC, 10 min 
Decomposition 
 
2 conc. H2SO4:H2O (1:3) 
microwave irradiation, 150 ºC, 10 min 
Decomposition 
 
3 conc. H2SO4:H2O (1:1) 
microwave irradiation, 150 ºC, 5 min 
Decomposition 
 
4 conc. H2SO4:H2O (1:1) 
microwave irradiation, 100 ºC, 10 min 
Decomposition 
 
5 LiAlH4, rt, on No reaction 
6 LiAlH4, rt, sonication, 1 h No reaction 
7  2N KOH, reflux No reaction 
8 Sodium naphthalide[26] No reaction 
These results demonstrate the large potential of chiral hypervalent iodine reagents in 
oxyaminations in place of metal-based protocols together with a rapid access to unusual 
amino acid derivatives 181. To avoid the stoichiometric amounts of the chiral reagent, 
developement of the catalytic reaction is still a pormising area of research and more 
advancement in this field is required.  
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4.1   Introduction to Hypervalent Iodine Mediated Oxidative Rearrangements  
Organic molecules bearing hypervalent iodine moieties have stunned chemists over 
years owing to their mild and environmentally friendly reaction conditions by replacing 
toxic heavy metals. The plethora of reactions that can be performed with excellent 
yields and high selectivities has led to their recent renaissance in synthetic organic 
chemistry. The nature of hypervalent iodine compounds to react as electrophiles and 
then behave as excellent leaving groups make them highly suitable reagents for 
generating cationic intermediates which has been successfully exploited in the synthesis 
of many biologically important molecules. Their use in the Hoffmann-type 
rearrangement is already well established and the intermediate isocyanate has been used 
in the synthesis of  different heterocycles.[1]  
Treatment of styrene derivatives with hypervalent iodine compounds can lead to the 
formation of intermediates that can be stabilized by aryl substituent via phenonium ions 
followed by the attack of nucleophiles to give rearranged products. This strategy has 
been exploited in the efficient synthesis of isoflavones in a one-pot reaction.[2] Ring 
contractions of cycloalkenes have been a key rearrangement in synthetic organic 
chemistry. In this context, the role of hypervalent iodine reagents have been remarkable 
to furnish the biologically important molecules such as (±)indatraline.[3] On the other 
hand, further developments have been also made in the field of ring expansion reactions 
mediated by hypervalent iodine reagents giving rise to versatile ketones in high yields. 
A brief summary on the background of such oxidative rearrangements by hypervalent 
iodine reagents and the requirement for their stereochemical induction is given below. 
4.2   Hoffmann Rearrangements 
The conversion of aliphatic amides into amines with [bis(trifluoroacetoxy)iodo]benzene 
was the basis for the first Hoffmann rearrangement reported by Loudon and co-
workers.[4] Since then, various hypervalent iodine reagents have been applied in the 
conversion of versatile amides to amines. Tomasini et al. reported an efficient route for 
the transformation of protected asparagines 180 and glutamines 181 to imidazolidin-2-
one-4-carboxylates 182 and (tetrahydro)-pyrimidin-2-one-5-carboxylate 183 respectiv- 
ely in good yields by employing (diacetoxyiodo)benzene (Scheme 4.1).[5] 
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Scheme 4.1: Hofmann rearrangement of asparagine and glutamine derivatives mediated by 
hypervalent iodine reagents 
In 2009 Yanda et al. reported the tandem synthesis of functionalized indoles by 
(diacetoxyiodo)benzene mediated by Hoffmann-type rearrangement of 2-
alkynylbenzamides in excellent yields.[6] The reaction for the transformation of  
alkynylbenzylamides 184 to heteroaromatics 185 was initiated by 
(diacetoxyiodo)benzene to form an isocyanate intermediate, which cyclized 
intramolecularly to give 185 in the presence of platinum chloride as a catalyst (Scheme 
4.2). 
 
Scheme 4.2: (Diacetoxyiodo)benzene-mediated and Pt-catalyzed transformation of 
alkynylbenzylamides 184 to benzo-fused nitrogen heteroaromatic systems 185 
In 2007, Akamanchi et al. developed the oxidative transformation of primary 
carboxamides of type 186 to one-carbon dehomologated nitriles 189 via formation of 
Hoffmann-type isocyanate intermediate 188 in the presence of 2-iodoxybenzoic acid 
(IBX) and tetraethylammonium bromide (TEAB).[7] It was suggested that the reaction is 
initiated with the addition of TEAB to IBX followed by the formation of corresponding 
N-bromoamide 187 which on subsequent rearrangement forms the isocyanate 
intermediate 188. Further nucleophilic attack of IBA on the isocyanate followed by the 
decomposition of the intermediate gives rise to an imine, carbon dioxide and o-
iodobenzoic acid. The imine on further oxidation leads to the nitriles 189 in good yields 
(Scheme 4.3). 
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Scheme 4.3: Transformation of primary carboxamides 186 to dehomologated nitriles 189 
Moriyama et al. reported the in situ generation of the Koser's reagent from iodobenzene, 
p-toluenesulfonic acid and m-CPBA and employed it successfully in the Hofmann-type 
rearrangement of phthalimide 190 to the corresponding anthranilic acid derivatives 191 
in good yields.[8] The same approach was further extended for the synthesis of 
numerous β- and γ-amino acids 192 from aliphatic imides (Scheme 4.4). 
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Scheme 4.4: Hofmann-rearrangement of aryl imides 190 to anthranilic acid derivatives 191 
Zhankdin et al. reported the Hofmann rearrangement of aromatic and aliphatic 
carboxamides 193 using (tosylimino)-phenyl-λ3-iodane 194 as a hypervalent iodine 
reagent.[9] Such rearrangements results in complex reaction mixtures if other 
hypervalent iodine oxidants are used. In these reactions the isocyanate 195 intermediate 
was trapped by different alcohols to give the corresponding carbamates 196 in good 
yields. Later on, the same research group was successful in the development of a similar 
reaction in a catalytic manner in the presence of iodobenzene and a stoichiometric 
oxidant like oxone by using 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) in aqueous 
methanol as a solvent mixture  to give the carbamates of  type 198 (Scheme 4.5).[10] 
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Scheme 4.5: Conversion of carboxamides to carbamates 
4.3   Wagner-Meerwein Rearrangement 
The Wagner-Meerwein rearrangement is an acid catalyzed conversion of alcohols to 
olefins involving an 1,2-carbocation rearrangement. Recently, hypervalent iodine(III) 
reagents have been used to induce Wagner-Meewein rearrangements. In 2009, Canesi 
and co-workers developed an oxidative 1,2-alkyl shift on phenol derivatives 199. The 
reaction proceeded by the oxidation of phenols 199, using (diacetoxyiodo)benzene, to 
form a carbocation 200 (aromatic ring umpolung) followed by the 1,2-alkyl or aryl 
group migration. The rearranged products 201 were obtained in moderate yields 
(Scheme 4.6).[11]  
 
Scheme 4.6: Oxidative 1,2-alkyl shifts for phenolic substrates 199 mediated by 
(diacetoxyiodo)benzene 
A seminal approach was used for the oxidative 1,3-allyl shifts on the aromatic phenols 
of type 202 in the presence of (diacetoxyiodo)benzene by the same research group. The 
rearranged products 203 were isolated in good yields (Scheme 4.7). This approach was 
further extended for the synthesis of tricyclic and tetracyclic systems of alkaloids.[12] 
 
Scheme 4.7: Oxidative 1,3-alkyl shifts on phenolic substrates 202 mediated by 
(diacetoxyiodo)benzene via aromatic ring umpolung 
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4.4   Ring Contractions 
Ring contractions are useful rearrangements in organic chemistry because they provide 
molecular complexity in a single step with a high level of selectivity to obtain products 
that are not easily accessible from other approaches. Traditionally, ring contraction 
reactions are performed by the aid of acids, bases, metal-based oxidizers and 
photochemically.[13] In this context, various hypervalent iodine(III) reagents have been 
employed in ring contraction reactions as they provide mild and environmental friendly 
reaction conditions. 
In 1984, Daum et al. reported that the reaction of the androstan-3-one 204 with 
(diacetoxyiodo)benzene lead to a mixture of ring contraction products with 205 as major 
isomer obtained in 65% yield after recrystallization.[14] In the same year, Moriarty et al. 
developed the ring contraction of 3-cholestanone 206 in the presence of different 
iodine(III) reagents to give product 207 as a major isomer in 60% yield (Scheme 
4.8).[15] 
 
 
Scheme 4.8: Ring contractions of androstan-3-one 204 and 3-cholestanone 206 mediated by 
hypervalent iodine(III) reagents 
The ring contraction of flavanone 208 was described by Parkash and co-workers to give 
dihydrobenzofuran derivative 209 in up to 39% yield employing trimethyl orthoformate 
(TMOF) as a solvent.[16] The similar reaction was reinvestigated by Juhász who also 
assigned the relative configuration of the products (Scheme 4.9).[17,18]  
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Scheme 4.9: Ring contractions of flavanone 208 mediated by (diacetoxyiodo)benzene 
A more detailed discussion on the ring contraction reactions of cycloalkenes and 
cycloalkanones using iodine(III) reagents until 2006 can be found by the review article 
written by Silva.[3] Continuing further advancement in the field of ring contraction 
reactions by Justic et al. the conversion of 1-benzosuberone 210 to methyl 1,2,3,4-
tetrahydronaphthalene-1-carboxylate 212 was reported in 2007 by using a cyclic 
hypervalent iodine(III) reagent, 1H-1-hydroxy-5-methyl-1,2,3-benziodoxathiole 3,3-
dioxide 211 (HMBI). The rearranged product 212 was obtained in 88% yield (Scheme 
4.10).[19] 
 
Scheme 4.10: HMBI 211 mediated ring contraction. 
In 2007, Silva et al. utilized the ring contraction of 1,2-dihydronaphthalenes 213 in the 
stereoselective synthesis of (±)-indatraline 214a. The reaction proceeded in the presence 
of (hydroxytosyloxyiodo)benzene to give the product 214 in 62% yield which after 6 
steps of synthesis gave rise to the (±)-indatraline 214a. In 2011, the same research 
group developed the modified synthesis of indatraline 214a and its analogues using 
similar type of ring contraction approach.[20,21] Furthermore, synthesis of indanes 216 
through ring contraction of 1,2-dihydronaphthalenes 215 using Koser's reagent was also 
developed. Indanes 216 bearing different functional groups were synthesized by using 
different solvents such as methanol and 2,2,2-trifluoroethanol (TFE) resulting in 
dimethoxy 216a and bis-2,2,2-trifluoroethoxyacetals 216b respectively (Scheme 
4.11).[22]   
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Scheme 4.11: Ring contraction of 1,2-dihydronaphthalenes mediated by the Koser's reagent 
Very recently Silva and co-workers reported the Koser reagent-mediated ring 
contraction of 2,3-dihydrobenzo[b]oxepine 217 to hydroxyl functionalized chromane 
219 in 87% yield. It was suggested that the reaction proceeded through the formation of 
an oxonium ion of type 218 followed by an aryl bond migration and deprotonation to 
give the corresponding ketone which on reduction with sodium borohydride gave rise to 
the product 219 (Scheme 4.12).[23] 
 
Scheme 4.12: Ring contraction of 2,3-dihydrobenzo[b]oxepine mediated by the Koser's reagent 
4.5   Ring Expansions 
The Koser's reagent has been used in various oxidative rearrangements and 
fragmentations. One of the oxidative rearrangements induced by the Koser's reagent is a 
ring expansion reaction. In 2005, Koser and co-workers reported the ring expansion of 
alkylidenebenzocycloalkenes 220 to β-benzocycloalkenones 222 containing six-, seven- 
and eight-membered rings. A plausible mechanism for such transformations was found 
to be proceeded by the formation of a cationic intermediate 221 which was stabilised by 
an aryl bond migration followed by the attack of the methanol to give rise to the 
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corresponding ketal. Further hydrolysis of the ketal furnished the rearranged product 
222 in up to 99% yield (Scheme 4.13).[24]  
 
Scheme 4.13: Koser's reagent mediated ring expansion of alkylidenebenzocycloalkenes 220 
Hara and co-workers reported the deiodonative ring expansion of iodoalkyl bearing 
cyclic ethers 223 using (diacetoxyiodo)toluene. The reaction proceeded by the in situ 
oxidation of the iodine moiety, followed by the decomposition and nucleophilic attack 
of an acetoxy group to give rise to the ring expansion product 224 in up to 80% yield 
(Scheme 4.14) .[25] 
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Scheme 4.14: Deiodonative ring expansion of iodoalkyl cyclic ethers 223 
The ring expansion of 1-vinyltetralol derivative 225 using Koser's reagentwas explored 
by Silva and different rearranged ketones 226-228 were isolated under different reaction 
conditions (Scheme 4.15).[26] 
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Scheme 4.15: Koser's reagent mediated ring expansion of 1-vinyltetralol derivative 225. 
4.6   Rearrangement of Tertiary Alcohols 
An oxidative rearrangement of tertiary allylic alcohols to the corresponding carbonyl 
compounds is normally performed using organochromium chemistry. Iwabuchi and co-
workers reported the rearrangement of cyclic tertiary allylic alcohols 229 to β-
disubstituted ,β-unsaturated ketones 230 using 2-iodoxybenzoic acid 231 in up to 88% 
yield.[27] Vatèle et al. reported the oxidative rearrangement of acyclic allylic alcohols to 
β-disubstituted enones under Lewis-acidic conditions in the combination with 
iodosylbenzene and catalytic amounts of TEMPO.[28] Later on, Ishihara developed a 2-
iodoxybenzenesulfonic acid 232 catalyzed oxidative rearrangement of tertiary allylic 
alcohols  to enones with up to 85% yield in product 230 using oxone as an oxidant in 
the presence of potassium carbonate and tetrabutylammonium hydrogen sulfate 
(Scheme 4.16).[29] 
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Scheme 4.16: An oxidative rearrangement of tertiary allylic alcohols 229 to enones 230 
4.7   Domino Reactions 
In 2010, Kita et al. described an unexpected (diacetoxyiodo)benzene-mediated domino 
reaction of 1-(p-hydroxyaryl)cyclobutanols 233 to spiro cyclohexadienone lactones 235 
in 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) and water. It was suggested that the 
reaction proceeded via oxidation of the phenolic hydroxyl group followed by a 
rearrangement as shown in intermediate 234 to produce a spirodiene dione compound 
which on hydrolysis gave rise to the carboxylic phenol derivative. Now, intramolecular 
cyclization under oxidation conditions gives rise to the final product 235 in up to 77% 
yield (Scheme 4.17).[30] 
 
Scheme 4.17: An oxidative 1,3-alkyl shift mediated by (diacetoxyiodo)benzene 
4.8   1,2 Aryl Migrations 
The involvement of aryl moieties in cationic species was proposed by Cram,[31] which 
was further proven by different experimental, spectroscopic and computational 
methods.[32] Despite the discovery of phenonium ions a long time ago,[33] these ions 
have not been widely used in synthetic chemistry. In 2004, Yusubov and co-workers 
reported the oxidative rearrangement of α-substituted styrenes 236 to the corresponding 
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arylacetones 240 via migration of aryl functionality involving phenonium ions by using 
(diacetoxyiodo)benzene. It was suggested that the reaction was initiated with the 
activation of the double bond of styrene 236 by (diacetoxyiodo)benzene in the presence 
of methanol to form phenyliodinated intermediate 237, which was stabilized by the aryl 
substituent via the formation of phenonium ion intermediate 238. Furthermore, 
phenonium ion 238 was attacked by a nucleophile leading to the formation of another 
intermediate 239 via 1,2-aryl group migration, which on hydrolysis yielded the 
rearranged product 240 (Scheme 4.18).[34] 
 
Scheme 4.18: An oxidative 1,2 aryl-migration of styrenes 236 involving phenonium ions 
Wirth et al. accidently discovered the oxidative cyclization of 4-phenyl-4-pentenoic 
acid 241 occurring with a 1,2-migration of aryl groups mediated by hypervalent iodine 
reagents.[35] It was suggested that the reaction proceeded through the formation of 
phenonium ion intermediate 242 which gave rise to the product 243 on the attack of the 
acetoxy nucleophile. In this rearrangement reaction the generation of a tetrasubstituted 
stereogenic centre allowed the use of such substrates in asymmetric synthesis. When 
chiral hypervalent iodine reagent 244 was used in the rearrangement reaction, the 
migrated product 243 was obtained in 56% yield but with only 4% ee (Scheme 4.19). 
The authors suggested the reason of low enantioselectivities probably due to a fast 
reversible first addition step of the chiral iodine electrophile 244 to the alkene 241. 
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Scheme 4.19: An oxidative 1,2 aryl-migration mediated by hypervalent iodine(III) reagents. 
Later on the same research group reported the oxidative rearrangements of 4-arylbut-3-
enoic acids 245 to furanones 248. It was found that only the hypervalent iodine 
bistriflates, which were synthesized in situ by mixing iodine(III) reagent and 
trimethylsilyl triflate, had sufficient reactivity for this transformation. Mechanistic 
investigations and detailed calculations revealed that the migration of the aryl moiety 
was followed by a 1,2-hydride transfer as shown in intermediate 247 and elimination to 
yield furanones 248 (Scheme 4.20).[36]  
 
        
Scheme 4.20: An oxidative rearrangement of unsaturated acids 245 to furanones 248 
By calculations, a phenonium ion intermediate could not be located as a stable 
intermediate on the mechanistic pathway. This rearrangement did also not lead to any 
stereoselective product formation using chiral hypervalent iodine reagent 249 (Scheme 
4.20). 
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Recently, Zhao and co-workers reported an 1,2-aryl migration of N-methyl-N-
phenylcinnamides 250 to 3-arylquinolin-2-ones 252 using [bis(trifluoroacetoxy)iodo]-
benzene in the presence of a Lewis acid. It was found that the intermediate 251 was 
obtained after nuclephilic attack of the carbonyl oxygen on the iodine centre followed 
by ring closure and deprotonation. Then 1,2-aryl migration occurred by a concerted 
process followed by breakage of the O-I bond and further deprotonation to give rise to 
the rearranged product 252 in up to 90% (Scheme 4.21).[37] 
 
Scheme 4.21: PhI(OCOCF3)2-mediated rearrangement of N-methyl-N-phenylcinnamides 250 to 
3-arylquinolin-2-ones 252 
4.9   Summary 
The oxidative rearrangement reactions mediated by hypervalent iodine reagents provide 
mild reaction conditions to obtain important synthetic intermediates and naturally 
occurring compounds. Alkyl or aryl group migration under Hoffmann rearrangement, 
ring contraction and ring expansion reactions lead to valuable compounds. 
Stereoselective rearrangements mediated by chiral hypervalent iodine reagents 
involving aryl migrations were unsatisfactory. Further advancement in the field of 
asymmetric migration reactions is still missing in the literature. 
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5.1   Objectives 
The main objective of this work is to develop a stereoselective rearrangement reaction 
mediated by chiral hypervalent iodine reagents. Keeping in mind the long history of 
oxidative rearrangements induced by hypervalent iodine reagents, no efficient 
stereoselective method has been developed with chiral hypervalent iodine reagents for 
rearrangement reactions. Therefore, the use of chiral hypervalent iodine reagents in 
asymmetric rearrangement reactions seems to be a very promising area of research.   
5.2   Project Approach 
The project approach starts with the synthesis of aryl-substituted ketones. These 
chalcones of type 253 can easily be accessible through an aldol condensation between 
methyl ketones and aryl aldehyde. The oxidative rearrangement of such compounds in 
the presence of alcohol nucleophiles mediated by hypervalent iodine reagents is already 
known in the literature and it leads to the α-arylated and β-oxygenated carbonyl 
compounds.[1] The reaction proceeds through the activation of aryl-substituted alkenes 
253 with electrophilic chiral iodine reagents resulting in the formation of 
phenyliodinated intermediates which are stabilized by the migration of an aryl group 
followed by the reaction with a second alcohol nucleophile to give the 1,2 migration 
products 254 with a new stereogenic centre (Scheme 5.1). Stereoselective 
rearrangement reactions mediated by chiral hypervalent iodine reagents are not known 
in the literature. Inspired by our previous results, the use of lactate-based chiral 
hypervalent iodine reagents will be examined in oxidative migration reactions to make 
this reaction enantioselective. 
 
Scheme 5.1: Rearrangement of 253 to 254 via aryl-migration using chiral hypervalent iodine 
reagents Ar*IL2 
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5.3   Synthesis of Chalcones 253 
We have investigated chalcones 253 for the oxidative rearrangement reactions induced 
by different hypervalent iodine(III) reagents. The chalcones 253 were synthesized 
effeciently by aldol condensation in the presence of sodium hydroxide between the 
corresponding aryl ketones and aldehydes.  
 
Table 5.1: Synthesis of chalcone derivatives 253a-k 
Entry R Ar Product Yield [%] 
1 Ph Ph 253a: 51 
2 Ph 4-F-C6H4 253b: 62 
3 Ph 4-Cl-C6H4 253c: 92 
4 Ph 4-Br-C6H4 253d: 61 
5 Ph 4-NO2-C6H4 253e: 79 
6 Ph 4-Me-C6H4 253f: 82 
7 Ph 4-iPr-C6H4 253g: 82 
8 Ph 4-tBu-C6H4 253h: 69 
9 Ph 3-Me-C6H4 253i: 79 
10 Ph 4-OMe-C6H4 253j: 32 
11 2-furyl Ph 253k: 48 
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5.4   Initial Rearrangement Reactions of 253a 
Initially the reaction of (E)-1,3-diphenylprop-2-en-1-one 253a with only 
(diacetoxyiodo)benzene [PhI(OAc)2] was investigated, but its reactivity was too low 
and no conversion into the rearranged product 254a was observed (Scheme 5.2).  
 
Scheme 5.2: (Diacetoxyiodo)benzene induced migration attempt 
Traditionally, hypervalent iodine mediated migration reactions are performed in the 
presence of Brønsted acids. The literature suggests that the activation of the hypervalent 
iodine(III) reagent by the addition of H2SO4 may result into more electrophilic 
intermediates A-C in situ which can act as better reagents for rearrangement reactions 
(Fig. 5.1).[1,2] 
 
Fig. 5.1: Activation of PhI(OAc)2 with H2SO4  
When (diacetoxyiodo)benzene was reacted with the chalcone 253a in combination with 
50% aq. H2SO4 as an activator, the reaction proceeded well and the rearranged product 
254a was obtained in 64% yield. While using [bis(trifluoroacetoxy)iodo]benzene as 
iodine(III) source, the yield increased to 82% (Scheme 5.3).  
 
Scheme 5.3: Iodine(III) mediated migration reactions in the presence of H2SO4  
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As a new stereogenic center is established in the product 254a, lactic acid-based chiral 
hypervalent iodine compounds 142 and 144 were synthesized according to the known 
literature method (Fig. 5.2).[3,4]  
 
Fig. 5.2: Lactate acid-based chiral hypervalent iodine(III) reagents 
These chiral hypervalent iodine reagents were then investigated for the asymmetric 
migration reaction of 253a in the presence of 50% aq. H2SO4. The reaction proceeded 
slowly and the rearranged product 254a was obtained in low yields and with poor 
enantioselectivities (Table 5.2, entries 1 and 2). Inspired by the successful activation of 
hypervalent iodine compounds with Lewis acids in the asymmetric aminohydroxylation 
of alkenes in which NMR studies proved that the addition of tert-butyldimethylsilyl 
triflate (TBDMSOTf) or trimethylsilyl triflate (TMSOTf) to the corresponding 
(diacetoxyiodo)arenes generates in situ the more reactive ArI(OTf)2.[5] Therefore, a 
similar approach was investigated in these migration reactions. When the reaction was 
performed with (diacetoxyiodo)benzene in the presence of tert-butyldimethylsilyl 
triflate (TBDMSOTf), the reaction product was obtained in 37% yield (Table 5.2, entry 
3). Unfortunately, when chiral reagents 142 was reacted, there was either no reaction at 
low temperatures or only racemic product after increasing the temperature was obtained 
by using tert-butyldimethylsilyl triflate (TBDMSOTf) in MeOH (Table 5.2, entries 4 
and 5).  
 
Table 5.2: Different hypervalent iodine reagents for the migration of 253a to 254a 
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Entry Reagents  Conditions 254a Yield 
[%] 
254a ee 
[%] 
1 1.15 equiv 144, 1.4 equiv 50% H2SO4, 
MeOH 
rt, 2 h 4 17 
2 1.15 equiv 142, 1.4 equiv 50% H2SO4, 
MeOH 
rt, 20 h 5 5 
3 1.2 equiv PhI(OAc)2, 1.4 equiv TBDMSOTf 
MeOH 
0 ºC to rt, 14 h 37 - 
4 1.5 equiv 142, 3 equiv TBDMSOTf, MeOH –78 ºC, 12 h - - 
5 1.5 equiv 142, 3 equiv TBDMSOTf, MeOH –78 ºC to rt,12h 50 0 
Previous investigations for aminohydroxylation of alkenes indicated that the solvent is 
crucial in an efficient stereochemical induction mediated by chiral hypervalent  
iodine(III) reagents. The selection of the appropriate solvent was indispensable for 
efficient conversions and selectivities. Therefore, a combination of different solvents 
were investigated in this rearrangement reaction to improve the enantioselectivites. 
Mixtures of methanol and dichloromethane did not improve the enantiomeric excess in 
254a (Table 5.3, entry 1). However, when the initial synthesis of the highly electrophilic 
hypervalent iodine reagent Ar*I(OTf)2 by prior mixing of the chiral hypervalent 
diacetoxyiodo derivative Ar*I(OAc)2 with TBDMSOTf in dichloromethane at –78 oC is 
followed by the addition of methanol along with starting material 253a, the rearranged 
product 254a was obtained with improved enantioselectivities (Table 5.3, entry 2). 
When the reaction temperature was kept at –15 oC, the enantioselectivity rose to a 
promising level of 86% (Table 5.3, entry 3). Also other Lewis acids have been utilized 
in the migration reaction in combination with different solvents and chiral hypervalent 
iodine reagents. When boron trifluoride diethyl etherate (BF3·OEt2) was utilized in the 
migration reaction, the enantioselectivities dropped to 24% ee (Table 5.3, entry 4). 
Other Lewis acids like trimethylsilyl triflate (TMSOTf) and BF2OTf·OEt2 (which is 
prepared by a 1:1 mixture of TMSOTf and BF3·OEt2 and is known as a more powerful 
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Lewis acid than its components)[6] also gave a high enantiomeric excess (Table 5.3, 
entries 5 and 7). When triflic acid was employed in this rearrangement reaction, the 
selectivities were increased to 92% ee in different solvents (Table 5.3, entries 8 and 9). 
All the results described in Table 5.3 were carried out on a sub-millimolar scale (0.033 
mmol) and the product 254a was purified using preparative TLC.  
 
Table 5.3: Conditions for the stereoselective rearrangement of 253a to 254a 
Entry Reagents[a] Solvent 254a ee[%] 
1 142, TBDMSOTf[b] CH2Cl2:MeOH (1:1) 12 
2 142, TBDMSOTf[b] CH2Cl2, 10 equiv MeOH 43 
3 142, TBDMSOTf CH2Cl2, 8 equiv MeOH 86 
4 142, BF3·OEt2 CH2Cl2, 8 equiv MeOH 24 
5 142, TMSOTf CH2Cl2, 8 equiv MeOH 88 
6 144, TMSOTf CH2Cl2, 8 equiv MeOH 12 
7 142, BF2OTf·OEt2[c] CH2Cl2, 8 equiv MeOH 89 
8 142, TfOH CH2Cl2, 8 equiv MeOH 91 
9 142, TfOH CH3CN, 8 equiv MeOH 92 
[a] 1.5 equiv 142 and 144, 3 equiv Lewis acid, reaction temperature –78 ºC to –15º C, reaction 
time 14 h. [b] Reaction temperature –78 ºC to rt, reaction time 14 h. [c] Prepared by a 1:1 
mixture of TMSOTf and BF3·OEt2.  
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To check the percentage conversion of the chalcone 253a into the rearranged product 
254a over time, a 1H NMR experiment was performed. The reaction was executed in the 
presence of triflic acid as a Lewis acid and dichloromethane and methanol (8 equiv) as 
solvents. For the close monitoring of the experiment, crude samples were taken after 
some time over different temperatures and these samples were filtered over silica 
followed by 1H NMR analysis. Two peaks were analyzed in this experiment, a doublet 
at 7.82 ppm (J = 15.7 Hz, 1H) corresponds to the Ha in the starting material and a 
doublet at 5.13 ppm (J = 8.5 Hz, 1H) corresponds to the Hb in the product. From the 
integration values of these doublets in the 1H NMR spectrum, percentage conversion of 
the chalcone 253a into the rearranged product 254a was calculated. It was revealed 
from these calculations that the maximum conversion of only 28.5% is obtained over 22 
hours (Fig. 5.3). These crude samples were also purified by preparative TLC to check 
the enantiomeric excess  which was found to be constant over the course of the reaction 
(ca. 85% ee), indicating no further interaction of the chiral reagent 142 with the product 
254a. 
 
Fig. 5.3: 1H NMR monitoring of the migration reaction over the course of time 
The 1H NMR experiment revealed the poor conversion of the starting material 253a into 
the product 254a. Therefore, further investigation of the reaction conditions to improve 
the yields and enantioselectvities by changing either the nucleophiles or the solvents 
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was carried out. The use of 2,2,2- trifluoroethanol (TFE) as a solvent in the oxidation of 
phenols mediated by hypervalent iodine reagents is quite unique.[7] The high ionizing 
power, low nucleophilicity and excellent hydrogen-bond donor abilities of this 
fluoroalcohol dramatically direct the course of reaction in many organic 
transformations. These properties have been successfully utilized in stabilizing the 
reactive cationic intermediates such as 255 and 256 generated by iodine(III) reagents in 
the oxidation of phenolic derivatives and single-electron-transfer (SET) oxidation of 
aromatic compounds respectively (Scheme 5.4). 
 
Scheme 5.4: Role of 2,2,2-trifluoroethanol in stabilizing cationic intermediates 255 and 256 
To see the effect of TFE in the migration reaction, an 1:1 mixture of dichloromethane 
and 2,2,2-trifluoroethanol in the presence of triflic acid together with chiral hypervalent 
iodine reagent 142 and 8.0 equivalents of methanol was tried over sub-millimolar scale. 
The reaction resulted in a mixture of the dimethoxy acetal 254a (95% ee) and the 
bis(trifluoroethoxy)acetal 254a' (99% ee) with very high enantioselectivities (Scheme 
5.5). 
 
Scheme 5.5: Rearrangement reaction of 253a in the presence of 2,2,2-trifluoroethanol 
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When the reaction was performed without the addition of methanol and by using only a 
1:1 mixture of dichloromethane and 2,2,2-trifluoroethanol with triflic acid as Lewis 
acid, a yield of 66% of the product 254a' with moderate selectivity of 69% ee. By 
employing TMSOTf as the Lewis acid for chiral iodine(III) reagent 142 activation, the 
asymmetric induction was found to be excellent, giving the product 254a' in 97% ee 
with 59% yield (Scheme 5.6). 
 
Scheme 5.6: Rearrangement reaction of 253a in the presence of 2,2,2-trifluoroethanol behaving 
as a solvent and a nucleophile leading to the product 254a' 
The structure of the rearranged product 254a' was further confirmed by X-ray 
crystallography.[13] The absolute stereochemistry of the product 254a' could not be 
determined based on the X-ray structure because of the absence of heavy atoms like 
sulfur, chlorine, bromine etc. in the molecule which are necessary to show the high 
anomalous dispersion effect (Fig. 5.4). 
 
Fig. 5.4: X-ray structure of rearranged product 254a' 
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5.5   Mechanistic Insight of the Rearrangement Reaction 
Aryl ketones also have the potential to migrate under Lewis acidic reaction conditions. 
This was demonstrated in a recent publication that an aryl ketone 257 migrates in a 
boron trifluoride catalyzed epoxide opening reaction giving the tetrasubstituted 
aldehyde 258 in optically pure form in 95% yield (Scheme 5.7).[8] 
 
Scheme 5.7: Migration potential for aryl ketones 257 under Lewis acidic conditions 
Therefore, to confirm that the reaction mechanism proceeds with aryl ring migration, 
the deuterium-labelled compound 253l was synthesized from aldol condensation 
between acetophenone and the corresponding deuterium-labelled benzaldehyde in 60% 
yield (Scheme 5.8). 
 
Scheme 5.8: Synthesis of deuterium-labelled chalcone 253l with aldol condensation reaction 
When the compound 253l was treated with PhI(OTf)2 which was synthesized in situ by 
mixing PhI(OAc)2 together with TfOH, the phenyl ring migrated product 254l was 
obtained exclusively alongside unreacted starting material 253l. The product 254l', 
which would result from an aryl ketone migration was not observed in this reaction. A 
plausible mechanism is depicted below which starts with the activation of  the double 
bond with electrophilic hypervalent iodine(III) followed by first nucleophilic attack of 
the CF3CH2OH to give rise to the phenyl iodinated intermediate A. Now this 
intermediate A can be stabilised by the phenonium ion to give rise to the intermediate 
B.[9] The hyper-leaving ability of the hypervalent iodine moeity in the intermediate A is 
the driving force for this transformation as it is attached to an sp3-hybridized carbon  
atom making it an excellent leaving group.[10] Finally the intermediate B is further 
attacked by the other fluoroalcohol nucleophile and it rearranges to give the product 
254l in 52% yield (Scheme 5.9).      
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Scheme 5.9: Deuterium-labelling to prove the reaction proceedings via phenyl ring migration  
5.6   Substrate Scope 
To investigate the substrate scope, many different chalcones 253b-k were exposed to 
the standardized reaction conditions. When the substrates 253b-e with electronically 
withdrawing groups at the 4-position of the aryl moiety were allowed to react under 
migration reaction conditions, an interesting trend in the yields was observed. The 
yields decrease with an increase in the Hammett value of the halide substituents from σp 
= 0.06 (F) to σp = 0.23 (Br) (Table 5.4, entries 2, 4 and 6). With the 4-nitro substituted 
chalcone 253e (σp = 0.78), the starting material was completely recovered and no 
rearrangement took place (Table 5.4, entry 8).[ 11 ] The enantioselectivities remained 
higher with substrates 253b when TMSOTf was employed as a Lewis acid (Table 5.4, 
entry 2) but when TfOH was utilized, enantioselevtivities dropped to 69% ee (Table 5.4, 
entry 1). The rearranged products were also synthesized as racemates by using 
(diacetoxyiodo)benzene [PhI(OAc)2] as an iodine(III) reagent on a small scale to serve 
as a reference for the determination of enantioselectivity on HPLC (Table 5.4, entries 3, 
5 and 7).   
 
Table 5.4: Electronically withdrawing groups at para-position of migrated aryl ring 
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Entry 
 
Substrate 
 
Product 
 
Reagents 
 
Yield 
[%] 
 
ee 
[%] 
 
 
 
1 
 
 
253b 
 
254b 
 
 
 
142, TfOH 
 
 
60     
 
 
69         
 
2 
 
253b 
 
 
254b 
 
142, TMSOTf 
 
50 
 
94 
 
3 
 
 
253b 
 
254b 
 
PhI(OAc)2 
TMSOTf 
 
 
30[a] 
 
- 
 
 
 
4 
 
 
253c 
 
254c 
 
 
142, TMSOTf 
 
 
38 
 
 
92 
 
5 
 
253c 
 
254c 
 
PhI(OAc)2 
TMSOTf 
 
 
32[a] 
 
- 
 
 
 
6 
 
 
253d 
254d 
 
 
142, TMSOTf 
 
 
17 
 
 
91 
 
7 
 
 
253d 
 
254d 
 
PhI(OAc)2 
TMSOTf 
 
 
23[a] 
 
- 
 
 
8 
 
 
253e 
 
254e 
 
 
 
PhI(OAc)2 
TMSOTf 
 
 
0 
 
 
- 
[a] Reaction was performed on sub-millimolar scale at 0 oC for 2 h and purified by preparative 
TLC.  
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The absolute configuration of the major isomer of 254c and 254d was found to be R by 
anomalous dispersion scattering, and the refined Flack parameters[12] were 0.17(16) and 
0.00(4), respectively, as determined by X-ray crystallography.[13] The X-ray structures 
of these isomers are shown below (Fig. 5.5).  
O
O
O
Cl
CF3
CF3
O
O
O
Br
CF3
CF3
254c 254d
 
Fig. 5.5: X-ray structure of major enantiomers of rearranged products 254c and 254d 
The general trend in the yield for the products 254b-e with electron-withdrawing groups 
at the 4-position of the aryl moiety demonstrates the reactivity patterns of the substrates 
253. It is evident from the experimental findings that if the alkene is more electron 
deficient because of electron-withdrawing substituents on the aryl ring B (Fig. 5.6), the 
electrophilic addition of the iodine(III) reagent to the alkene is slower and this results in 
lower yields of the migrated products. Especially, in the case of substrate 253e, there 
was no reactivity even under achiral reaction conditions (Table 5.4, entry 8).       
 
Fig. 5.6: Substituents effects on reactivity of the chalcones 253 
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When compounds 253 with electron-donating substituents on the aryl moiety were 
subjected to the rearrangement reaction conditions, products 254 were obtained in high 
yields and selectivities (Table 5.5, entries 1 and 4). Unfortunately, compounds 253 with 
a 4-tert-butyl (253h) and a 3-methyl substituent (253i) resulted in products 254h and 
254i with only moderate selectivities (Table 5.5, entries 6 and 8). Compound 253j with 
a 4-methoxy substituent led to complete decomposition under different reaction 
conditions (Table 5.5, entry 10). From these results it is obvious that both steric and 
electronic parameters from substituents in the para-position are strongly influencing the 
yield and selectivity of the reaction. 
 
Table 5.5: Electron-donating groups on the migrated aryl ring 
 
Entry 
 
Substrate 
 
Product 
 
Reagents 
 
Yield [%] 
 
ee 
[%] 
 
 
 
 
 
1 
 
 
 
 
253f 
 
 
254f 
 
 
 
142 
TMSOTf 
 
 
 
80 
 
 
 
86 
 
2 
 
253f 
 
 
254f 
 
142, TfOH 
 
92 
 
66 
 
3 
 
 
253f 
 
254f 
 
PhI(OAc)2 
TMSOTf 
 
 
80[a] 
 
- 
 
 
 
4 
 
 
 
253g 
 
254g 
 
 
142 
TMSOTf 
 
 
68 
 
 
89 
 
5 
 
 
253g 
 
254g 
 
PhI(OAc)2 
TMSOTf 
 
 
30[b] 
 
- 
79 
 
 
 
6 
 
 
253h 
 
254h 
 
 
 
142 
TMSOTf 
 
 
65 
 
 
52 
 
 
 
 
 
 
7 
 
253h 
 
254h 
 
 
PhI(OAc)2 
TMSOTf 
 
 
23[b] 
 
- 
 
 
8 
 
253i 
 
 
254i 
 
 
 
142 
TMSOTf 
 
 
42 
 
 
53 
 
9 
 
 
253i 
 
254i 
 
PhI(OAc)2 
TMSOTf 
 
 
50[b] 
 
- 
 
 
 
 
10 
 
 
 
 
253j 
 
254j 
 
 
 
PhI(OAc)2 
TMSOTf 
 
 
 
decomposition    
 
 
-        
[a] Reaction was performed on a millimolar scale and column chromatography was performed 
for purification. [b] Reaction was performed on sub-millimolar scale at 0 oC for 2 h and purified 
by preparative TLC.  
The absolute configuration for the products 254f-i were assigned in an analogy to the 
rearranged products 254c and 254d. It is evident from the results in the Table 5.5 that 
electron donating groups on the aryl ring B (Fig. 6) make the electrophilic addition of 
the iodine(III) reagent to the alkene faster resulting in higher yields of the migrated 
products. Especially, in the case of substrate 253j,  the substrate was so reactive that it 
resulted in the decomposition and no rearranged product 254j was isolated (Table 5.5, 
entry 10).  
The optimized reaction conditions were then applied to different alkenes. The 
heteroaromatic compound 253k was synthesized from the aldol condensation (Table 
5.6, entry 1) and the substrates 253m and 253n were purchased from commercially 
available sources. When heteroaromatic compound 253k, the cinnamyl ester substrate 
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253m and the methyl-substituted ketones 253n were exposed to the reaction conditions, 
they underwent the rearrangement reaction with high enantioselectivities, but only gave 
the reaction products 254 in low yields (Table 5.6, entries 1, 3 and 5). Further 
optimization of the reaction in the presence of the chiral reagent  for these substrates is 
necessary to increase yields. The reaction resulted in moderate to poor yields while 
using [PhI(OAc)2] as an electrophillic iodine(III) source (Table 5.6, entry 2, 4 and 6). 
The absolute configuration for the products 254k, 254m and 254n were assigned in an 
analogy to the rearranged products 254c and 254d. The enantiomers of the rearranged 
product 254n were inseparable on the chiral HPLC but the product was found to be 
optically active in the polarimeter analysis suggesting that the reaction proceeded in  
enantioselective manner (Table 5.6, entry 5).  
 
Table 5.6: Different unsaturated carbonyl compounds for the migration reaction 
 
Entry 
 
Substrate 
 
Product 
 
Reagents 
 
Yield [%] 
 
ee [%] 
 
 
 
 
 
1 
 
 
 
253k 
 
 
254k 
 
 
 
142, TMSOTf 
 
 
8     
 
 
83         
 
2 
 
 
253k 
 
254k 
 
PhI(OAc)2 
TMSOTf 
 
 
25[a] 
 
- 
 
 
 
3 
 
 
253m  254m 
 
 
142, TMSOTf 
 
 
12 
 
 
96 
 
4 
 
 
253m 
 
254m 
 
PhI(OAc)2 
TMSOTf 
 
 
52[a] 
 
- 
 
 
 
81 
 
 
 
 
5 
 
 
253n  254n 
 
142, TMSOTf 
 
10 
 
-
[b]
 
 
6 
 
 
253n 
 
254n 
 
PhI(OAc)2 
TMSOTf 
 
 
26[a] 
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 [a] Reaction was performed on sub-millimolar scale at 0 oC for 2 h and purified by preparative 
TLC. [b] The enantiomers were inseparable on the chiral HPLC. 
We also investigated the compound 253o in an attempt to generate quaternary carbon 
centers in this process. The compound 253o was synthesized by indium(III) catalyzed 
coupling reaction between 1-phenyl-1-propyne and benzaldehyde in 85% yield.[ 14 ] 
When the substrate 253o was exposed to the asymmetric reaction conditions by 
employing 142 as a iodine(III) chiral source, no rearranged product was observed, but 
the reaction proceeded by using (diacetoxyiodo)benzene and TMSOTf as an activating 
reagent to give the expected rearranged product 254o in 48% yield. This reactivity 
pattern could be because of the fact that the chiral reagent Ar*I(OTf)2, 142 was not 
reactive enough to activate the methyl-substituted double bond in the substrate 253o 
resulting in no reactivity (Scheme 5.10). 
 
 
Scheme 5.10: Synthesis and migration of the substrate 253o to generate a quaternary carbon 
centre 
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To investigate the reactivity of (Z)-chalcones 253 towards migration reaction, 
photoisomerization of (E)-253a was performed leading to an inseparable mixture of (E)-
253a and (Z)-253a (1:1) isomers, which was further crystallized to obtain a mixture of 
(E)-253a and (Z)-253a (4:10).[15] When this mixture was subjected to the rearrangement 
reaction conditions using reagent 142, product 254a' was obtained in 31% yield and 
with 55% ee. The recovered starting material 253a showed an altered E/Z ratio of about 
10:2 (determined by 1H NMR studies). This indicates that (Z)-253a reacts much faster 
than (E)-253a, but the enantiomeric excess obtained in the product 254a' is lower 
(Scheme 5.11).  
 
 
Scheme 5.11: Photoisomerization of chalcone 253a and its reactivity in migration reaction  
Hypervalent iodine mediated ring contraction reactions have been known for a while but 
the enantioselective version of such rearrangements is not yet reported.[16] In 2007, 
Silva et al. reported the ring contraction of 1,2-dihydronaphthalenes 213 induced by the 
Koser reagent leading to the synthesis of (±)-indatraline 214a over 6 steps. The 
synthesis of indanes 216 through ring contraction of 1,2-dihydronaphthalenes 215 using 
Koser reagent was also developed. Further functionalization of these compound 216 can 
lead to the synthesis of compounds of biological importance.[ 17 ] Therefore, ring 
contraction reactions of these derivatives in the presence of 142 have also been 
performed using this method. When compound 215 was subjected to the rearrangement 
reaction conditions, rearranged product 216b was obtained in 59% ee. The selectivity 
was improved at lower temperature to 70% ee but with decreased yields. Unfortunately, 
substrate 213 gave a very low selectivity in product 214 when methanol was used as a 
nucleophile. The use of 2,2,2-trifluoroethanol in this ring contraction reaction resulted 
in a complex mixture of products (Scheme 5.12). 
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Scheme 5.12: Ring contractions of tetralone derivatives 
In conclusion, we have developed an efficient and highly stereoselective method for the 
α-arylation of a wide range of carbonyl compounds by an oxidative rearrangement 
procedure. These results are noteworthy as they are the first examples of chiral 
hypervalent iodine(III) reagents in highly stereoselective rearrangement reactions. 
Further investigations for developing a catalytic reaction and for the synthesis of 
enantiomerically enriched building blocks using this approach are currently in progress. 
5.7   Further Functionalization of the Rearranged Products  
Compound 254a' was reduced with sodium borohydride to obtain 259 as a major 
diastereomer as determined by the 1H NMR analysis. The corresponding alcohol was 
obtained in 98% yield (Scheme 5.13). Products of these type are versatile building 
blocks for further manipulations. Moreover, this asymmetric method allowed the 
synthesis of fluorinated acetals, which have many applications in biological chemistry 
and industry.[18] 
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Scheme 5.13: Reduction of the carbonyl moiety in 254a' 
The bis(trifluoroethoxy)acetal in 254a' can also be cleaved to obtain an aldehyde. 
Indium triflate(III) is known as an efficient catalyst for the deprotection of a wide range 
of acetals and ketals.[19] Therefore, many different reaction conditions were tried by 
employing catalytic amounts of indium triflate(III) to cleave the 
bis(trifluoroethoxy)acetal in 254a' to give an aldehyde. These reactions (Table 5.7, 
entries 1, 2, 3 and 4) resulted in no reactivity and no aldehyde 260 was obtained 
probably because of the fact that bis(trifluoroethoxy)acetals are too electron poor to be 
coordinated with indium. Acid mediated cleavage of the bis(trifluoroethoxy)acetal in 
254a' was also unsuccessful and it gave the product 261 with full conversion (Table 5.7, 
entries 7 and 8). However, when iodine was used as a catalyst in the cleavage of 
dimethoxy acetal of 254a, the reaction proceeded with a mixture of products along with 
traces of the aldehyde 260 (Table 5.7, entry 10). Unfortunately compound 254a' showed 
no reactivity towards the catalytic use of the iodine for the bis(trifluoroethoxy)acetal 
cleavage (Table 5.7, entry 11).  
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Table 5.7: Reaction conditions for the cleavage of acetals 
Entry Substrate Conditions 260 261 
1 254a' 10 mol % In(OTf)3, MeOH, rt, o.n 0 0 
2 254a' 10 mol % In(OTf)3, acetone, Microwave 
(M. W) 100 oC, 10 min 
0 0 
3 254a' 10 mol % In(OTf)3, MeOH, M. W. 100 
oC, 10 min 
0 0 
4 254a' 10 mol % In, acetone, reflux, 6 h 0 0 
5 254a' 10 mol % In, acetone, conc. HCl, reflux, 
6 h 
0 0 
6 254a' conc. HCl:H2O (1:1), reflux, 14 h 0 0 
7 254a' conc. HCl:MeOH (1:1), M. W. 100 oC, 
15 min 
0 Complete 
conversion 
8 254a' TsOH (1.0 equiv), M. W. 100 oC, 15 min 0 Complete 
conversion 
9 254a cat. TsOH, acetone, rt, 6 h 0 Complete 
conversion  
10 254a cat. I2, acetone, rt, 6 h Traces, mixture 0 
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of products 
11 254a' cat. I2, acetone, rt, 6 h 0 0 
The deprotection of the acetals to obtain the aldehyde 260 remains a challenge in our 
experiments. These electron poor acetals are not very easy to be cleaved because of 
their lack of nucleophilicities in the coordination with Lewis acids like indium 
triflate(III) or their capabilities to be protonated under acidic conditions. Further 
investigations for developing a catalytic reaction and for the synthesis of 
enantiomerically enriched building blocks using this approach are still missing. 
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Experimental 
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6.1   General Methods 
The reactions were carried out using standard laboratory equipment. Air and/or moisture 
sensitive experiments were performed under an inert atmosphere of argon and with 
flame dried glassware. All reactions were stirred by magnetic stirring and when needed 
warmed to defined constant temperatures by hotplates with temperature probe control in 
dry heating blocks or silicon oil baths. Reactions performed at low temperatures were 
stirred in reaction vessels in a dry ice/diethylether/liquid nitrogen (–100 oC), dry 
ice/acetone bath (–78 °C), acetone/liquid nitrogen bath (–50 °C and –40 °C), ice/NaCl 
bath (–15 °C), or ice/water (0 °C) or a chiller (0 oC to –40 oC). Rotary evaporators 
Büchi B-461, B-481 or B-490 were used for solvent evaporations (reduced pressure to 
15 mbar); further drying was undertaken by the use of a high vacuum apparatus. A 
Büchi GKR-50 Kugelrohr distillation apparatus was employed for Kugelrohr 
distillations. For inert reactions, freshly over drying agents and under inert atmosphere 
distilled anhydrous solvents were used. Other chemicals were purchased from Acros, 
Aldrich, Alfa Aesar or Fluka and were used without further purification, except if 
indicated otherwise in the experimental procedure. 
6.2   Chromatographic Methods 
6.2.1  Thin Layer Chromatography 
All reactions were monitored by thin-layer chromatography (TLC) which was 
performed on precoated aluminium sheets of Merck silica gel 60 F254 (0.20 mm) and 
visualised by UV radiation or by staining with ceric ammonium molybdate solution 
(235 ml distilled H2O, 12 g ammonium molybdate, 0.5 g ceric ammonium molybdate, 
15 ml concentrated sulfuric acid), potassium permanganate solution (1.5 g KMnO4, 10 g 
K2CO3, 1.25 ml 10% NaOH, 200 ml distilled H2O) or iodine.  
6.2.2  Column Chromatography 
Column chromatography was performed with silica gel 60 (Merck, 230-400 mesh) 
under increased pressure (Flash Chromatography) or as gravitational column 
chromatography. The used eluting solvents are indicated in the text. 
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6.2.3  High Pressure Liquid Chromatography (HPLC) 
For HPLC measurements was used an arrangement from Shimadzu. The Shimadzu 
Class VP consisted of SIL-10ADVP (auto injector), LC-10 ATVP (liquid 
chromatograph), FCV-10ALVP (pump), DGU-14A (degasser), CTO-10ASVP (column 
oven), SCL-10AVP (system controller) and a SPD-M10A (diode array detector). The 
only solvents used were hexane and 2-propanol (both of HPLC grade purity, Fisher 
Scientific). Analytical chiral columns Chiracel® OD (0.46 cm Ø x 25 cm), Chiracel® 
OD-H (0.46 cm Ø x 25 cm), Chiracel® OB-H (0.46 cm Ø x 25 cm), Chiracel® AD 
(0.46 cm Ø x 25 cm) were used for separation of enantiomers at solvent flow rates of 
0.5 ml/min. 
6.3   Physical Data 
6.3.1  1H NMR Spectroscopy 
Bruker DPX 600 (600 MHz), Bruker DPX 500 (500 MHz), Bruker DPX 400 (400 
MHz), Bruker DPX 250 (250 MHz) or Oxford 300. The chemical shifts δ are given in 
ppm downfield of tetramethylsilane (δ = 0 ppm). Compounds and crude reaction 
mixtures are dissolved in either deuterated chloroform, deuterated acetone or deuterated 
dimethylsulfoxide. Coupling constants (J) are given in Hertz. The multiplicity of signals 
is designated: s = singlet:, d = doublet, t = triplet, q = quartet, quin = quintet, dt = 
doublet of triplets, td = triplet of doublets, m = multiplet. Residual solvent peaks are 
assigned as follows: 7.26 ppm for chloroform, 2.54 ppm for dimethylsulfoxide, 2.05 
ppm for acetone.  
6.3.2  13C NMR Spectroscopy 
Bruker DPX 600 (150 MHz), Bruker DPX 500 (125 MHz), Bruker DPX 400 (100 
MHz), Bruker DPX 250 (62.5 MHz) The chemical shifts δ are given in ppm downfield 
of tetramethylsilane (δ = 0 ppm). Compounds and crude reaction mixtures are dissolved 
in either deuterated chloroform, deuterated acetone or deuterated dimethylsulfoxide. 
Residual solvent peaks are assigned as follows: 77.36 ppm for chloroform, 40.45 ppm 
for dimethylsulfoxide, 29.84 ppm and 206.26 ppm for acetone.  
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6.3.3  Mass Spectrometry 
Swansea: LTQ Orbitrap XL or Cardiff: Water LCR Premier XE-tof. 
Mass spectrometric measurements have been performed by the EPSRC Mass 
Spectrometry Service Centre, Swansea University or by R. Jenkins/R. Hick at Cardiff 
University. Ions were generated by the atmospheric pressure ionisation techniques 
voltage applied corana discharge pin (APCI), Electrospray (ES) or Electron Ionisation 
(EI). Mass fragments usually are in atomic mass units per elementary charges (m/z) 
with relative abundance of ion in percentage (%). The high resolution mass 
spectrometry (HRMS) for most of the compounds was carried out at EPSRC Mass 
Spectrometry Service Centre, Swansea University. The molecular ion peaks values 
quoted for either molecular ion (M+), molecular ion plus hydrogen (M+H+) or molecular 
ion peaks plus ammonium ion (M+NH4+) or molecular ion plus sodium (M+Na+). 
6.3.4  IR Spectroscopy 
IR spectra were recorded on either a Perkin Elmer 1600 series FTIR or a PC supported 
JASCO FT/IR 660 plus with “Spectra Manager for Windows 95/NT”, Version 1.53.01 
from JASCO Cooperation. Wavenumbers are quoted in cm–1. Crystalline compounds 
were measured as KBr disk, non-crystalline samples were measured as neat film 
between NaCl disks. 
6.3.5  Melting Points 
Melting Points were measured using a Gallenkamp variable heater with samples in open 
capillary tubes. All melting points are uncorrected. 
6.3.6  Optical Rotation 
The optical rotation of compounds was measured at 20 °C in cuvettes of 50 mm length 
with an AA-1000 Polarimeter from Optical Activity LTD. 
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6.3.7  X-Ray Crystallography 
Bruker CCD diffractometer with graphite-monochromatised Mo-Kα radiation (λ = 
0.71073 Å). X-Ray crystallographic studies were carried out at the X-Ray 
Crystallography Service at Cardiff University. The structures were solved by direct 
methods and refined using the SHELXTL software package. In general, all non-
hydrogen atoms were refined anisotropically. Hydrogen atoms were assigned at 
idealized locations. The structure was solved by a direct method and refined by a 
fullmatrix least-squares procedure on F2 for all reflections (SHELXL-97). 
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6.4   Experimental for Oxyamination Reactions 
2,2-Diphenylpent-4-enenitrile (134) 
 
A solution of diphenylacetonitrile (10 g, 51.8 mmol) in dry THF (25 mL) was added 
slowly to a suspension of NaH (60% dispersion in mineral oil) (3.26 g, 81.5 mmol) in 
THF (75 mL) which was prewashed with petroleum ether (3 × 10 mL) and the resulting 
mixture was stirred at room temperature for 1 h.  The resulting bright yellow suspension 
was cooled to 0 °C, treated with allyl bromide (5.29 mL, 67.3 mmol), and warmed to 
room temperature overnight with stirring.  The resulting solution was poured into an 
ice/water mixture (100 mL) and extracted with dichloromethane (3 × 100 mL). The 
combined dichloromethane extracts were washed with water (2 × 50 mL), dried over 
MgSO4, and concentrated to give 134 2,2-diphenyl-4-pentenenitrile (9.39 g, 78%), 
which was used in the subsequent step without further purification. The NMR data is in 
agreement with the literature.[1] Yellow oil, 1H NMR (400 MHz, CDCl3): δ = 3.07 (dt, 
J = 7.0, 1.1 Hz, 2H, H-3), 5.10 (d, J = 10.2, 1H, H-5), 5.14  (d,  J = 17.0 Hz,  1H, H-5), 
5.64 (m, 1H, H-4), 7.27 (m, 10H, Ar-H). 
2,2-Diphenylpent-4-en-1-amine (135) 
 
A suspension of LiAlH4 (3.66 g, 96.4 mmol) in dry diethylether (75 mL) was treated 
with 134 (9.0 g, 38.6 mmol) at 0 °C and then warmed slowly to room temperature and 
stirred overnight.  The resulting suspension was cooled to 0 °C and quenched by slow 
addition of water dropwise (5.0 mL) and then it was washed with diethylether (3 × 50 
mL). The resulting mixture was filtered and the  filterate was dried (MgSO4) and 
concentrated to give 2,2-diphenyl-4-pentenylamine 135 (5.49 g, 60%) as a pale yellow 
viscous oil. The spectroscopic data are in agreement with the literature.[1] Yellow oil, 1H 
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NMR (250 MHz, CDCl3): δ = 0.78 (br, 2H, N-H), 2.85 (d, J = 7.0 Hz, 2H, H-3), 3.25 (s, 
2H, H-1), 4.88-4.96 (m, 2H, H-5), 5.37 (ddt, J = 7.0, 9.9, 17.1 Hz, 1H, H-4), 7.07-7.25 
(m, 10H, Ar-H) ppm. 
General procedure 1 for reactions with isocyanates 
To the corresponding amine (1 equiv) in dry CH2Cl2 under argon at 0 °C was added the 
tosyl isocyanate (1.1 equiv). The reaction was warmed to room temperature and stirred 
while monitoring the consumption of the amine by TLC (12 h).  1 N HCl was added to 
the reaction, the mixture was stirred, and the layers were separated. The organic layer 
was dried over MgSO4, filtered, and concentrated. The crude products were purified by 
using flash chromatography on silica gel (ethyl acetate/hexane 0.5:1). 
1-(2,2-Diphenylpent-4-enyl)-3-tosylurea (136) 
 
The product was obtained in 78% yield. The spectroscopic data are in agreement with 
the literature.[2]  
Colourless solid, m.p. 114-115 ºC (Lit. m.p 114-115 ºC)[2] ; 1H NMR (500 MHz, 
CDCl3): δ = 2.34 (s, 3H, H-17), 2.74 (d, J = 7.1 Hz, 2H, H-3), 3.83 (d, J = 5.2 Hz, 2H, 
H-1), 4.84 (d, J = 18.0 Hz, 1H, H-5), 4.87 (d, J = 10.1 Hz, 1H, H-5), 5.26 (ddt, J = 7.1, 
10.2, 17.2 Hz, 1H, H-4), 6.21 (br, 1H, N-H), 7.07-7.33 (m, 14H, H-7,8,9,10,11,14 and 
15), 8.53 (br, 1H) ppm; 13C NMR (126 MHz, CDCl3): δ = 21.6 (C-17), 41.9 (C-3), 47.1 
(C-2), 49.6 (C-1), 118.8 (C-5), 126.7 (2C), 126.8 (2C), 127.9 (4C), 128.4 (4C), 129.8 
(2C), 133.4 (C-4), 133.6 (C-16), 144.6 (C-13), 144.9 (2C, C-6), 151.6 (C-12) ppm. 
Synthesis of [bis(trifluoromethylsulfonyl)iodo]benzene 
In a NMR tube containing (diacetoxyiodo)benzene (15 mg, 0.047 mmol) in CDCl3 (0.6 
mL), a solution of 0.62 M trimethylsilyl triflate (1 equiv., 84 µL, 0.047 mmol in 76 µL 
CDCl3) was added at –40 ºC. The NMR spectra shown below were also taken at at –40 
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ºC and clearly indicate the formation of [bis(trifluoromethylsulfonyl)iodo]benzene, 
PhI(OTf)2, through exchange of both acetate groups with triflate moieties after addition 
of 2 equivalents (or more) of trimethylsilyl triflate. 1H NMR (500 MHz, CDCl3, –40 
ºC): δ = 7.60 (br s, 2H), 7.74 (br s, 1H), 8.20-8.24 (m, 2H) ppm; 13C NMR (126 MHz, 
CDCl3, –40 ºC): δ = 118.3, 130.1 (2C), 132.3, 134.4 (2C); CF3 groups not visible.
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1H NMR (500 MHz, CDCl3, –40 ºC): PhI(OAc)2 + n eq. TMSOTf 
 
13C NMR (126 MHz, CDCl3, –40 ºC): PhI(OAc)2 + n eq. TMSOTf 
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General Procedure 2 for initial cyclizations to 137a and 137b (Table 3.1)  
 To the substrate 136 (50 mg, 0.1 mmol) in dry CH2Cl2 (3.0 mL) under argon, added the 
reagents given in the table 3.1. The mixture was stirred at the given temperature and the 
progress of reaction was monitored bt using TLC. The reaction was quenched with sat. 
NaHCO3 (3.0 mL). The resulting mixture was extracted with CH2Cl2  (3  × 10 mL) and 
the combined CH2Cl2 extracts were dried (MgSO4) and concentrated to give the crude 
products 137a and 137b which were isolated by using flash chromatography on silica 
gel (ethyl acetate/hexane 0.5:1). 
N-(6,6-Diphenyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-ylidene)-4 methylbenzene- 
sulfonamide  (137a) 
 
The spectroscopic data are in agreement with the literature.[2] Colourless solid, m.p. 88 
ºC; 1H NMR (500 MHz, CDCl3): δ = 2.33 (s, 3H, H-11), 2.32-2.36 (m, 1H, H-3), 2.52 
(dd, J = 5.2, 11.7 Hz, 1H, H-3), 3.82 (d, J = 11.6 Hz, 1H, H-1), 4.05-4.12 (m, 1H, H-4), 
4.24 (d, J = 11.6 Hz, 1H, H-1), 4.29 (dd, J = 7.3, 8.8 Hz, 1H, H-5), 4.64 (t, J = 8.8 Hz, 
1H, H-5), 7.07-7.23 (m, 12H, Ar-H), 7.78 (d, J = 8.2 Hz, 2H, H-8) ppm; HRMS: 
[M+H+] calcd. for C25H24N2O3S: 433.1580; found: 433.1573. 
6,6-Diphenyl-2-tosyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (137b) 
 
The spectroscopic data are in agreement with the literature.[2] Colourless solid, m.p. 148 
ºC; 1H NMR (500 MHz, CDCl3): δ = 2.17 (dd, J = 9.9, 11.7 Hz, 1H, H-3), 2.37 (s, 1H, 
H-11), 2.48 (dd, J = 5.2, 11.9 Hz, 1H, H-3), 3.56 (dd, J = 5.3, 9.5 Hz, 1H, H-1), 3.78 (d, 
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J = 12 Hz, 1H, H-1), 3.81-3.87 (m, 1H, H-4), 3.99 (d, J = 12 Hz, 1H, H-5), 3.99 (t, J = 9 
Hz, 1H, H-5), 7.02-7.25 (m, 12H, Ar-H), 7.82 (d, J = 8.2 Hz, 2H, H-8) ppm. 
Synthesis of chiral hypervalent iodine reagents 
The compound 138 was prepared according to literature procedure from resorcinol in 
the presence of NaHCO3 in 68% yield.[3]  
2-Iodobenzene-1,3-diol (138) 
 
Colourless solid; 1H NMR (400 MHz, CDCl3): δ = 6.32 (d, J = 8.0 Hz, 2H, H-3), 6.91 
(t, J = 8.0 Hz, 1H, H-4), 10.1 (s, 2H, O-H) ppm. 
(2R,2'R)-Diethyl 2,2'-(2-iodo-1,3-phenylene)bis(oxy)dipropanoate (139) 
 
To a solution of 2-iodoresorcinol 138 (2.36 g, 10.0 mmol), PPh3 (6.56 g, 25.0 mmol) 
and (–)-lactic acid ethylester ( 2.80 mL, 25.0 mmol) in THF (50 mL) was added slowly 
diisopropyl azodicarboxylate (DIAD, 1.9 M in toluene, 25.0 mmol, 13.2 mL) at 0 °C. 
The reaction mixture was allowed to warm to room temperature. After stirring for 
overnight, the resulting mixture was concentrated in vacuo. The residue was purified by 
flash column chromatography on silica gel (eluent: hexane-EtOAc = 15:1) to give 139 
(2.70 g, 62%). 1H NMR (400 MHz, CDCl3): δ = 1.23 (t, J = 7.1 Hz, 6H, H-9), 1.68 (d, J 
= 6.8 Hz, 6H, H-6), 4.19 (dq, J = 1.7, 7.1 Hz, 4H, H-8), 4.75 (q, J = 6.8 Hz, 2H, H-5), 
6.38 (d, J = 8.3 Hz, 2H, H-3), 7.14 (t, J = 8.3 Hz, 1H, H-4) ppm. 
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(2R,2'R)-2,2'-(2-Iodo-1,3-phenylene)bis(oxy)dipropanoic acid (140) 
 
To a solution of  139 (2.70 g, 6.2 mmol) in THF (20 mL) and MeOH (20 mL) was 
added 2 N NaOH (20 mL) and stirred overnight at room temperature.  The reaction 
mixture was cooled to 0 °C, quenched with 1N HCl (till it is acidic) and extracted with 
EtOAc (3 × 25 mL). The organic layers were dried over anhydrous MgSO4 and the 
solvents were removed in  vacuo to give pure  140  (2.35 g, 6.2 mmol) in 99% yield.  
White solid 1H NMR (400 MHz, d6-DMSO): δ = 1.55 (d, J = 6.8 Hz, 6H, H-6), 3.33 (s, 
2H, COO-H), 4.86 (q, J = 6.8 Hz, 2H, H-5), 6.42 (d, J = 8.4 Hz, 2H, H-3), 7.22 (t, J = 
8.3 Hz, 1H, H-4) ppm. 
 (2R,2'R)-2,2'-(2-Iodo-1,3-phenylene)bis(oxy)bis(N mesitylpropanamide) (141) 
  
A solution of 140 (2.0 g, 5.26 mmol) in SOCl2 (6.0 mL) was refluxed for 1 h. To the 
resulting mixture was added benzene (2 × 5 mL), and excess reagents were removed in 
vacuo. The residue was dissolved in dry CH2Cl2 (25 mL), and to the resulting mixture 
was added mesityl aniline (1.26 mL, 11.6 mmol) with cooling (0 °C). The resulting 
mixture was stirred at 0 °C for 2 h, and gradually warmed to room temperature. After 
stirring for overnight, the reaction mixture was poured into 1N HCl and extracted with 
CHCl3 (2 × 25 mL). The organic layers were dried over anhydrous MgSO4 and the 
solvents were removed in vacuo. The residue was purified by flash column 
chromatography on silica gel (eluent: chloroform-EtOAc = 4:1) to give 141 (2.84 g, 
4.62 mmol) in 88% yield. White solid 1H NMR (400 MHz, CDCl3): δ = 1.78 (d, J = 6.6 
Hz, 6H, H-6), 2.15 (s, 12H, H-14), 2.27 (s, 6H, H-15), 5.01 (q, J = 6.6 Hz, 2H, H-5), 
6.65 (d, J = 8.3 Hz, 2H, H-3), 6.90 (s, 4H, H-9 and 11), 7.35 (t, J = 8.3 Hz, 1H, H-4), 
8.01 (s, 2H, N-H) ppm. HPLC; Chiracel OD-H, hexane:2-propanol (7:3), flow rate: 0.5 
ml • min–1, tr (13.8 min, 232 nm), 99% ee. 
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General procedure 3 for the oxidation of aryl iodides to the hypervalent 
compounds  
A solution of the aryl iodide (0.1 mmol) and 1-(chloromethyl)-4-fluoro-1,4-
diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) [Selectfluor®] (177 mg, 0.5 mmol) 
in AcOH (1 mL) and CH3CN (3.2 mL) was stirred overnight at room temperature. The 
solvent was evaporated in vacuo and water (50 mL) was added to the residue, the 
resulting solution was extracted with CH2Cl2 (3 × 25 mL) and washed with water (25 
mL). The combined organic layers were dried over MgSO4. The solvents were removed 
in vacuo to give the hypervalent compounds. 
(2R,2'R)-2,2'-{[2-(Diacetoxy)iodo-1,3-phenylene]bis(oxy)}bis(N-mesitylpropanamide) 
(142) 
 
Colourless solid, m.p. 119 ºC; 1H NMR (400 MHz, CDCl3): δ = 1.43 (s, 6H, H-17), 1.77 
(br, 12H, H-14), 1.81 (d, J = 6.7 Hz, 6H, H-6), 2.14 (s, 6H, H-15), 5.06 (q, J = 6.7 Hz, 
2H, H-5), 6.72 (s, 4H, H-9 and 11), 6.85 (d, J = 8.5 Hz, 2H, H-3), 7.50 (t, J = 8.4 Hz, 
1H, H-4), 8.28 (s, 2H, N-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 16.8 (4C, C-14), 
17.1 (2C, C-17), 19.5 (2C, C-6), 19.9 (2C, C-15), 79.5 (2C, C-5), 106.1 (2C, C-3), 
128.0, 128.7, 128.9, 129.0, 129.7 (C-13), 134.1, 136.3 (C-4), 156.0 (2C, C-2), 168.8 (C-
7), 174.0 (C-16) ppm. 
 (2R,2'R)-Diethyl 2,2'-{[2-(diacetoxy)iodo-1,3-phenylene]bis(oxy)}dipropanoate (144) 
 
[α]D25 = –41.6 (c = 1.25, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.18 (t, J = 7.2 Hz, 
6H, H-9), 1.61 (d, J = 6.8 Hz, 6H, H-6), 1.91 (s, 6H, H-11), 4.14 (q, J = 7.2 Hz, 4H, H-
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8), 4.77 (q, J = 6.8 Hz, 2H, H-5), 6.50 (d, J = 8.4 Hz, 2H, H-3), 7.32 (t, J = 8.4 Hz, 1H, 
H-4) ppm; 13C NMR (100 MHz, CDCl3): δ = 14.5 (2C, C-9), 19.0 (2C, C-6), 20.9 (2C, 
C-11), 62.0 (2C, C-8), 74.9 (2C, C-5), 106.5 (2C, C-3), 107.3 (C-1), 135.5, 157.1 (2C), 
171.3 (2C, C-7), 177.4 (2C, C-10) ppm. 
(S)-2-Ethoxy-2-oxo-1-phenylethyl 2-iodobenzoate (145) 
 
To a solution of 2-iodobenzoic acid (1.0 g, 4.03 mmol), PPh3 (1.32 g, 5.04 mmol) and 
(R)-(–)-mandelic acid ethylester (0.91 g, 5.04 mmol) in THF (50 mL), diisopropyl 
azodicarboxylate (DIAD, 2 M in toluene, 10 mmol, 5 mL) was added slowly at 0 °C. 
The reaction mixture was warmed up to room temperature and stirred overnight. The 
reaction mixture was concentrated in vacuo and the residue purified by flash 
chromatography on silica gel (ethyl acetate/hexane 1:15) to give 145 (1.43 g, 3.49 
mmol) in 87% yield. 
[α]D25 = 19.5 (c = 0.4, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.16 (t, J = 7.2 Hz, 3H, 
H-11), 4.09-4.20 (m, 2H, H-10), 6.08 (s, 1H, H-8), 7. 09 (ddd, J = 7.9, 7.5, 1.7 Hz, 1H, 
Ar-H), 7.33 (m, 4H, Ar-H), 7.50 (m, 2H, Ar-H), 7.92 (d, J = 7.9 Hz, 1H, Ar-H) ppm; 
13C NMR (100 MHz, CDCl3): δ = 14.5 (C-11), 62.3 (C-10), 74.8 (C-8), 94.9 (C-1), 
128.2 (2C, Ar-C), 128.4 (Ar-C), 129.3 (2C, Ar-C), 129.8 (Ar-C), 132.1 (Ar-C), 133.6 
(Ar-C), 134.0 (Ar-C), 134.1 (Ar-C), 141.9 (C-2), 166.0 (C-7), 169.0 (C-9) ppm; IR 
(KBr): 3065, 2981, 1732, 1583, 1465, 1246, 1212, 1099, 1013, 738 cm–1; HRMS: [M+ 
NH4+] calcd. for C17H15IO4•NH4+: 428.0353; found: 428.0352. 
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(S)-2-Ethoxy-2-oxo-1-phenylethyl 2-iodosylbenzoate (146) 
 
Synthesized from the general procedure of oxidation reaction.1H NMR (500 MHz, 
CDCl3): δ = 1.23 (t, J = 7.1 Hz, 3H, H-11), 4.16-4.30 (m, 2H, H-10), 6.26 (s, 1H, H-8), 
7.44 (m, 3H, Ar-H), 7.53 (m, 2H, Ar-H), 7.66 (t, J = 7.5 Hz, 1H, Ar-H), 7.91 (t, J = 7.5 
Hz, 1H, Ar-H), 8.21 (d, J = 7.6 Hz, 1H, Ar-H), 8.41 (t, J = 7.5 Hz, 1H, Ar-H) ppm; 13C 
NMR (126 MHz, CDCl3): δ = 14.0 (C-11), 62.3 (C-10), 125.2 (Ar-C), 125.9 (Ar-C), 
127.9 (2C, Ar-C), 129.0 (Ar-C), 129.7 (2C, Ar-C), 131.0 (Ar-C), 132.5 (Ar-C), 133.0 
(Ar-C), 135.7 (Ar-C), 149.1 (Ar-C), 167.2 (C-7), 167.6 (C-9) ppm. IR (KBr): 1734, 
1685, 1291, 1212, 1098, 1016, 913, 743 cm–1. 
(2R,2'R)-2,2'-(1,3-phenylenebis(oxy))bis(propan-1-ol) (139a) 
 
A suspension of LiAlH4 (3.9 g, 10.3 mmol) in dry diethylether (30 mL) was treated with 
139 (1.5 g, 3.4 mmol) at 0 °C and then warmed slowly to room temperature and stirred 
for 30 min. The resulting suspension was cooled to 0 °C and quenched by slow addition 
of water dropwise (5.0 mL) then it was washed with diethylether (3 × 25 mL). The 
resulting mixture was filtered and the filterate was dried (MgSO4) and concentrated to 
give 139a (0.62 g, 81%) as a viscous oil.  
 
1H NMR (400 MHz, CDCl3): δ = 1.23 (d, J = 6.2 Hz, 6H, H-6), 2.61 (s, 2H, O-H), 3.64-
3.68 (m, 4H, H-7), 4.39-4.67 (m, 2H, H-5), 6.50-6.52 (m, 3H, Ar-H), 7.11-7.16 (m, 1H, 
Ar-H) ppm.  
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1,3-bis{[(R)-1-methoxypropan-2-yl]oxy}benzene (147) 
 
A solution of 139a (0.48 g, 2.1mmol) in THF (5 mL) was added slowly to a suspension 
of NaH (0.17 g, 4.2 mmol) in THF (15 mL) and the resulting mixture was stirred at 
room temperature for 1 h. The resulting suspension was cooled to 0 °C, treated with 
methyl iodide (0.26 mL, 4.2 mmol), and warmed to room temperature overnight with 
stirring. The resulting solution was poured into an ice/water mixture (10 mL) and 
extracted with dichloromethane (3 × 10 mL). The combined dichloromethane extracts 
were washed with water (2 × 5 mL), dried (MgSO4), and concentrated to give 147 (0.46 
g, 93%), which was used in the subsequent step without further purification. 1H NMR 
(CDCl3, 400 MHz): δ = 1.30 (d, J = 6.3 Hz, 6H, H-6), 3.40 (s, 6H, H-8), 3.47 (dd, J = 
4.5, 10.1 Hz, 2H, H-7), 3.57 (dd, J = 5.7, 10.1 Hz, 2H, H-7), 4.47-4.54 (m, 2H, H-5), 
6.51-6.53 (m, 3H, Ar-H), 7.14 (t, J = 8.3 Hz, 1H, H-4) ppm.  
2-Iodo-1,3-bis{[(R)-1-methoxypropan-2-yl]oxy}benzene (148) 
 
To a solution of 147 (660 mg, 2.6 mmol) in dry THF (25 mL), n-butyllithium (1.06 mL, 
2.5 M solution in hexane, 2.65 mmol) was added slowly at 0 ºC. The mixture was 
stirred for 30 min at this temperature. At –78 ºC a solution of iodine (762 mg, 3 mmol) 
in THF (5 mL) was added with stirring. After 10 min at room temperature the mixture 
was quenched with sat aqueous Na2S2O3 (15 mL) and extracted with CH2Cl2 (3 × 25 
mL). The combined organic phases were dried with MgSO4 and the solvent was 
removed in vacuo. After column chromatography (hexane/ethyl acetate 10:1) compound 
148 was isolated as yellow oil in 93% yield (919 mg, 2.42 mmol).  
[α]D25 = –46.5 (c = 0.4, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.37 (d, J = 6.3 Hz, 
6H, H-6), 3.46 (s, 6H, H-8), 3.55 (dd, J = 4.8, 10.3 Hz, 2H, H-7), 3.68 (dd, J = 5.9, 10.3 
Hz, 2H, H-7), 4.55 (m, 2H, H-5), 6.56 (d, J = 8.3 Hz, 2H, H-3), 7.20 (t, J = 8.2 Hz, 1H, 
H-4) ppm; 13C NMR (100 MHz, CDCl3): δ = 17.2 (2C, C-6), 59.6 (2C, C-8), 75.4 (2C, 
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C-7), 75.9 (2C, C-5), 82.9 (C-1), 107.6 (2C, C-3), 129.4 (C-4), 158.5 (2C, C-2) ppm; 
HRMS: [M+NH4+] calcd. for C14H21IO4•NH4: 398.0823; found: 398.0822. 
2-(Diacetoxy)iodo-1,3-bis{[(R)-1-methoxypropan-2-yl]oxy}benzene (149) 
 
Synthesized from the general procedure of oxidation reaction. Not complete conversion, 
some starting material 148 present. [α]D25 = –27.1 (c = 1.26, CHCl3); 1H NMR (400 
MHz, CDCl3): δ = 1.28 (d, J = 6.4 Hz, 6H, H-6), 1.88 (s, 6H, H-10), 3.33 (s, 6H, H-8), 
3.44 (dd, J = 4.7, 10.3 Hz, 2H, H-7), 3.57 (dd, J = 6.1, 10.3 Hz, 2H, H-7), 4.61 (m, 2H, 
H-5), 6.69 (d, J = 8.4 Hz, 2H, H-3), 7.37 (t, J = 8.4 Hz, 1H, H-4) ppm; 13C NMR (100 
MHz, CDCl3): δ = 15.9 (2C, C-6), 19.5 (2C, C-10), 58.5 (2C, C-8), 74.70 (2C, C-7), 
74.74 (2C, C-5), 105.5 (2C, C-3), 106.6 (C-1), 134.1 (C-4), 156.1 (2C, C-2), 175.8 (2C, 
C-9) ppm; IR (KBr): 1635, 1457, 1218, 1110, 772 cm–1. 
(2R,2'R)-Bis[(S)-2-ethoxy-2-oxo-1-phenylethyl] 2,2'-{[2-iodo-1,3-phenylene]bis(oxy)} 
dipropanoate (150) 
 
To a solution of 140 (500 mg, 1.32 mmol), PPh3 (863 mg, 3.29 mmol) and (R)-(–)-
mandelic acid ethyl ester (592 mg, 3.29 mmol) in THF (50 mL), diisopropyl 
azodicarboxylate (DIAD, 1 M in toluene, 3.3 mmol, 3.3 mL) was added slowly at 0 °C. 
The reaction mixture was warmed up to room temperature and stirred overnight. The 
reaction mixture was concentrated in vacuo and the residue was purified by flash 
chromatography on silica gel (ethyl acetate/hexane 1:8) to give 150 (670 mg, 0.95 
mmol) in 72% yield. 
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 [α]D25 = 26.7 (c = 1.3, CHCl3); 1H NMR (500 MHz, CDCl3): δ = 1.13 (t, J = 7.0 Hz, 
6H, H-11), 1.67 (d, J = 7.0 Hz, 6H, H-6), 4.10 (m, 4H, H-10), 4.83 (q, J = 6.5 Hz, 2H, 
H-5), 5.89 (s, 2H, H-8), 6.41 (d, J = 8.0 Hz, 2H, H-3), 7.09 (t, J = 8.2 Hz, 1H, H-4), 
7.30-7.37 (m, 10H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 14.0 (2C, C-11), 18.5 
(2C, C-6), 61.9 (2C, C-10), 73.9 (C-1), 74.9 (2C, C-5), 80.4 (2C, C-8), 107.2 (2C, C-3), 
127.5 (4C), 128.7 (4C, Ar-C), 129.2 (2C, Ar-C), 129.7 (Ar-C), 133.4 (2C, Ar-C), 158.1 
(2C, C-2), 168.2 (2C, C=O), 170.9 (2C, C=O) ppm; IR (KBr): 2980, 2931, 1744, 1456, 
1254, 1180, 1131, 910, 743 cm–1; HRMS: [M+NH4+] calcd. for C32H33IO10•NH4: 
722.1457; found: 722.1455. 
(2R,2'R)-Bis[(S)-2-ethoxy-2-oxo-1-phenylethyl] 2,2'-{[2-(diacetoxy)iodo-1,3phenylene] 
bis(oxy)} dipropanoate (151) 
 
Synthesized from the general procedure of oxidation reaction. [α]D25 = 34.9 (c = 1.26, 
CHCl3); 1H NMR (500 MHz, CDCl3): δ = 1.13 (t, J = 7.1 Hz, 6H, H-11), 1.65 (d, J = 
6.9 Hz, 6H, H-6), 1.83 (s, 6H, H-19), 4.06-4.16 (m, 4H, H-10), 4.92 (q, J = 6.9 Hz, 2H, 
H-5), 5.92 (s, 2H, H-8), 6.66 (d, J = 6.8 Hz, 2H, H-3), 7.30-7.38 (m, 11H, Ar-H) ppm; 
13C NMR (126 MHz, CDCl3): δ = 14.0 (C-11), 18.3 (C-6), 20.3 (C-19), 62.0 (C-10), 
74.2, 75.0, 106.7 (C-3), 126.5, 127.5, 128.8, 129.3, 133.2, 135.3, 156.4 (C-2), 168.2 
(C=O), 170.1 (C=O), 176.9 (C=O) ppm; IR (KBr): 2986, 1746, 1635, 1462, 1255, 1214, 
1179, 1132, 1029, 760 cm–1. 
General procedure 4 for the stereoselective cyclizations from 136 to 137a (Table 
3.2) 
To the solution of 136 (50 mg, 0.11 mmol) and chiral hypervalent iodine reagents (0.12 
mmol) in the corresponding solvent (3.0 mL), added the Lewis acid (0.12 mmol) at _78 
°C. The reaction mixture was stirred at lower temperature for 14 h. The bath was 
removed and the reaction was quenched with saturated aqueous NaHCO3 (2 mL/0.1 
mmol alkene), and the layers were separated. The aqueous layer was extracted with 
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CH2Cl2 (2.0 mL/0.1 mmol alkene) and combined with the organic layer, dried over 
MgSO4, filtered and concentrated in vacuo. The products were purified by 
chromatography (silica gel, ethyl acetate/hexane 3:5). 
(3-Bromoprop-1-en-2-yl)benzene (152) 
 
N-Bromosuccinimide (8.90 g, 50.0 mmol) was added to a solution of α-methylstyrene 
(10.4 mL, 80.0 mmol) in CCl4 (5 mL), and the mixture was rapidly heated in an oil bath 
at 170 oC until the solids were dissolved. The reaction mixture was allowed to cool to 
room temperture and filtered to remove the precipitates. The compound 152 is 
lachrymator, therefore it was used without purification and isolation.[4] The 
characteristic peaks for the product 152 using 400 MHz 1H NMR were at 4.38 (s, 2H, 
H-1), 5.48 (s, 1H, H-2), 5.52 (s, 1H, H-2) ppm.  
4-Cyano-2-phenyl-1-butene (154) 
 
α-Lithioacetonitrile,[5] generated by addition of n-BuLi (21 mmol, 1.6 M hexane 
solution) into a solution of acetonitrile (20 mmol) in 30 mL of dry THF at _78 oC 
followed by stirring at _78 oC for 2 h, was alkylated by treatment with 152 (21 mmol) at 
_78 oC  for 2 h and then was warmed to the room temperature and stirred over night. A 
mixture of THF-water (5:1, v/v, 4.6 mL) and then 15% aqueous NaOH was added 
dropwise into the reaction mixture with vigorous stirring and cooling. The aqueous 
layer was extracted with CH2Cl2 (25 mL × 3) and combined with the organic layer, 
dried over MgSO4, filtered and concentrated in vacuo. The products were purified by 
chromatography (silica gel, ethyl acetate/hexane 1:15). 1H NMR (250 MHz, CDCl3): δ 
= 2.37 (t, J = 7.3 Hz, 2H, H-3), 2.77 (t, J = 7.3 Hz, 2H, H-2), 5.11 (d, J = 0.8 Hz, 1H, H-
5), 5.32 (s, 1H, H-5), 7.13-7.28 (m, 5H, Ar-H) ppm. 
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4-Phenylpent-4-en-1-amine (155) 
 
Synthesized in 87% as a pale yellow viscous oil from 154 by using the reduction 
procedure for the synthesis of compound 135. The spectroscopic data are in agreement 
with the literature. 1H NMR (400 MHz, CDCl3): δ = 1.07-1.15 (m, 2H, N-H), 1.53 
(quint, J = 7.6 Hz, 2H, H-2), 2.48 (t, J = 7.6 Hz, 2H, H-3), 2.64 (t, J = 6.8 Hz, 2H, H-1), 
5.00 (d, J = 1.2 Hz, 1H, H-5), 5.20 (d, J = 1.2 Hz, 1H, H-5), 7.19-7.35 (m, 5H, Ar-H) 
ppm. 
4-Methyl-N-[(4-phenylpent-4-en-1-yl)carbamoyl]benzenesulfonamide (156) 
 
Amine 155 was reacted with tosyl isocyanate to yield compound 156 in 84% yield using 
the general procedure for reactions with isocyanates. 
Colourless solid, m.p. 122-124 ºC; 1H NMR (400 MHz, CDCl3): δ = 1.56 (quint, J = 7.4 
Hz, 2H, H-2), 2.33 (s, 3H, H-17), 2.40 (t, J = 7.4 Hz, 2H, H-3), 3.15 (d, J = 6.8 Hz, 1H, 
H-1), 3.18 (d, J = 6.8 Hz, 1H, H-1), 4.97 (d, J = 1.2 Hz, 1H, H-5), 5.22 (d, J = 1.2 Hz, 
1H, H-5), 6.52 (m, 1H, N-H), 7.17-7.30 (m, 7H, Ar-H), 7.67 (d, J = 8.4 Hz, 2H, H-14), 
8.43 (s, 1H, N-H) ppm; 13C NMR (100 MHz, CDCl3): δ = 22.0 (C-17), 28.3 (C-2), 32.7 
(C-3), 40.2 (C-1), 113.4 (C-5), 126.5 (2C, Ar-C), 127.3 (2C, Ar-C), 128.0 (Ar-C), 128.8 
(2C, Ar-C), 130.4 (2C, Ar-C), 137.0 (C-16), 141.1 (C-13), 145.3 (C-6), 147.6 (C-4), 
152.1 (C=O) ppm; IR (KBr): 3328, 2980, 1700, 1657, 1542, 1465, 1347, 1159, 1088, 
888 cm–1; HRMS: [M+H+] calcd. for C19H22N2O3S•H+: 359.1427; found: 359.1424. 
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General procedure 5 for cyclizations to 157 (Table 3.3) 
 
To a solution of the urea-tethered alkene (1 equiv) and the hypervalent iodine 
compound (1.5 equiv) in the solvent/solvent mixture (2 mL/0.1 mmol alkene) at –78 °C 
TMSOTf (1.5 or 2.0 equiv) was added slowly. The dry ice/acetone bath was removed 
and the reaction was allowed to warm to room temperature. The reaction was stirred 
overnight. The reaction was quenched with sat. aqueous NaHCO3 (2 mL/0.1 mmol 
alkene), and the layers were separated. The aqueous layer was extracted with CH2Cl2 (2 
× 5 mL/0.1 mmol alkene) and combined with the organic layer, dried over MgSO4, 
filtered and concentrated in vacuo. The products were purified by chromatography 
(ethyl acetate/hexane 3:5). Typically, 80-85% of the reduced aryl iodide are isolated 
without loss of optical purity. 
(S)-4-Methyl-N-(7a-phenyltetrahydropyrrolo[1,2-c]oxazol-3(1H) ylidene)benzenesulfo- 
namide (157)                     
 
Colourless solid, m.p. 197-199 ºC; [α]D25 = +3.5 (c = 1.06, CHCl3) (92% ee); 1H NMR 
(500 MHz, CDCl3): δ = 1.72 (m, 1H, H-2), 1.90 (dt, J = 8.1, 11.8 Hz, 1H, H-2), 2.05 (m, 
1H, H-3), 2.33 (s, 3H, H-15), 2.35 (m, 1H, H-3), 3.30 (ddd, J = 3.2, 9.6, 11.7 Hz, 1H, 
H-1), 3.75 (dt, J = 8.3, 11.7 Hz, 1H, H-1), 4.35 (d, J = 8.9 Hz, 1H, H-9), 4.69 (d, J = 8.9 
Hz, 1H, H-9), 7.15-7.32 (m, 7H, Ar-H), 7.80 (d, J = 8.2 Hz, 2H, H-12) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 21.5 (C-2), 25.1 (C-15), 37.4 (C-3), 46.8 (C-1), 73.4 (C-4), 79.5 
(C-9), 124.6 (2C, Ar-H), 127.0 (2C, Ar-H), 128.3 (Ar-C), 129.1 (2C, Ar-C), 129.2 (2C, 
Ar-C), 139.9 (C-5), 140.9 (C-14), 142.5 (C-11), 161.6 (C-10) ppm; IR (KBr): 1617, 
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1420, 1276, 1155, 749 cm–1; HRMS: [M+H+]; ee = 92% ; determined by HPLC 
analysis: Daicel Chiracel OD-H column (25 cm), hexanes/i-PrOH = 50/50, 0.5 mL/min, 
232 nm; tr (major) = 15.1 min, tr (minor) = 17.2 min. 
Procedure for large-scale cyclization of 156 to 157  
To a solution of 142 (0.24 mmol, 180 mg) in dry CH2Cl2 : Et2O mixture (1.5 ml : 4.5 
mL) TMSOTf (0.49 mmol, 0.088 mL) was added at –78 ºC and stirred for 30 min. Then 
tosyl amide (0.16 mmol, 28 mg) dissolved in dry CH2Cl2 : Et2O mixture (1.5 ml : 4.5 
mL) was added and stirred for 30 min at –78 ºC. The mixture was cooled down to –90 
ºC and compound 156 (0.16 mmol, 58 mg), dissolved dry CH2Cl2 : Et2O mixture (1.5 
ml : 4.5 mL) was added and stirred for 4 h. After evaporation of the solvents the 
reaction mixture was subjected (without quenching) to column chromatography (ethyl 
acetate/hexane 1:2) to obtain compound 157 (0.095 mmol, 34 mg) in 60% yield with 
92% ee. 
1-(3-Bromoprop-1-en-2-yl)-4-fluorobenzene (159a)  
 
It was synthesized similarly as the compound 152 from the bromination of 1-fluoro-4-
(prop-1-en-2-yl)benzene. The spectroscopic data are in agreement with the literature.[6] 
1H NMR (400 MHz, CDCl3): δ = 4.25 (s, 2H, H-1), 5.37 (s, 1H, H-3), 5.40 (s, 1H, H-3), 
6.90-6.99 (m, 2H, H-5), 7.35-7.39 (m, 2H, H-6) ppm. 
1-(3-Bromoprop-1-en-2-yl)-4-methoxybenzene (159b)  
 
It was synthesized from the corresponding ketone by using Tebbe's reagent.[7] The 
spectroscopic data was in agreement with the literature.[8] 
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1-(3-Bromoprop-1-en-2-yl)-4-methoxybenzene (159b)  
8
6
7
1
2
3
45
H3CO
Br
159b
 
 
1HNMR (400 MHz, CDCl3): δ = 3.86 (s, 3H, H-8), 4.41 (s, 2H, H-1), 5.44 (s, 1H, H-3), 
5.52 (s, 1H, H-3), 6.94 (d, J = 8.8 Hz, 2H, H-6), 7.48 (d, J = 8.8 Hz, 2H, H-5) ppm. 
Synthesis of 160a and 160b 
To a solution of isobutyronitrile (10mmol) in THF (50 mL) at 0 ºC added freshly 
prepared LDA (12 mmol)[9] and stirred for 2 hours. Then added the compounds 159a or 
159b (12 mmol) at 0 ºC and stirred over night at room temperature. Next day the 
mixture was quenched by using excess amount of water at 0 ºC. After stirring for 10 
min, the layers were separated and the aqueous phase extracted with CH2Cl2 (2 × 15 
mL). The combined organic layers were dried over MgSO4, filtered, and concentrated in 
vacuo. The crude product was purified by chromatography (ethyl acetate/hexane 10:1). 
2,2-Dimethyl-4-(4-fluorophenyl)-pent-4-enenitrile (160a) 
 
1H NMR (400 MHz, CDCl3): δ = 1.28 (s, 6H, H-10), 2.76 (s, 2H, H-3), 5.28 (s, 1H, H-
5), 5.42 (s, 1H, H-5), 7.05 (t, J = 8.6 Hz, 2H, H-8), 7.38 (dd, J = 5.6, 8.8 Hz, 2H, H-7) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 27.5 (C-2), 33.4 (2C, C-10), 46.1 (C-3), 115.8 
(C-5), 119.1, 124.9, 128.6, 138.0, 143.4 (C-4), 162.9 (d, J = 246 Hz, C-9) ppm; IR 
(KBr): 1979, 1936, 2234, 1602, 1509, 1226, 1161, 842, 748 cm–1; HRMS: [M+H+] 
calcd. for C13H14FN•H+: 204.1183; found: 204.1182. 
 
 
110 
 
2,2-Dimethyl-4-(4-methoxyphenyl)-pent-4-enenitrile (160b) 
 
1H NMR (400 MHz, CDCl3): δ = 1.19 (s, 6H, H-11), 2.66 (s, 2H, H-3), 3.74 (s, 3H, H-
10), 5.12 (s, 1H, H-5), 5.30 (d, J = 1.2 Hz, 1H, H-5), 6.80 (d, J = 8.7 Hz, 2H, H-8), 7.25 
(d, J = 8.7 Hz, 2H, H-7) ppm; 13C NMR (100 MHz, CDCl3): δ = 27.1 (C-2), 33.5 (C-
11), 45.9 (C-3), 55.8 (C-10), 114.1 (C-5), 117.6, 125.2, 128.0, 134.4, 143.7 (C-4), 159.7 
(C-9) ppm; IR (KBr): 2977, 2235, 1680, 1603, 1512, 1466, 1248, 1179, 1032, 835, 772 
cm–1; HRMS: [M+H+] calcd. for C14H17NO•H+: 216.1383; found: 216.1385. 
2,2-Dimethyl-4-(4-fluorophenyl)-pent-4-en-1-amine (161a) 
 
Synthesized from 160a using the synthetic procedure as of compound 135. 1H NMR 
(400 MHz, CDCl3): δ = 0.73 (s, 6H, H-3), 2.34 (s, 2H, H-4), 2.45 (s, 2H, H-1), 5.02 (s, 
1H, H-6), 5.19 (d, J = 1.8 Hz, 1H, H-6), 6.98 (t, J = 8.6 Hz, 2H, H-9), 7.33 (dd, J = 5.4, 
8.5 Hz, 2H, H-8) ppm; 13C NMR (100 MHz, CDCl3): δ = 25.7 (2C, C-3), 36.4 (C-2), 
45.1 (C-4), 53.2 (C-1), 115.5 (t, J = 26.1 Hz, 2C, C-9), 117.2 (C-6), 128.4 (2C, C-8), 
140.1 (C-7), 146.5 (C-5), 162.5 (d, J = 305.5 Hz, C-10) ppm; IR (KBr): 2960, 1624, 
1602, 1508, 1224, 841, 749 cm–1; HRMS: [M+H+] calcd. for C13H18FN•H+: 208.1496; 
found: 208.1493. 
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2,2-Dimethyl-4-(4-methoxyphenyl)-pent-4-en-1-amine (161b): 
 
Synthesized from 160b using the synthetic procedure as of compound 135. 1H NMR 
(500 MHz, CDCl3): δ = 0.68 (s, 6H, C-3), 1.25-1.40 (br, 2H, N-H), 2.28 (s, 2H, C-4), 
2.37 (s, 2H, C-1), 3.73 (s, 3H, C-11), 4.89 (s, 1H, C-6), 5.11 (d, J = 1.9 Hz, 1H, C-6), 
6.77 (d, J = 8.6 Hz, 2H, H-9), 7.23 (d, J = 8.6 Hz, 2H, H-8) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 25.4 (2C, C-3), 36.0 (C-2), 44.6 (C-4), 52.8 (C-1), 55.2 (C-11), 113.6 (2C, 
C-9), 115.4 (C-6), 127.5 (2C, C-8), 136.1 (C-7), 146.4 (C-5), 158.9 (C-10) ppm; IR 
(KBr): 3466, 2957, 1607, 1511, 1465, 1247, 1179, 1034, 835 cm–1; HRMS: [M+H+] 
calcd. for C14H21NO•H+: 220.1693; found: 220.1694.  
N-{[4-(4-Fluorophenyl)-2,2-dimethylpent-4-en-1-yl]carbamoyl}-4 methylbenzenesulfo- 
namide (162a) 
 
Synthesized from 161a by using the general procedure 1. 
 
1H NMR (400 MHz, CDCl3): δ = 0.71 (s, 6H, H-3), 2.41 (s, 2H, H-4), 2.44 (s, 3H, H-
16), 2.98 (d, J = 6.4 Hz, 2H, H-1), 5.01 (s, 1H, H-6), 5.23 (s, 1H, H-6), 6.65 (t, J = 6.2 
Hz, 1H, N-H), 7.01 (t, J = 8.6 Hz, 2H, H-9), 7.27-7.35 (m, 4H, Ar-H), 7.77 (d, J = 8.2 
Hz, 2H, H-13), 9.37 (s, 1H, N-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 22.1 (C-16), 
25.9 (2C, C-3), 36.1 (C-2), 45.3 (C-4), 50.3 (C-1), 115.7 (d, J = 26.4 Hz, 2C, C-9), 
117.8 (C-6), 127.2 (2C, Ar-C), 128.4 (d, J = 10 Hz, 2C, C-8), 130.4 (2C, Ar-C), 137.2, 
139.6, 145.2, 145.6, 152.5 (C=O), 162.6 (d, J = 310 Hz, C-10) ppm; IR (KBr): 3446, 
1675, 1653, 1507, 1274, 1162, 1091, 764 cm–1; HRMS: [M+H+] calcd. for 
C21H25FN2O3S•H+: 405.1643; found: 405.1643. 
112 
 
N-{[4-(4-Methoxyphenyl)-2,2-dimethylpent-4-en-1-yl]carbamoyl}-4                       
methylbenzenesulfonamide (162b) 
 
Synthesized from 161b by using the general procedure 1.  
1H NMR (400 MHz, CDCl3): δ = 0.62 (s, 6H, H-3), 2.31 (s, 2H, H-4), 2.35 (s, 3H, H-
17), 2.88 (d, J = 6.1 Hz, 2H, H-1), 3.72 (s, 3H, H-11), 4.85 (s, 1H, H-6), 5.12 (d, J = 1.2 
Hz, 1H, H-6), 6.53 (t, J = 5.9 Hz, 1H, N-H), 6.78 (d, J = 8.7 Hz, 2H, H-9), 7.21 (d, J = 
8.6 Hz, 2H, Ar-H), 7.68 (d, J = 8.3 Hz, 2H, Ar-H), 7.72 (d, J = 8.3 Hz, 2H, H-14), 8.75-
8.99 (br, 1H, N-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 21.7 (C-17), 25.5 (2C, C-3), 
35.6 (C-2), 44.8 (C-4), 49.8 (C-1), 55.3 (C-11), 113.8 (2C, C-9), 116.0 (C-6), 126.9 (Ar-
C), 127.5 (Ar-C), 129.7 (2C, Ar-C), 130.0 (2C), 135.5, 136.8, 144.8, 145.6, 152.1 
(C=O), 159.0 (C-10) ppm; IR (KBr): 3390, 2961, 1668, 1607, 1549, 1511, 1456, 1339, 
1247, 1163 cm–1; HRMS: [M+H+] calcd. for C22H29N2O4S•H+: 417.1843; found: 
417.1842. 
(S)-N-[7a-(4-Fluorophenyl)-6,6-dimethyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-
ylidene]-4-methylbenzenesulfonamide (163a) 
 
Compound 162a (0.12 mmol, 50 mg) was cyclized according to the general procedure 5 
(Table 3.3, entry 1) to give 163a. The crude product was purified by chromatography 
(ethyl acetate/hexane 1:2) to yield 163a (40 mg, 0.1 mmol, 80%, 61% ee) as a 
colourless solid.  
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Colorless solid: m.p. 160 ºC (decomp.); [α]D25 = –16.2 (c = 0.12, CHCl3); 1H NMR (400 
MHz, CDCl3): δ = 0.81 (s, 3H, H-3'), 1.00 (s, 3H, H-3), 2.00 (d, J = 13.1 Hz, 1H, H-4), 
2.19 (d, J = 13.1 Hz, 1H, H-4), 2.34 (s, 3H, H-16), 2.92 (d, J = 12.0 Hz, 1H, H-1), 3.69 
(d, J = 12.0 Hz, 1H, H-1), 4.31 (d, J = 8.8 Hz, 1H, H-6), 4.55 (d, J = 8.8 Hz, 1H, H-6), 
7.00 (t, J = 8.6 Hz, 2H, H-9), 7.12-7.20 (m, 4H, Ar-H), 7.81 (d, J = 8.3 Hz, 2H, H-13) 
ppm; 13C NMR (100 MHz, CDCl3): δ = 21.6 (C-16), 27.7 (C-3), 29.1 (C-3'), 42.2 (C-2), 
52.8 (C-4), 60.2 (C-1), 72.6 (C-5), 81.5 (C-6), 116.3 (J = 21 Hz, 2C, C-10), 126.1 (J = 8 
Hz, 2C, C-9), 127.0 (2C), 129.1 (2C), 139.6, 142.6, 162.0 (C-11), two carbon missing, 
ppm; IR (KBr): 2925, 1607, 1508, 1420, 1156, 913, 743 cm–1; HRMS: [M+H+] calcd. 
for C21H23FN2O3S•H+: 403.1486; found: 403.1486; ee: 61%; determined by HPLC 
analysis: Chiralcel AD column, hexanes/i-PrOH = 90/10, 0.5 mL/min, 232 nm; tr 
(minor) = 21.5 min, tr (major) = 24.4 min. 
(Z)-N-(7-(4-Methoxyphenyl)-6,6-dimethyl-5,6-dihydropyrrolo[1,2-c]oxazol-3(1H)-
ylidene)-4-methylbenzenesulfonamide (163b) 
 
To a solution of (diacetoxyiodo)benzene (0.11 mmol, 36 mg) in dry CH2Cl2 (2 mL) 
TBDMSOTf (0.15 mmol, 34 µL) was added at –78 ºC and stirred for 20 min. Then 
162b (0.075 mmol, 31 mg), dissolved in dry CH2Cl2 (2 mL) was added, stirred at _78 ºC 
for 1 h and then subjected to column chromatography (ethyl acetate/hexane 4:3) without 
quenching to obtain 163b in 66% yield (0.05 mmol, 21 mg) as a colourless oil. 1H NMR 
(400 MHz, CDCl3): δ = 1.21 (s, 6H, H-3), 2.32 (s, 3H, H-17), 2.65 (s, 2H, H-1), 3.56 (s, 
2H, H-11), 3.77 (s, 3H, H-9), 6.85 (d, J = 8.9 Hz, 2H, H-7), 7.19-7.24 (m, 4H, Ar-H), 
7.81 (d, J = 8.3 Hz, 2H, H-6) ppm; 13C NMR (126 MHz, CDCl3): δ = 21.5 (C-17), 27.3 
(2C, C-3), 37.4 (C-2), 45.7 (C-1), 55.4 (C-9), 56.5 (C-11), 114.5 (2C, C-7), 119.6 (C-4), 
124.9 (2C, Ar-C), 125.5, 127.1 (2C, Ar-C), 129.1 (2C, Ar-C), 136.5 (C-10), 140.0, 
142.4, 150.0, 159.4 ppm; IR (KBr): 1623, 1514, 1298, 1252, 1156, 1092, 913 cm–1; 
HRMS: [M+H+] calcd. for C22H24N2O4S•H+: 413.1530; found: 413.1526. 
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1-(2,2-Diphenylpent-4-enyl)-3-phenylurea (164) 
 
The synthesis of  164 was performed by reacting amine 135 (400 mg, 1.7 mmol) with 
phenyl isocyanate (0.203 ml, 1.87 mmol) similar to the general procedure 1 for 
reactions with isocyanates. Compound 164 was obtained in 90% yield (545 mg, 1.53 
mmol). 
The spectroscopic data are in agreement with the literature.[10] Colourless solid, m.p. 
148-150 ºC (Lit. 171-172.5 oC)(10) ; 1H NMR (250 MHz, CDCl3): δ = 2.79 (d, J = 7.05 
Hz, 2H, H-3), 3.89 (d, J = 5.8 Hz, 2H, H-1), 4.26 (t, J = 5.70 Hz, 1H, N-H), 4.88-4.96 
(m, 2H, H-5), 5.37 (ddt, J = 7.0, 9.9, 17.1 Hz, 1H, H-4), 6.04 (br, 1H, N-H), 7.96-7.25 
(m, 15H, Ar-H) ppm. 
1-(2,2-Diphenylpent-4-enyl)-3-(4-trifluoromethyl)phenyl)urea (165) 
 
The synthesis of 165 was performed by reacting amine 135 (400 mg, 1.7 mmol) with  4-
trifluoromethylphenyl isocyanate (0.255 mL, 1.78 mmol) similar to the general 
procedure 1 for reactions with isocyanates. Compound 165 was obtained in 99% yield 
(721 mg, 1.7 mmol). 
1H NMR (400 MHz, CDCl3): δ = 2.96 (d, J = 7.0 Hz, 2H, H-3), 3.98 (d, J = 5.7 Hz, 2H, 
H-1), 4.97-5.05 (m, 2H, H-5), 5.46-5.56 (m, 1H, H-4), 5.75 (t, J = 5.7 Hz, N-H), 7.26-
7.61 (m, 14H, Ar-H), 9.03 (s, 1H, N-H) ppm; 13C NMR (100 MHz, CDCl3): δ = 41.3 
(C-3), 45.8 (C-2), 50.0 (C-1), 113.4 (C-5), 117.4, 118.6, 123.7, 126.3, 126.4, 126.5, 
128.1 (4C), 128.5 (4C), 134.6, 144.4, 146.0 (2C), 155.0 (C=O) ppm.  
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1-(4-Phenylpent-4-enyl)-3-(4-(trifluoromethyl)phenyl)urea (166) 
 
The synthesis of 166 was performed by reacting amine 155 (240 mg, 1.48 mmol) with 
4-trifluoromethylphenyl isocyanate (0.21 ml, 1.48 mmol) similar to the general 
procedure 1 for reactions with isocyanates. Compound 166 was obtained in 73% yield 
(375 mg, 1.07 mmol).  
Colourless solid, m.p. 84-86 oC;  1H NMR (400 MHz, CDCl3): δ = 1.55 (quint, J = 7.2 
Hz, 2H, H-2), 2.42 (t, J = 7.4 Hz, 2H, H-3), 3.12 (d, J = 6.9 Hz, 1H, H-1), 3.15 (d, J = 
6.5 Hz, 1H, H-1), 4.92 (s,1H, H-5), 5.17 (s, 1H, H-5), 5.23 (t, J = 5.1 Hz, 1H, N-H), 
7.17-7.31 (m, 7H, Ar-H), 7.37 (d, J = 8.6 Hz, 2H, H-15), 8.21 (s, 1H, N-H) ppm; 13C 
NMR (100 MHz, CDCl3): δ = 28.7 (C-2), 32.9 (C-3), 40.3 (C-1), 113.4 (C-5), 119.2, 
119.4 (2C, Ar-C), 126.7 (2C), 126.8, 128.0, 128.8 (2C), 141.0, 142.3, 147.6 (C-4), 
156.1 (C=O); IR (KBr): 3084, 3058, 2941, 1946, 1653, 1603, 1478, 1163, 1067, 1014, 
757 cm–1. 
N-(6,6-diphenyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-ylidene)aniline (167a) 
 
The compound 167a was synthesized from 164 in the presence of PhI(OAc)2 (1.2 
equiv) and TMSOTf (2.0 equiv) in 31% yields. 1H NMR (400 MHz, CDCl3): δ = 2.36 
(dd, J = 8.9, 11.9 Hz, 1H, H-3), 2.53 (dd, J = 4.8, 11.8 Hz, 1H, H-3), 3.96 (d, J = 11.2 
Hz, 1H, H-1), 4.0-4.08 (m, 2H, H-5), 4.26 (d, J = 11.3 Hz, 1H, H-1), 4.45-4.52 (m, 1H, 
H-4), 7.00 (d, J = 9.1 Hz, 2H, Ar-H), 7.04 (d, J = 9.1 Hz, 2H, Ar-H), 7.15-7.26 (m, 9H, 
Ar-H) ppm. 
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2,6,6-Triphenyltetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one (167b) 
 
The compound 167b was synthesized from general procedure 5 for cyclizations of 157 
(Table 3.3, entry 1) in 15% yield and 42% ee by using CH3CN as a solvent. 
1H NMR (400 MHz, CDCl3): δ = 2.35 (dd, J = 9.1, 11.8 Hz, 1H, H-3), 2.52 (dd, J = 4.9, 
11.8 Hz, 1H, H-3), 3.98-4.06 (m, 3H), 4.28 (d, J = 11.3 Hz, 1H, H-1), 4.42-4.48 (m, 1H, 
H-4), 6.97 (d, J = 7.4 Hz, 2H, Ar-H), 7.15-7.26 (m, 13H, Ar-H) ppm. 
N-(6,6-Diphenyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-ylidene)aniline (168) 
 
The compound 168 was synthesized from general procedure 5 for cyclizations of 157 
(Table 3.3, entry 1) in 45% yield and 39% ee.  
Colourless solid, m.p. 154–156 ºC; 1H NMR (500 MHz, CDCl3): δ = 2.37 (dd, J = 9.3, 
11.7 Hz, 1H, H-3), 2.53 (dd, J = 4.8, 11.8 Hz, 1H, H-3), 3.98-4.10 (m, 3H), 4.27 (d, J = 
11.1 Hz, 1H, H-1), 4.46-4.50 (m, 1H, H-4), 7.02 (d, J = 8.1 Hz, 2H, Ar-H), 7.13-7.27 
(m, 10H, Ar-H), 7.40 (d, J = 8.1 Hz, 2H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δ = 
43.9 (C-3), 58.7 (C-2), 59.0 (C-1), 59.4 (C-4), 71.5 (C-5), 123.9, 126.1, 127.2 (d, J = 3.4 
Hz ), 127.3 (2C), 127.4 (2C), 129.0 (4C), 129.1 (4C), 145.9 (d, J = 33.8 Hz ), 151.0 (C-
7), 157.5 (C-6). ppm. IR (KBr): 3445, 1674, 1603, 1485, 1395, 1323, 1241, 1159, 1107, 
851, 791, 700 cm–1; HRMS: [M+H+] calcd. for C25H21F3N2O•H+: 423.1679; found: 
423.1677. 
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(S)-N-(7a-Phenyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-ylidene)-4-(trifluoromethyl) 
aniline (169) . 
 
The compound 169 was synthesized from procedure 5 for cyclizations of 157 (Table 
3.3, entry 1) in 30% yield and 79% ee. 
Colourless solid, m.p.: 62–64 ºC; 1H NMR (500 MHz, CDCl3): δ = 1.65-1.75 (m, 1H, 
H-2), 1.92 (dd, J = 11.4, 19.8 Hz, 1H, H-2), 2.02-2.06 (m, 1H, H-3), 2.33 (dd, J = 7.3, 
11.3 Hz, 1H, H-3), 3.34-3.36 (m, 1H, H-1), 3.88-3.89 (m, 1H, H-1), 4.22 (d, J = 8.5 Hz, 
1H, H-9), 4.48 (d, J = 8.5 Hz, 1H, H-9), 7.11 (d, J = 8.3 Hz, 2H, H-12) 7.25-7.35 (m, 
5H, Ar-H), 7.43 (d, J = 8.4 Hz, 2H, H-13) ppm; 13C NMR (126 MHz, CDCl3): δ = 25.4 
(C-2), 37.3 (C-3), 48.4 (C-1), 77.1 (C-9), 123.6, 124.9, 125.7, 127.8, 129.0, 137.5, 
141.0, 142.5, 150.6 (C-10) (2 carbon atoms not appearing due to small amount of 
compound and coupling to F); IR (KBr): 3465, 1674, 1605, 1322, 1114, 1065, 913, 743 
cm–1; HRMS: [M+H+] calcd. for C19H17F3N2O•H+: 347.1366; found: 347.1368; ee: 
79%; determined by HPLC analysis: Chiracel AD column, hexanes/i-PrOH = 95/5, 0.5 
mL/min, 232 nm; tr (major) = 3.3 min, tr (minor) = 4.6 min. 
2,2-Diallylmalononitrile (170) 
 
In a two neck flask, sodium hydride (5.43 g, 227 mmol) was added and cleaned with 
petroleum ether under flow of nitrogen. After 10 min, the petroleum ether was removed. 
Then, dry THF (100 mL) was added and the mixture was stirred vigorously. At 0 °C, 
malononitrile (3 g, 45.4 mmol) was added and the reaction mixture was stirred for 2 h at 
room temperature. Then, allyl bromide (9.82 mL, 113.5 mmol) was slowly added at 0 
°C and stirring was continued for 4 h at room temperature. The reaction is quenched 
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with H2O and extracted with EtOAc (3 × 20 mL). The organic layers were combined, 
dried over anhydrous MgSO4, and evaporated under reduced pressure to provide the 
crude compound. This compound was made pure by column chromatography on silica 
gel (Hex:EtOAc/10:1/v:v) to give 3.18 g (21.8 mmol) of the pure product 170 in 85% 
yield. 
Colourless oil, 1H NMR (250MHz, CDCl3): δ = 2.71 (d, J = 7.3Hz, 4H, H-3), 5.41-5.50 
(m, 4H, H-5), 5.85-6.02 (m, 2H, H-4). 
2,2-Diallylpropane-1,3-diamine (171) 
 
Synthesized from general procedure for reduction, using LiAlH4 (4.0 equiv) in 88% 
yield. 
Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 1.05 (br s, 4H, N-H), 1.96 (d, J = 7.5 
Hz, 4H, H-3), 2.50 (s, 4H, H-1), 5.03 (m, 4H, H-5), 5.71-5.81 (m, 2H, H-4) ppm. 
N,N'-{[(2,2-Diallylpropane-1,3-diyl)bis(azanediyl)]bis(carbonyl)}bis(4 
methylbenzenesulfonamide) (172) 
 
To solution of diamine 171 (750 mg, 4.87 mmol) in dry CH2Cl2 (8 mL) under argon, 
tosyl isocyanate (1.77 mL, 10.53 mmol) was added at 0 ºC and the mixture was stirred 
overnight at room temperature. Then, the reaction mixture was quenched with 1 N HCl 
(10 mL) and extracted with CH2Cl2 (3 × 25 mL). The organic layers were combined, 
dried over anhydrous MgSO4 and evaporated under reduced pressure to yield 1.97 g 
(3.59 mmol, 74%) of the product 172, which was used without further purification. 
Colourless solid, m.p. = 72-77 ºC; 1H NMR (400 MHz, CDCl3): δ = 1.72 (d, J = 7.3 Hz, 
4H, H-2), 2.32 (s, 6H, H-11), 2.84 (d, J = 6.4 Hz, 4H, H-5), 4.98 (m, 4H, H-4), 5.68 (m, 
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2H, H-3), 6.58 (t, J = 6.4 Hz, 2H, N-H), 7.20 (d, J = 8.2 Hz, 4H, H-9), 7.72 (d, J = 8.3 
Hz, 4H, H-8), 9.26 (br, 2H, N-H) ppm; 13C NMR (100 MHz, CDCl3): δ = 20.4 (2C, C-
11), 35.7 (C-1), 40.6 (2C, C-2), 42.3 (2C, C-5), 117.6 (2C, C-4), 126.1 (4C, Ar-C), 
128.7 (4C, Ar-C), 131.7 (2C), 135.1 (2C), 143.7 (2C, C-7), 151.6 (2C, C-6) ppm; IR 
(KBr): 3065, 1675, 1539, 1448, 1341, 1162, 1090, 764 cm–1; HRMS: [M+H+] calcd. for 
C25H32N4O6S2•H+: 549.1836; found: 549.1829. 
Procedure for the synthesis of racemic 173a and 173b 
To a solution of 172 (100 mg, 0.18 mmol) and (diacetoxyiodo)benzene (141 mg, 0.44 
mmol) in anhydrous CH2Cl2 (6 mL) under argon, TMSOTf (79 µL, 0.44 mmol) was 
added slowly at –78 °C. The mixture was allowed to warm to room temperature and 
was stirred overnight. The reaction mixture was quenched with sat. aq. NaHCO3 and 
extracted with CH2Cl2 (3 × 25 mL). The organic layers were combined, dried over 
anhydrous MgSO4, and evaporated under reduced pressure. The reaction mixture was 
purified by column chromatography on silica gel (hexane:EtOAc:MeOH 3:3:2 v:v:v) to 
give 8 mg of 173a (0.015 mmol, 8%), and 32 mg of 173b (0.059 mmol, 33%). 
N,N'-(Tetrahydro-1H,1'H-6,6'-spirobi[pyrrolo[1,2-c]oxazol]-3,3'(5H,5'H)-
diylidene)bis(4-methylbenzenesulfonamide) (173a) 
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The possible stereoisomers are following, 
 
Colourless solid, m.p. = 96-99 ºC; 1H NMR (400 MHz, CDCl3): δ = 1.62 (dd, J = 8.6, 
13.1 Hz, 2H, H-2), 2.09 (dd, J = 6.4, 12.8 Hz, 2H, H-2), 2.34 (s, 6H, H-11), 3.14 (d, J = 
12 Hz, 2H, H-5), 3.71 (d, J = 12 Hz, 2H, H-5), 4.10 (m, 2H, H-3), 4.26 (dd, J = 5.9, 9.3 
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Hz, 2H, H-4), 4.66 (t, J = 8.8 Hz, 2H, H-4), 7.19 (d, J = 8.2 Hz, 4H, H-9), 7.75 (d, J = 
8.2 Hz, 4H, H-8) ppm; 13C NMR (100 MHz, CDCl3): δ = 21.6 (2C, C-11), 42.2 (C-1), 
57.2 (2C, C-2), 59.1 (2C, C-5), 73.5 (2C, C-3), 77.3 (2C, C-4), 127.1 (4C, Ar-C), 129.2 
(4C, Ar-C), 139.1 (2C, C-10), 142.9 (2C, C-7), 161.1 (2C, C-6) ppm; IR (KBr): 2950, 
1595, 1436, 1218, 1157, 771 cm–1; HRMS: [M+H+] calcd. for C25H28N4O6S2•H+: 
545.1523; found: 545.1507. 
4-Methyl-N-(3-oxo-2-tosyloctahydro-1'H-spiro{pyrrolo[1,2-c]imidazole-6,6'-
pyrrolo[1,2-c]oxazol}-3'(5'H)-ylidene)benzenesulfonamide (173b) 
 
The possible stereoisomers are following, 
 
Colourless solid, m.p. = 126-131 ºC; 1H NMR (400 MHz, CDCl3): δ = 1.59-1.72 (m, 
2H), 1.98 (dd, J = 6.0, 12.8 Hz, 1H), 2.11 (dd, J = 6.1, 12.5 Hz, 1H), 2.32 (s, 3H), 2.33 
(s, 3H), 3.12 (d, J = 12.0 Hz, 1H), 3.20 (d, J = 11.7 Hz, 1H), 3.53 (t, J = 12.1 Hz, 2H), 
4.10-4.15 (m, 2H), 4.21-4.23 (m, 1H), 4.33 (dd, J = 5.1, 9.2 Hz, 1H), 4.62-4.68 (m, 2H), 
7.17-7.19 (m, 4H), 7.72-7.53 (m, 4H) ppm; 13C NMR (100 MHz, CDCl3): δ = 21.6 
(2C), 29.7, 41.9, 42.6, 54.7, 56.3, 57.4, 59.27, 59.34, 73.2, 73.5, 77.3, 127.0 (4C), 
129.25 (2C), 129.28 (2C), 139.2, 139.3, 142.9, 143.0, 160.5, 161.0 ppm; IR (KBr): 
2922, 1700, 1594, 1276, 1157, 1082, 749 cm–1; HRMS: [M+H+] calcd. for 
C25H28N4O6S2•H+: 545.1523; found: 545.1514. 
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Synthesis of 174 and 175 
The compound 174 and 175 were synthesized from known literature procedures from 
their corresponding amines.[11]  
N-(2,2-diphenylpent-4-en-1-yl)-4-methylbenzenesulfonamide (174)  
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1H NMR (400 MHz, CDCl3): δ = 2.42 (s, 3H, H-10), 2.89 (d, J = 7.1 Hz, 2H, H-3), 3.51 
(d, J = 6.4 Hz, 2H, H-1), 3.81 (t, J = 6.4 Hz, 1H, N-H), 4.92-4.96 (m, 2H, H-5), 5.20-
5.31 (m, 1H, H-4), 7.04-7.06 (m, 4H, Ar-H), 7.19-7.28 (m, 8H, Ar-H), 7.59 (d, J = 8.3 
Hz, 2H, H-7) ppm.   
4-Methyl-N-(4-phenyl-4-pentenyl)benzenesulfonamide (175) 
 
1H NMR (500 MHz, CDCl3): δ = 1.21 (quint, J = 7.2 Hz, 2H, H-2), 2.34 (s, 3H, H-10), 
2.42 (t, J = 7.2 Hz, 2H, H-3), 2.87 (q, J = 6.6 Hz, 2H, H-1), 4.49 (t, J = 6.2 Hz, 1H, N-
H), 4.92 (d, J = 1.2 Hz, 1H, H-5), 5.17 (d, J = 1.1 Hz, 1H, H-5), 7.18-7.23 (m, 7H, Ar-
H), 7.63 (d, J = 8.3 Hz, 2H, H-7) ppm; 13C NMR (126 MHz, CDCl3): δ = 21.5 (C-10), 
28.0 (C-2), 32.3 (C-3), 42.8 (C-1), 113.1 (C-5), 126.1 (2C), 127.1 (2C), 127.6, 128.4 
(2C), 129.7 (2C), 137.0, 140.6, 143.3, 147.2 (C-4) ppm; HRMS: [M+H+] calcd. for 
C18H22NO2S•H+: 316.1366; found: 316.1367. 
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3-Acetoxy-5,5-diphenyl-1-tosylpiperidine (176) 
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Compound 142 (45 mg, 0.061 mmol) and TMSOTf (0.082 mmol, 10 µL) were stirred at 
–78 ºC for 30 min in dry CH2Cl2 (5 mL), before  174 (0.04 mmol, 15 mg) and acetic 
acid (0.2 mmol, 12 µL) were added. After 20 h at –78 ºC stirring was continued for 4 h 
at 0 ºC. The reaction mixture was concentrated in vacuo and directly purified by 
chromatography (ethyl acetate/hexane 2:5). Compound 176 was obtained in 54% yield 
(0.021 mmol, 10 mg) as colourless solid. 
Colourless solid, m.p. 132-133 ºC; 1H NMR (250 MHz, CDCl3): δ = 1.80 (s, 3H, H-7), 
2.09 (dd, J = 12.7, 9.9 Hz, 1H, H-3), 2.35 (s, 3H, H-16), 2.41 (t, J = 9.3 Hz, 1H, H-3), 
2.75 (d, J = 12.4 Hz, 2H), 3.62 (dd, J = 10.4, 4.3 Hz, 1H), 4.14 (d, J = 11.9 Hz, 1H), 
4.74 (tt, J = 9.4, 4.6 Hz, 1H, H-4), 7.02-7.41 (m, 12H, Ar-H), 7.56 (d, J = 8.3 Hz, 2H) 
ppm; ee: 27%; determined by HPLC analysis: Chiracel OD-H column, hexanes/i-PrOH 
= 95/5, 0.5 mL/min, 232 nm; tr (major) = 37.8 min, tr (minor) = 41.6 min. 
5-Phenyl-1-tosyl-1,2,3,6-tetrahydropyridine (177a) 
 
To a solution of (diacetoxyiodo)benzene (0.19 mmol, 61 mg) in dry CH2Cl2 (2 mL), 
TBDMSOTf (0.26 mmol, 0.059 mL) was added at –78 ºC and stirred for 30 min. Then a 
mixture of 175 (0.13 mmol, 40 mg) and acetic acid (0.37 mmol, 22 µL) in dry CH2Cl2 
(2 mL) was added and stirred at –78 ºC for 2 h. After warming to room temperature the 
reaction mixture was subjected to column chromatography (ethyl acetate/hexane 1:10, 
without any quenching) and the title compound 177a was obtained in 48% yield (0.063 
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mmol, 18 mg) as colourless oil. The spectroscopic data are in agreement with the 
literature.[12] 
1HNMR (500 MHz, CDCl3): δ = 2.30-2.33 (m, 2H, H-4), 2.35 (s, 3H, H-10), 3.17 (t, J = 
5.8 Hz, 2H, H-5), 3.87 (q, J = 2.4 Hz, 2H), 5.98-6.01 (m, 1H, H-3), 7.19-7.26 (m, 7H, 
Ar-H), 7.65 (d, J = 8.5 Hz, 2H, H-7) ppm. 
5-Phenyl-1-tosyl-1,2,3,4-tetrahydropyridine (177b) 
 
To a solution of (diacetoxyiodo)benzene (0.19 mmol, 61 mg) in dry CH2Cl2 (2 mL) 
BF3•OEt2 (0.26 mmol, 0.032 mL) was added at –78 ºC and stirred for 30 min. Then a 
mixture of 175 (0.13 mmol, 40 mg) and acetic acid (0.64 mmol, 37 µL) in dry CH2Cl2 
(2 mL) was added and stirred at –78 ºC for 2 h and then at room temperature for another 
2 h the reaction mixture was subjected to column chromatography (ethyl acetate/hexane 
1:10, without any quenching) and the title compound 177b was obtained in 42% yield 
(0.055 mmol, 16 mg) as colourless oil. The spectroscopic data are not described in 
literature although the synthesis of the compound 177b has been reported.[13]  
1HNMR (500 MHz, CDCl3): δ = 1.70-1.77 (m, 2H, H-4), 2.26 (dt, J = 6.3 Hz, 2H, H-3), 
2.34 (s, 3H, H-10), 3.34-3.37 (m, 2H, H-5), 7.10 (t, J = 1.4 Hz, 1H, H-1), 7.21-7.26 (m, 
7H, Ar-H), 7.61 (d, J = 8.3 Hz, 2H, H-7) ppm; 13C NMR (62.5 MHz, CDCl3): δ = 21.0, 
21.6, 23.7, 43.5 (C-5), 119.6, 122.2, 124.5 (2C), 126.6, 127.1 (2C), 128.5, 129.9 (2C), 
135.0 (2C), 139.7, 143.8 ppm; IR (KBr): 2928, 1636, 1494, 1447, 1343, 1164, 1094, 
1027, 767, 697, 666, 562 cm–1; HRMS: [M+H+] calcd. for C18H20NO2S•H+: 314.1209; 
found: 314.1210. 
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Synthesis of 178 
(S)-7a-Phenyltetrahydropyrrolo[1,2-c]oxazol-3(1H)-imine (178) 
 
Protocol for cleavage is similar to literature procedure. A solution of 157 (0.05 mmol, 
18 mg) in a mixture of conc. H2SO4/H2O (1.2 mL, 1:1) was heated to 150 °C while 
stirring for 4 h. The reaction was cooled to room temperature, CH2Cl2 (5 mL) and water 
(5 mL) were added, the mixture was stirred, and the layers were separated. The aqueous 
layer was washed with CH2Cl2 (2 × 5 mL), then the aqueous layer was cooled in an ice 
bath and KOH pellets were added until the solution was basic (pH = 14). Precipitated 
salts were removed by filtration, then the basic aqueous layer was extracted with 
CH2Cl2 (3 × 5 mL), the combined organic phases dried over MgSO4, filtered and 
concentrated in vacuo. Column chromatography was performed with CHCl3 : MeOH 
(4:1) to yield compound 178 in 30% yield (0.015 mmol, 3 mg). A similar reaction was 
performed using rac-157 (0.48 mmol, 171 mg) yielding rac-178 in 36% yield (0.17 
mmol, 35 mg). 
 [α]D25 = +16.6 (c = 0.19, CHCl3) (92% ee); 1H NMR (400 MHz, CDCl3): δ = 1.62-1.74 
(m, 1H, H-2), 1.87-1.94 (m, 1H, H-2), 1.98-2.06 (m, 1H, H-3), 2.28 (ddd, J = 12.0, 6.8, 
2.0 Hz, 1H, H-3), 3.31-3.37 (m, 1H, H-1), 3.67-3.74 (m, 1H, H-1), 4.14 (d, J = 8.4 Hz, 
1H, H-5), 4.44 (d, J = 8.4 Hz, 1H, H-5), 4.77-4.87 (br, 1H, N-H), 7.23-7.33 (m, 5H, Ar-
H) ppm; 13C NMR (126 MHz, CDCl3): δ = 25.6 (C-2), 37.2 (C-3), 48.3 (C-1), 74.3, 
76.9, 124.8 (2C), 127.7, 128.9 (2C), 142.6 (C-7), 165.4 (C-6) ppm; IR (KBr): 3466, 
2084, 1639, 1585, 1276, 1157, 769 cm–1; HRMS: [M+H+] calcd. for C12H14N2O•H+: 
203.1179; found: 203.1175. 
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(S)-(2-Phenylpyrrolidin-2-yl)methanol (179)[14] 
 
Protocol for cleavage is similar to literature.[15] To compound 178 (0.015 mmol, 3 mg) 
11.6N aq. KOH (1.5 mL) was added and heated to reflux for 3 h. The reaction was 
cooled to room temperature and the basic aqueous layer was extracted with CHCl3 (3 x 
5 mL), filtered through a phase separator (Isolute SPE, Biotage) and concentrated to 
give the product in 75 % yield (0.011 mmol, 2 mg). A similar reaction was performed 
using rac-178 (0.12 mmol, 25 mg) yielding rac-179 in 80% yield (0.096 mmol, 17 mg). 
 [α]D25 = +21.4 (c = 0.13, CHCl3) (92% ee); 1H NMR (400 MHz, CDCl3): δ = 1.68-1.73 
(m, 1H, H-2), 1.74-1.81 (m, 1H, H-2), 1.85-1.95 (m, 1H, H-3), 2.02-2.08 (m, 1H, H-3), 
2.23-2.55 (br, 2H, NH and OH), 2.99-3.02 (m, 2H, H-1), 3.43 (d, J = 10.6 Hz, 1H, H-5), 
3.53 (d, J = 10.6 Hz, 1H, H-5), 7.25-7.31 (m, 5H, Ar-H) ppm; 13C NMR (126 MHz, 
CDCl3): δ = 25.5 (C-2), 35.2 (C-3), 45.9 (C-1), 68.3, 69.1, 125.7 (2C), 126.8, 128.4 
(2C), 145.8 (C-7) ppm; IR (KBr): 3400, 2959, 1634, 1446, 1054, 913, 760, 701 cm–1; 
HRMS: [M+H+] calcd. for C11H15NO•H+: 178.1232; found: 178.1239. 
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6.5   Experimental for Rearrangement Reactions 
General procedure 6 for the synthesis of starting materials 253a-k 
To a solution of the acetophenone derivative (10 mmol) and the corresponding 
benzaldehyde (10 mmol) in MeOH (25 mL) an aqueous solution of NaOH (1 mL, 50% 
w/v) was added dropwise. The reaction mixture was stirred overnight at room 
temperature. The reaction mixture was then neutralized with a 1 M aqueous solution of 
HCl. The resulting solution was extracted with EtOAc (3 × 35 mL), the combined 
organic layers were dried over MgSO4 and the solvents were removed in vacuo. The 
chalcone was obtained after crystallization from hexane/EtOAc or by column 
chromatography (Hexane/EtOAc = 95:5). 
 
Table 5.1: Synthesis of chalcone derivatives 253a-k 
Entry R Ar Product Yield [%] 
1 Ph Ph 253a: 51 
2 Ph 4-F-C6H4 253b: 62 
3 Ph 4-Cl-C6H4 253c: 92 
4 Ph 4-Br-C6H4 253d: 61 
5 Ph 4-NO2-C6H4 253e: 79 
6 Ph 4-Me-C6H4 253f: 82 
7 Ph 4-iPr-C6H4 253g: 82 
8 Ph 4-tBu-C6H4 253h: 69 
9 Ph 3-Me-C6H4 253i: 79 
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10 Ph 4-OMe-C6H4 253j: 32 
11 2-furyl Ph 253k: 48 
(E)-1,3-Diphenyl prop-2-en-1-one (253a) 
 
The spectroscopic data are in agreement with literature.[16] Yellow solid, m.p. 59-61 ºC 
(Lit. 55-57 ºC)[17] ; 1H NMR (400 MHz, CDCl3): δ = 7.42-7.44 (m, 3H, Ar-H), 7.50-
7.67 (m, 6H, Ar-H), 7.82 (d, J = 15.7 Hz, 1H, H-4), 8.02-8.04 (m, 2H, Ar-H) ppm. 
(E)-3-(4-Fluorophenyl)-1-phenylprop-2-en-1-one (253b) 
 
The spectroscopic data are in agreement literature.[16] Yellow solid, m.p.72-75 ºC (Lit. 
75-78 ºC) [18] ; 1H NMR (400 MHz, CDCl3): δ = 7.09-7.13 (m, 2H, H-7 and 9), 7.44-
7.66 (m, 6H, Ar-H), 7.78 (d, J = 15.7 Hz, 1H, H-4), 8.00-8.03 (m, 2H, H-11 and 15) 
ppm. 
(E)-3-(4-Chlorophenyl)-1-phenylprop-2-en-1-one (253c) 
 
The spectroscopic data are in agreement with literature.[19] Yellow solid m.p.72-75 ºC; 
1H NMR (300 MHz, CDCl3): δ = 7.40 (d, J = 8.6 Hz, 2H, Ar-H), 7.48-7.63 (m, 6H, Ar-
H), 7.76 (d, J = 15.8 Hz, 1H, H-4), 8.00-8.04 (m, 2H, H-11 and 15) ppm. 
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(E)-3-(4-Bromophenyl)-1-phenylprop-2-en-1-one (253d) 
 
The spectroscopic data are in agreement with literature.[19] Yellow solid, m.p. 116-119 
ºC (Lit. 115  ºC)[20] ; 1H NMR (300 MHz, CDCl3): δ = 7.48-7.63 (m, 8H, Ar-H), 7.75 (d, 
J = 15.6 Hz, 1H, H-4), 8.00-8.03 (m, 2H, H-15 and 11) ppm. 
(E)-3-(4-Nitrophenyl)-1-phenylprop-2-en-1-one (253e) 
O
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The spectroscopic data are in agreement with literature.[21] Yellow solid, m.p. 157-158 
ºC (Lit. 149-150 ºC)[22] ; 1H NMR (300 MHz, CDCl3): δ = 7.51-7.56 (m, 2H, Ar-H), 
7.61-7.68 (m, 2H, Ar-H), 7.77-7.86 (m, 3H, Ar-H), 8.03-8.06 (m, 2H, H-4), 8.26-8.31 
(m, 2H, Ar-H) ppm. 
(E)-1-Phenyl-3-(p-tolyl)prop-2-en-1-one (253f) 
 
The spectroscopic data are in agreement with literature.[23] Yellow solid, m.p. 80-84 ºC; 
(Lit. 92-96 ºC)[21] ; 1H NMR (400 MHz, CDCl3): δ 2.32 (s, 3H, H-9), 7.14-7.18 (m, 2H, 
Ar-H), 7.40-7.53 (m, 6H, Ar-H), 7.72 (d, J = 15.7 Hz, 1H, H-4), 7.93-7.95 (m, 2H, Ar-
H) ppm. 
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(E)-3-(4-Isopropylphenyl)-1-phenylprop-2-en-1-one (253g) 
 
Yellow oil; 1H NMR (400 MHz, CDCl3): δ = 1.28 (d, J = 6.9 Hz, 6H, H-10), 2.95 (sept, 
J = 6.9 Hz, 1H, H-9), 7.28-7.30 (m, 2H, Ar-H), 7.50-7.53 (m, 3H, Ar-H), 7.56-7.61 (m, 
3H, Ar-H), 7.82 (d, J = 15.7 Hz, 1H, H-4), 8.01-8.04 (m, 2H, Ar-H) ppm; 13C NMR 
(126 MHz, CDCl3): δ = 23.8 (2C, C-10), 34.2 (C-9), 121.2 (C-3), 127.1 (2C), 128.5 
(2C), 128.6 (2C), 128.7 (2C), 132.5, 132.7, 138.4 (C-1), 145.0 (C-4), 152.0 (C-8), 190.7 
(C-2) ppm; IR (NaCl): 639, 693, 735, 827, 984, 1017, 1033, 1054, 1071, 1143, 1178, 
1280, 1332, 1419, 1458, 1577, 1601, 1639, 1661, 1700, 1772 cm–1; HRMS: [M+H+] 
calcd. for C18H18O•H+: 251.1430; found: 251.1425. 
(E)-3-(4-(tert-Butyl)phenyl)-1-phenylprop-2-en-1-one (253h) 
 
 Yellow oil; 1H NMR (400 MHz, CDCl3): δ = 1.35 (s, 9H, H-10), 7.44-7.46 (m, 2H, Ar-
H), 7.49-7.53 (m, 3H, Ar-H), 7.57-7.61 (m, 3H, Ar-H), 7.81 (d, J = 15.7 Hz, 1H, H-4), 
8.01-8.03 (m, 2H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 31.2 (3C, C-10), 35.0 
(C-9), 121.3 (C-3), 126.0 (2C), 128.4 (2C), 128.5 (2C), 128.6 (2C), 132.2, 132.7, 138.4 
(C-1), 144.9 (C-4), 154.2 (C-8), 190.7 (C-2) ppm; IR (NaCl): 551, 643, 691, 736, 795, 
828, 984, 1017, 1033, 1071, 1109, 1178, 1364, 1398, 1447, 1561, 1602, 1640, 1664, 
1698, 1772 cm–1; HRMS: [M+ H+] calcd. for C19H20O•H+: 265.1587; found: 265.1580. 
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(E)-1-Phenyl-3-(m-tolyl)prop-2-en-1-one (253i) 
 
The spectroscopic data are in agreement with literature.[19] Yellow solid, m.p. 64-65 ºC 
(Lit. 64 ºC)[24] ; 1H NMR (400 MHz, CDCl3): δ = 2.41 (s, 3H, H-10), 7.23-7.25 (m, 1H, 
Ar-H), 7.32 (t, J = 7.9 Hz, 1H, Ar-H), 7.45-7.61 (m, 6H, Ar-H), 7.80 (d, J = 15.7 Hz, 
1H, H-4), 8.02-8.04 (m, 2H, Ar-H) ppm. 
(E)-3-(4-Methoxyphenyl)-1-phenylprop-2-en-1-one (253j) 
 
The spectroscopic data are in agreement with literature. Yellow solid, m.p. 75-77 ºC; 
(Lit. 70-73 ºC)[21] ; 1H-NMR: (250 MHz, CDCl3): δ = 3.85 (s, 3H, H-9), 6.97-6.91 (m, 
2H, Ar-H), 7.42 (d, J = 15.6 Hz, 1H, H-3), 7.63-7.50 (m, 5H, Ar-H), 7.79 (d, 
J = 15.6 Hz, 1H, H-4), 8.09-7.93 (m, 2H, Ar-H), ppm. 
(E)-1-(Furan-2-yl)-3-phenylprop-2-en-1-one (253k) 
 
The spectroscopic data are in agreement with literature.[25] Colourless solid, m.p. 79-83 
ºC (Lit. 70-73 ºC)[26] ; 1H NMR (250 MHz, CDCl3): δ = 6.60 (dd, J = 1.7 Hz, 3.6 Hz, 
1H, Ar-H), 7.33-7.35 (m, 1H, Ar-H), 7.41-7.49 (m, 4H, Ar-H), 7.64-7.68 (m, 3H, Ar-
H), 7.89 (d, J = 15.8 Hz, 1H, H-7) ppm. 
General procedure 7 for synthesis of compound 254a using H2SO4 
Chalcone 253a and the hypervalent iodine reagent (1.05 equiv) were dissolved in 3 mL 
of methanol. Then 0.15 mL of 50% H2SO4 (1.4 equiv) is added. Reaction mixture is 
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stirred for 3 h. The residue is recrystallized in diethylether and hexane (1:20). The 
crystals are filtered and washed with hexane (2 x 2 ml). The desired compound 254a is 
obtained as a colourless solid. 
General procedure 8 for synthesis of compound 254a using TBDMSOTf 
To the solution of hypervalent iodine reagent (1.5 equiv) in dry solvent (3.0 mL) at 0° 
C, added TBDMSOTf  (3.0 equiv) and was then allowed to stir for 10 min. To this 
mixture, added the chalcone (0.24 mmol, 1.0 equiv) dissolved in the corresponding 
solvent (1.0 mL) and 8.0 equiv. of methanol and stirred for further 10 min. Then it was 
warmed to the room temperature and stirred over night. The reaction mixture was 
quenched with a saturated aqueous solution of NaHCO3 and extracted with CH2Cl2  (3 x 
5 mL). The combined organic layers were dried over MgSO4 and the solvents were 
removed in vacuo. The migration product was purified by flash column chromatography 
(Hexane/Ethyl Acetate = 90:10). 
General procedure 9 for asymmetric synthesis of compound 254a 
To the solution of chiral hypervalent iodine 142 or 144 (0.05 mmol) in dry solvent (1.0 
mL) at _78 °C, added lewis acid  (0.1 mmol) and was then allowed to stir for 10 min. To 
this mixture, added the chalcone (0.033 mmol) dissolved in the corresponding solvent 
(0.5 mL) and 8.0 equiv. of methanol and stirred for further 10 min. Then it was warmed 
to _15 °C and stirred over night. The reaction mixture was quenched with a saturated 
aqueous solution of NaHCO3 and extracted with CH2Cl2  (3 x 5 mL). The combined 
organic layers were dried over MgSO4 and the solvents were removed in vacuo. The 
product was purified by preparative TLC (Hexane/Ethyl Acetate = 90:10). 
3,3-Dimethoxy-1,2-diphenylpropan-1-one (254a) 
 
The spectroscopic data are in agreement with literature.[27] Colourless solid, m.p. 95-96 
ºC (Lit. 93-94 ºC)28; 1H NMR (400 MHz, CDCl3): 3.21 (s, 3H, H-6), 3.45 (s, 3H, H-5), 
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4.91 (d, J = 8.5 Hz, 1H, H-3), 5.13 (d, J = 8.5 Hz, 1H, H-4), 7.22-7.52 (m, 8H, A-H), 
7.97-7.99 (m, 2H, Ar-H) ppm. 
NMR experiment for monitoring of reaction of 254a 
To the solution of chiral hypervalent iodine (0.263 g, 0.36 mmol) in dry solvent (3.0 
mL) at _78 °C, added TfOH  (0.063 mL, 0.72 mmol) and was then allowed to stir for 10 
min. To this mixture, added the chalcone (0.05 g, 0.24 mmol) dissolved in the 
dichloromethane (0.5 mL) and 8.0 equiv. of methanol and stirred for further 10 min. 
Then it was warmed to _15 °C and stirred. After regular intervals 0.3 mL of the sample 
was taken and filtered over silica by using chloroform. Then the solvent was evaporated 
in the vacuo and measured the NMR yields. The fractions were also purified by using 
preparative TLC (Hexane/Ethyl Acetate = 90:10) for the HPLC analysis. 
 
Fig. 1: 1H NMR monitoring of the migration reaction over the course of time 
General procedure 10 for asymmetric reactions 254a' to 254m 
To the solution of chiral hypervalent iodine 142 (0.36 mmol) in dry dichloromethane 
(1.5 mL) and 2,2,2-trifluoroethanol (1.5 mL) at –40 °C, added TMSOTf or TfOH (0.72 
mmol) and was then allowed to stir for 30 min. To this mixture, added the dissolved 
chalcone (0.24 mmol) in dry dichloromethane (0.5 mL) and 2,2,2-trifluoroethanol (0.5 
mL) and stirred for further 30 min. Then it was warmed to –15 °C and stirred overnight. 
The reaction mixture was quenched with a saturated aqueous solution of NaHCO3 and 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over 
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MgSO4 and the solvents were removed in vacuo. The migration product was purified by 
flash chromatography (CHCl3/Hexane = 1:1). 
1,2-Diphenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254a'): 
 
Colourless solid, m.p. 46-47 ºC; 1H NMR (500 MHz, CDCl3): δ = 3.63-3.74 (m, 2H, H-
7), 3.99-4.10 (m, 2H, H-5), 4.89 (d, J = 8.4 Hz, 1H, H-3), 5.48 (d, J = 8.4 Hz, 1H, H-4),  
7.28-7.43 (m, 7H, Ar-H), 7.51-7.54 (m, 1H, Ar-H), 7.93-7.94 (m, 2H, Ar-H) ppm; 13C 
NMR (126 MHz, CDCl3): δ = 57.8 (C-3), 64.3 (q, J = 34.7 Hz, C-7), 66.1 (q, J = 35.0 
Hz, C-5), 106.1 (C-4), 123.6 (q, J = 276.4 Hz, C-8), 123.7 (q, J = 276.0 Hz, C-6), 128.7 
(C-12), 129.09 (2C), 129.1 (2C), 129.4 (2C), 129.6 (2C), 133.6, 133.9 (C-9), 136.7 (C-
1), 196.8 (C-2) ppm; IR (NaCl): 698, 753, 838, 1012, 1097, 1167, 1281, 1449, 1497, 
1598, 1680 cm–1; HRMS: [M+Na+] calcd. for C19H16F6O3•Na+: 429.0896; found: 
429.0900; ee: 97%, determined by HPLC analysis: Daicel Chiralcel AD column (5 cm), 
hexanes/i-PrOH = 99.8/0.2, 0.5 mL/min, 243 nm; tr (minor) = 5.3 min, tr (major) = 7.8 
min; [α]D20 = + 70.7 (c = 1.41, CHCl3). (Hexane/EtOAc = 90:10).  
(E)-3-Deuterio-1,3-diphenyl prop-2-en-1-one (253l): 
 
The compound 253l was synthesised by using general procedure for starting materials 
in 60% yield. The spectroscopic data are in agreement with literature.[29] 1H NMR (400 
MHz, CDCl3): δ = 7.42-7.44 (m, 4H, Ar-H), 7.49-7.54 (m, 3H), 7.64-7.66 (m, 2H, Ar-
H), 8.02-8.04 (m, 2H, Ar-H) ppm; 13C NMR (100 MHz, CDCl3): δ = 122.4 (C-3), 128.8 
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(2C), 128.9 (2C), 129.1 (2C), 129.4 (2C), 131.0, 132.2, 135.3 (C-5), 138.7 (C-1), 145.0 
(t, J = 23.7 Hz, C-4), 191.0 (C-2) ppm. 
Procedure for synthesis of deuterated product 254l 
PhI(OAc)2 (0.116g, 0.36 mmol) and the deuterated chalcone 253l (0.05 g, 0.24 mmol) 
were dissolved in dry dichloromethane (1.5 mL) and 2,2,2-trifluoroethanol (1.5 mL) and 
cooled to -40 °C. TfOH (0.06 mL, 0.36 mmol) was then added dropwise and the 
resulting mixture was allowed to stirred for 3 hours at 0 °C. The reaction mixture was 
quenched with a saturated aqueous solution of NaHCO3 and extracted with CH2Cl2 (3 x 
10 mL). The combined organic layers were dried over MgSO4 and the solvents were 
removed in vacuo. The product was purified by flash column chromatography in 52% 
yield. 
3-Deuterio-1,2-diphenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254l)  
    
1H NMR (500 MHz, CDCl3): δ = 3.65-3.72 (m, 2H, H-7), 4.00-4.08 (m, 2H, H-5), 4.89 
(s, 1H, H-1), 7.29-7.43 (m, 7H, Ar-H), 7.51-7.54 (m, 1H, Ar-H), 7.92-7.94 (m, 2H, Ar-
H) ppm; 13C NMR (150 MHz, CDCl3): δ = 57.7 (C-3), 64.2 (q, J = 35.2 Hz, C-7), 66.1 
(q, J = 35.1 Hz, C-5), 105.7 (t, J = 25.8 Hz. C-4), 123.3 (q, J = 276.4 Hz, C-8), 123.7 (q, 
J = 276.3 Hz, C-6), 128.7 (C-12), 129.09 (2C), 129.1 (2C), 129.3 (2C), 129.6 (2C), 
133.5, 133.9, 136.6 (C-1), 196.8 (C-2) ppm; IR (NaCl): 426, 668, 699, 750, 769, 835, 
966, 1023, 1104, 1164, 1282, 1418, 1448, 1597, 1683, 2342 cm–1; HRMS: [M+ H+] 
calcd. for C19H152HF6O3•H+: 408.1139; found: 408.1132. 
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Position 1H NMR 13C NMR HSQC (H → C) HMBC (H → C) 
1 - 196.8 - - 
2 - 136.6 - - 
3, 3’ 7.29-7.43 (m, 2H) 129.1 C-3 C-2, C-4 
4, 4’ 7.92-7.94 (m, 2H) 129.09 C-4 C-3, C-5 
5 7.51-7.54 (m, 1H) 133.9 C-5 C-4 
6 4.89 (s, 1H) 57.7 C-6 C-1, C-11, C-7, C-8 
7 - 133.5 - - 
8, 8’ 7.29-7.43 (m, 2H) 129.3 C-8 C-7, C-9 
9, 9’ 7.29-7.43 (m, 2H) 128.7 C-9 C-8, C-10 
10 7.29-7.43 (m, 2H) 129.6 C-10 C-8, C-9 
11 - 105.7 (t, J = 25.8 Hz) - - 
12 3.65 – 3.72 (m, 2H) 64.2 (q, J = 35.2 Hz) C-12 - 
13 - 123.3 (q, J = 276.4 Hz) - - 
14 4.00 – 4.08 (m, 2H) 66.1 (q, J = 35.1 Hz) C-14 - 
15 - 123.7 (q, J = 276.3 Hz) - - 
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2-(4-Fluorophenyl)-1-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254b) 
 
Colourless solid, m.p. 56-59 ºC; 1H NMR (500 MHz, CDCl3): δ = 3.69-3.78 (m, 2H, H-
7), 3.95-4.11 (m, 2H, H-5), 4.89 (d, J = 8.5 Hz, 1H, H-3), 5.43 (d, J = 8.0 Hz, 1H, H-4), 
7.01-7.06 (m, 2H, Ar-H), 7.34-7.38 (m, 2H, Ar-H), 7.41-7.44 (m, 2H, Ar-H), 7.53-7.56 
(m, 1H, Ar-H), 7.91-7.92 (m, 2H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 56.7 
(C-3), 64.3 (q, J = 35.3 Hz, C-7), 66.0 (q, J = 35.3 Hz, C-5), 105.8 (C-4), 116.3 (d, J = 
21.7 Hz, 2C, C-11), 123.3 (q, J = 278.5 Hz, C-8), 123.5 (q, J = 278.5 Hz, C-6), 128.8 
(2C, Ar-C), 128.9 (2C), 129.2 (d, J = 3.3 Hz, C-9), 130.7 (d, J = 8.2 Hz, 2C, C-10), 
133.8, 136.2 (C-1), 162.6 (d, J = 249.5 Hz, C-12), 196.4 (C-2) ppm; IR (NaCl): 581, 
723, 762, 821, 968, 1096, 1164, 1228, 1449, 1506, 1598, 1682, 2961 cm–1; HRMS: 
[M+Na+] calcd. for C19H15F7O3•Na+: 447.0802; found: 447.0805; ee: 94%, determined 
by HPLC analysis: Daicel Chiralcel ODH column (25 cm), hexanes/i-PrOH = 99.7/0.3, 
0.5 mL/min, 246 nm; tr (major) = 16.8 min, tr (minor) = 29.4 min; [α]D20 = + 45.5 (c = 
1.09, CHCl3).   
2-(4-Chlorophenyl)-1-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254c) 
 
Colourless solid, m.p. 53-55 ºC; 1H NMR (500 MHz, CDCl3): δ = 3.71-3.81 (m, 2H, H-
7), 3.99-4.09 (m, 2H, H-5), 4.88 (d, J = 8.2 Hz, 1H, H-3), 5.44 (d, J = 8.2 Hz, 1H, H-4), 
7.32 (m, 4H, Ar-H), 7.41-7.45 (m, 2H, Ar-H), 7.53-7.56 (m, 1H, Ar-H), 7.90-7.91 (m, 
2H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 56.7 (C-3), 64.4 (q, J = 35.3 Hz, C-
7), 65.8 (q, J = 35.3 Hz, C-5), 105.5 (C-4), 123.2 (q, J = 278.7 Hz, C-8), 123.3 (q, J = 
278.6 Hz, C-6), 128.6 (2C, Ar-C), 128.8 (2C), 129.4 (2C), 130.2 (2C), 131.7, 133.7, 
 134.4, 136.0 (C-1), 196.2
1681 cm–1; HRMS: [M+
ee: 92%, determined by HPLC analysis: Daicel Chiralcel ODH column (25 cm), 
hexanes/i-PrOH = 99.5/0.5, 0.5 
(minor, S isomer) = 20.6 min; 
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Colourless solid, m.p. 52
7), 4.01-4.04 (m, 2H, H
7.24-7.26 (m, 2H, Ar
NMR (126 MHz, CDCl
Hz, C-5), 105.4 (C-4)
Hz, C-6), 128.6 (2C, Ar
1), 196.1 (C-2) ppm; IR (NaCl): 425, 809, 848, 1012, 1092, 1165, 1280, 1448, 1488, 
1596, 1683, 2284 cm
found: 507.0004; ee
column (25 cm), hexanes/
= 13.4 min, tr (minor, 
 
 (C-2) ppm; IR (NaCl): 770, 1016, 1093, 1165, 1281, 1492, 
Na+] calcd. for C19H15ClF6O3•Na+: 463.0506; found: 463.0510; 
mL/min, 246 nm; tr (major, R isomer
[α]D20 = + 44.5 (c = 0.49, CHCl3).   
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-55 ºC; 1H NMR (500 MHz, CDCl3): δ = 3.73
-5), 4.86 (d, J = 8.1 Hz, 1H, H-3), 5.43 (d, 
-H), 7.41-7.56 (m, 5H, Ar-H), 7.89-7.91 (m, 2H
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-C), 128.8 (2C), 130.5 (2C), 132.2, 132.3 (2C), 133.7, 135.9
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i-PrOH = 99.5/0.5, 0.5 mL/min, 246 nm; t
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137 
) = 14.8 min, tr 
-1-one (254d) 
-3.78 (m, 2H, H-
J = 8.1 Hz, 1H, H-4), 
, Ar-H) ppm; 13C 
-7), 65.8 (q, J = 35.5 
), 123.3 (q, J = 278.8 
 (C-
6O3•Na+: 507.0001; 
r (major, R isomer) 
3).   
 X-ray Crystallographic structure of
1-Phenyl-2-(4-tolyl)-3,3
8
10
11
7
6
13
12
1 2
3 4
5
14
15
16 9
O
O
O CF3
CF3
18
17
Light yellow solid, m.p. 37
3.64-3.74 (m, 2H, H-
J = 8.4 Hz, 1H, H-4), 7.14 (d, 
7.43 (m, 2H, Ar-H), 7.50
(126 MHz, CDCl3): δ
35.1 Hz, C-5), 104.8 
127.81 (2C, Ar-C), 127.84 (2C), 127.9 (2C), 129.1 (2C), 129.2, 132.6, 135.3, 137.3, 
195.6 (C-2) ppm; IR (NaCl): 689, 759, 804, 968, 1008, 1095, 11
1597, 1682 cm–1; HRMS: 
443.1055; ee: 86%, determined by HPLC analysis: Daicel Chiralcel ODH column (25 
cm), hexanes/i-PrOH = 99.7/0.3, 0.5 mL/min, 217 nm; t
= 14.7 min; [α]D20 = +
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-40 ºC; 1H NMR (500 MHz, CDCl3): δ
7), 3.98-4.10 (m, 2H, H-5), 4.86 (d, J = 8.4 
J = 7.9 Hz, 2H, Ar-H), 7.26-7.28 (m, 2H
-7.53 (m, 1H, Ar-H), 7.92-7.94 (m, 2H, Ar
 = 20.2 (C-13), 56.1 (C-3), 62.8 (q, J = 35.1 H
(C-4), 122.3 (q, J = 278.7 Hz, C-8), 122.4 (q, 
[M+Na+] calcd. for C20H18F6O3•Na
r (major) = 12.3 min, t
 48.6 (c = 1.64, CHCl3).    
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2-(4-Isopropylphenyl)-1-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254g) 
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Colourless solid, m.p. 42-43 ºC; 1H NMR (500 MHz, CDCl3): δ = 1.20 (d, J = 6.5 Hz, 
6H, H-14), 2.86 (sept, J = 6.5 Hz, 1H, H-13), 3.66-3.70 (m, 2H, H-7), 4.00-4.07 (m, 2H, 
H-5), 4.87 (d, J = 8.3 Hz, 1H, H-3), 5.47 (d, J = 8.3 Hz, 1H, H-4), 7.19 (d, J = 7.6 Hz, 
2H, Ar-H, H-11), 7.30 (d, J = 7.7 Hz, 2H, H-10), 7.42 (d, J = 7.2 Hz, 2H, Ar-H), 7.52 (t, 
J = 7.0 Hz, 1H, Ar-H), 7.95 (d, J = 7.4 Hz, 2H, H-15 and 19) ppm; 13C NMR (126 
MHz, CDCl3): δ = 23.8 (2C, C-14), 33.7 (C-13), 56.8 (C-3), 63.5 (q, J = 35.3 Hz, C-7), 
65.6 (q, J = 35.0 Hz, C-5), 105.7 (C-4), 123.2 (q, J = 277.9 Hz, C-8), 123.3 (q, J = 
277.8 Hz, C-6), 127.2 (2C, Ar-C), 128.6 (4C), 128.7 (2C), 130.2, 133.4, 136.2 (C-1), 
148.9 (C-12), 196.4 (C-2) ppm; IR (NaCl): 688, 818, 1020, 1098, 1164, 1282, 1387, 
1448, 1597, 1682, 1718, 2962 cm–1; HRMS: [M+Na+] calcd. for C22H22F6O3•Na+: 
471.1365; found: 471.1367; ee: 89%, determined by HPLC analysis: Daicel Chiralcel 
AD column (5 cm), hexanes/i-PrOH = 99.8/0.2, 0.5 mL/min, 243 nm; tr (major) = 12.5 
min, tr (minor) = 16.4 min; [α]D20 = + 25.3 (c = 1.42, CHCl3). 
2-(4-(tert-Butyl)phenyl)-1-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254h) 
 
Colourless solid, m.p. 99-103 ºC; 1H NMR (500 MHz, CDCl3): δ = 1.27 (s, 9H, H-14), 
3.64-3.74 (m, 2H, H-7), 3.96-4.10 (m, 2H, H-5), 4.88 (d, J = 8.4 Hz, 1H, H-3), 5.48 (d, 
J = 8.4 Hz, 1H, H-4), 7.31-7.36 (m, 4H, Ar-H), 7.42 (t, J = 7.5 Hz, 2H, Ar-H), 7.52 (t, J 
= 7.3 Hz, 1H, Ar-H), 7.96 (d, J = 7.3 Hz, 2H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): 
δ = 30.2 (3C, C-14), 33.5 (C-13), 55.7 (C-3), 62.5 (q, J = 35.3 Hz (C-7), 64.6 (q, J = 
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35.3 Hz, C-5), 104.5 (C-4), 122.27 (q, J = 278.2 Hz, C-8), 122.3 (q, J = 278.1 Hz, C-6), 
125.1 (2C, Ar-C), 127.5 (2C), 127.66 (2C), 127.67 (2C), 128.9, 132.4, 135.2 (C-1), 
150.3 (C-12), 195.4 (C-2) ppm; IR (NaCl): 684, 721, 773, 816, 838, 998, 1084, 1167, 
1418, 1448, 1597, 1673, 2956 cm–1; HRMS: [M+Na+] calcd. for C23H24F6O3•Na+: 
485.1522; found: 485.1521; ee: 52%, determined by HPLC analysis: Daicel Chiralcel 
ODH column (25 cm), hexanes/i-PrOH = 99.8/0.2, 0.5 mL/min, 243 nm; tr (major) = 
22.1 min, tr (minor) = 27.6 min; [α]D20 = + 25.1 (c = 1.75, CHCl3).    
1-Phenyl-2-(m-tolyl)-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254i) 
 
Colourless oil; 1H NMR (500 MHz, CDCl3): δ = 2.32 (s, 3H, H-14), 3.62-3.74 (m, 2H, 
H-7), 3.98-4.10 (m, 2H, H-5), 4.85 (d, J = 8.4 Hz, 1H, H-3), 5.47 (d, J = 8.4 Hz, 1H, H-
4), 7.09-7.10 (m, 1H, Ar-H), 7.17-7.24 (m, 3H, Ar-H), 7.40-7.43 (m, 2H, Ar-H), 7.51-
7.54 (m, 1H, Ar-H), 7.93-7.95 (m, 2H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 
21.4 (C-14), 57.4 (C-3), 63.9 (q, J = 35.0 Hz, C-7), 65.7 (q, J = 35.0 Hz, C-5), 105.8 (C-
4), 123.0 (q, J = 278.7 Hz, C-8)  123.4 (q, J = 278.5 Hz, C-6), 126.1 (Ar-C), 128.6 (2C), 
128.7 (2C), 129.0, 129.1, 129.4, 132.9, 133.4, 136.3 (C-1), 138.9 (C-13), 196.4 (C-2) 
ppm; IR (NaCl): 772, 1050, 1098, 1166, 1282, 1679 cm–1; HRMS: [M+NH4+] calcd. for 
C20H18F6O3•NH4+: 438.1498; found: 438.1490; ee: 54%, determined by HPLC analysis: 
Daicel Chiralcel ODH column (25 cm), hexanes/i-PrOH = 99.8/0.2, 0.3 mL/min, 245 
nm; tr (major) = 22.2 min, tr (minor) = 28.6 min. 
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1-(Furan-2-yl)-2-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254k)  
    
Colourless solid, m.p. 43-44 ºC; 1H NMR (500 MHz, CDCl3): δ = 3.64-3.78 (m, 2H, H-
7), 3.98-4.09 (m, 2H, H-5), 4.74 (d, J = 8.7 Hz, 1H, H-3), 5.52 (d, J = 8.7 Hz, 1H, H-4), 
6.53 (dd, J = 1.7, 3.6 Hz,  1H, Ar-H), 7.23-7.58 (m, 7H, Ar-H) ppm; 13C NMR (150 
MHz, CDCl3): δ = 56.1 (C-3), 62.1 (q, J = 35.2 Hz, C-7), 64.5 (q, J = 35.2 Hz, C-5), 
103.6 (C-4), 111.8 (C-14), 117.8 (C-15), 122.3 (q, J = 277.7 Hz, C-8), 122.4 (q, J = 
277.7 Hz, C-6), 127.4 (Ar-C), 128.0 (2C), 128.1 (2C), 131.9 (C-9), 146.2 (C-13), 150.9 
(C-1), 183.8 (C-2) ppm; IR (NaCl): 426, 591, 671, 700, 729, 765, 813, 884, 967, 1022, 
1033, 1085, 1164, 1229, 1281, 1395, 1431, 1497, 1568, 1601, 1672, 1732, 2243 cm–1; 
HRMS: [M+H+] calcd. for C17H14F6O4•H+: 397.0869; found: 397.0862; ee: 83%, 
determined by HPLC analysis: Daicel Chiralcel AD column (5 cm), hexanes/i-PrOH = 
99.9/0.1, 0.5 mL/min, 273 nm; tr (minor) = 10.1 min, tr (major) = 22.6 min; [α]D20 = + 
11.6 (c = 0.17, CHCl3). 
Methyl 2-phenyl-3,3-bis(2,2,2-trifluoroethoxy)propanoate (254m) 
 
Colourless solid, m.p. 43-44 ºC; 1H NMR (500 MHz, CDCl3): δ = 3.60-3.78 (m, 2H, H-
7), 3.70 (s, 3H, H-1), 3.89 (d, J = 8.9 Hz, 1H, H-3), 3.98-4.10 (m, 2H, H-5), 5.35 (d, J = 
8.9 Hz, 1H, H-4), 7.36 (m, 5H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 52.5 (C-
3), 55.4 (C-1), 62.7 (q, J = 35.3 Hz, C-7), 64.6 (q, J = 35.2 Hz, C-5), 103.9 (C-4), 123.2 
(q, J = 278.0 Hz, C-8), 123.4 (q, J = 278.5 Hz, C-6), 128.5 (Ar-C), 128.6 (2C), 128.9 
(2C), 132.7, 170.4 (C-2) ppm; IR (NaCl): 771, 1005, 1084, 1165, 1282, 1438, 1739 cm–
1; HRMS: [M+NH4+] calcd. for C14H14F6O4•NH4+: 378.1135; found: 378.1132; ee: 96%, 
determined by HPLC analysis: Daicel Chiralcel ODH column (25 cm), hexanes/i-PrOH 
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= 99.8/0.2, 0.5 mL/min, 208 nm; tr (minor) = 14.4 min, tr (major) = 18.7 min; [α]D20 = + 
17.5 (c = 0.23, CHCl3). 
3-Phenyl-4,4-bis(2,2,2-trifluoroethoxy)butan-2-one (254n) 
 
Yellow oil; 1H NMR (400 MHz, CDCl3): δ = 2.15 (s, 3H, H-1), 3.53-3.63 (m, 1H, H-7), 
3.67-3.75 (m, 1H, H-7), 3.94-4.11 (m, 2H, H-5), 4.02 (d, J = 8.4 Hz, 1H, H-3), 5.35 (d, 
J = 8.4 Hz, 1H, H-4), 7.27-7.39 (m, 5H, Ar-H) ppm; 13C NMR (126 MHz, CDCl3): δ = 
29.1 (C-1), 61.3 (C-3), 61.8 (q, J = 35.6 Hz, C-7), 64.6 (q, J = 35.4 Hz, C-5), 103.1 (C-
4), 122.2 (q, J = 278.6 Hz, C-8), 122.4 (q, J = 278.5 Hz, C-6), 127.4 (Ar-C), 127.8 (2C), 
128.2 (2C), 131.5 (C-9), 203.3 (C-2) ppm; IR (NaCl): 427, 652, 693, 735, 778, 983, 
1017, 1033, 1097, 1178, 1214, 1294, 1362, 1419, 1511, 1577, 1601, 1639, 1661, 1694, 
2283 cm–1; HRMS: [M+NH4+] calcd. for C14H14F6O3•NH4+: 362.1185; found: 
362.1187; enantiomers were inseparable by HPLC; [α]D20 = -11.8 (c = 0.34, CHCl3).  
General procedure 11 for synthesis of racemic products 254 
PhI(OAc)2 (0.18 mmol) and the chalcone (0.12 mmol) were dissolved in dry 
dichloromethane (1.0 mL) and 2,2,2-trifluoroethanol (1.0 mL) and cooled to 0 °C. 
TMSOTf (0.36 mmol) was then added dropwise and the resulting mixture was allowed 
to stirred for 2 hours at 0 °C. The reaction mixture was quenched with a saturated 
aqueous solution of NaHCO3 and extracted with CH2Cl2 (3 × 5 mL). The combined 
organic layers were dried over MgSO4 and the solvents were removed in vacuo. The 
product was purified by preparative TLC (CHCl3/Hexane = 3:1). 
Procedure for synthesis of 253o 
To a solution of the acetophenone derivative (10 mmol) and the benzaldehyde 
(10mmol) in MeOH (25 mL) was added dropwise an aqueous solution of NaOH (1 mL, 
50% w/v). The reaction mixture was stirred overnight at room temperature. The reaction 
mixture was then neutralized with a 1M aqueous solution of HCl. The resulting solution 
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was extracted with EtOAc, the combined organic layers were dried over MgSO4 and the 
solvents were removed in vacuo.  The chalcone 253o was obtained in 85% yield after 
purification by column chromatography (Hexane/EtOAc = 95:5). 
(E)-2-Methyl-1,3-diphenylprop-2-en-1-one (253o) 
 
The compound 253o was synthesised by using known literature procedure[30] in 85% 
yield. The spectroscopic data are in agreement with literature. Brown oil; 1H NMR (400 
MHz, CDCl3): δ 2.28 (d, J = 1.4 Hz, 3H, H-3), 7.19 (q, J = 1.4 Hz, 1H, H-4), 7.34-7.57 
(m, 8H, Ar-H), 7.74-7.76 (m, 2H, Ar-H) ppm. 
2-Methyl-1,2-diphenyl-3,3-bis(2,2,2-trifluoroethoxy)propan-1-one (254o) 
 
Prepared from general procedure for racemic products in 48% yields. Colourless oil; 1H 
NMR (500 MHz, CDCl3): δ = 1.78 (s, 3H, H-4), 3.27-3.35 (m, 1H, H-8), 3.56-3.64 (m, 
1H, H-8), 4.06-4.17 (m, 2H, H-6), 5.25 (s, 1H, H-5), 7.23-7.41 (m, 10H, Ar-H) ppm; 
13C NMR (126 MHz, CDCl3): δ = 16.1 (C-4), 59.8 (C-3), 66.7-67.4 (m, 2C, C-6 and 8), 
108.9 (C-5), 123.1(q, J = 279.3 Hz, C-9), 123.5 (q, J = 279.2 Hz, C-7), 127.3 (2C, Ar-
C), 128.1 (3C), 129.0 (2C), 129.1 (2C), 132.0, 136.5, 137.7 (C-1), 202.2 (C-2) ppm; IR 
(NaCl): 671, 730, 768, 848, 970, 1100, 1165, 1281, 1447, 1558, 1675 cm1; HRMS: 
[M+NH4+] calcd. for C20H18F6O3•NH4+: 438.1498; found: 438.1494. 
Photoisomerization of (E)-253a 
The mixture of isomers were synthesised by modifying literature procedure.[31] After 
irradiating a solution of (E)-chalcone (253a, 1.0 g, 4.80 mmol) in acetonitrile (25 mL) 
with a 400-W mercury lamp with circulated 0.2 M aqueous CuSO4 as a UV filter for 24 
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h, a (1:1) mixture of the isomers was obtained. The solvent was removed and the oil 
was crystallized to obtain a 4:10 mixture of E/Z isomers (0.50 g, 2.40 mmol). 
1,3-Diphenyl prop-2-en-1-one (253a E/Z mixture) 
 
The spectroscopic data are in agreement literature.[16] 4:10 mixture of E/Z isomers; 1H 
NMR (400 MHz, CDCl3): δ 6.65 (d, J = 12.8 Hz, 1H, Z-isomer, H-3), 7.04 (d, J = 12.8 
Hz, 1H, Z-isomer, H-4), 7.25-7.69 (m, 17H, E and Z-isomers, Ar-H), 7.85 (d, J = 15.7 
Hz, 1H, E-isomer, H-4), 7.98-8.00 (m, 2H, Z-isomer, Ar-H), 8.04-8.06 (m, 2H, E-
isomer, Ar-H) ppm. 
General procedure 12 for ring contraction reactions of 216b 
To the solution of chiral hypervalent iodine (0.36 mmol) in dry dichloromethane (3.0 
mL) and 2,2,2-trifluoroethanol (1.0 mL) at –78 °C, added Lewis acid  (0.72 mmol) and 
was then allowed to stir for 30 min. To this mixture, added the dissolved starting 
material (0.24 mmol) in dry dichloromethane (1.0 mL) and stirred overnight at –78°C. 
The reaction mixture was quenched with a saturated aqueous solution of NaHCO3 and 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over 
MgSO4 and the solvents were removed in vacuo. The product was purified by flash 
chromatography (Hexane/Ethyl Acetate = 90:10). 
1-(Bis(2,2,2-trifluoroethoxy)methyl)-2,3-dihydro-1H-indene (216b) 
 
The spectroscopic data is in agreement with the literature.[32] Yellow oil; 1H NMR (400 
MHz, CDCl3): δ = 1.99-2.07 (m, 1H, H-6), 2.20-2.30 (m, 1H, H-6), 2.85-3.02 (m, 2H, 
H-7), 3.48 (q, J = 7.7 Hz, 1H, H-2), 3.89-4.07 (m, 4H, H-4), 4.71 (d, J = 8.2 Hz, 1H, H-
3), 7.17-7.24 (m, 3H, Ar-H), 7.39-7.41 (m, 1H, Ar-H) ppm; ee: 59%, determined by 
HPLC analysis: Daicel Chiralcel ODH column (25 cm), hexanes/i-PrOH = 99.7/0.3, 0.3 
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mL/min, 215 nm; tr (major) = 30.4 min, tr (minor) = 34.7 min; [α]D20 = +3.7 (c = 0.53, 
CHCl3). 
Synthesis of 213 
 
The compound 213 was synthesised by using known literature procedure from the 
corresponding ketone in overall 75% yield (1.42 g, 5.16 mmol).[33] The spectroscopic 
data are in agreement with literature.[34]  
4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-naphthalen-1-ol 
 
1H NMR (250 MHz, CDCl3): 1.78-1.82 (m, 1H, H-2), 1.90-2.01 (m, 3H, H-2 and 3), 
2.23-2.33 (m, 1H, H-4), 3.89-4.01 (m, 1H), 4.78-4.85 (m, 1H, H-1), 6.70-7.49 (m, 7H, 
Ar-H). 
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1-(3,4-Dichlorophenyl)-1,2-dihydronaphthalene (213) 
8
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1H NMR (300 MHz, CDCl3): 2.49-2.61 (m, 1H, H-3), 2.65-2.75 (m, 1H, H-3), 4.09 (t, J 
= 8.0 Hz, 1H, H-4), 5.92-5.99 (m, 1H, H-2), 6.55 (d, J = 9.6 Hz, 1H, H-1), 6.82-7.30 
(m, 6H, Ar-H), 7.36 (d, J = 8.2 Hz, 1H, Ar-H) ppm. 
Procedure for synthesis of compound 214 
To the solution of chiral hypervalent iodine (0.36 mmol) in dry dichloromethane (3.0 
mL) at _78 °C, added TMSOTf  (0.72 mmol) and was then allowed to stir for 30 min. 
To this mixture, added the starting material 213 (0.24 mmol) dissolved in the 
dichloromethane (0.5 mL) and 8 equiv. of methanol and stirred for further overnight. 
The reaction mixture was quenched with a saturated aqueous solution of NaHCO3 and 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over 
MgSO4 and the solvents were removed in vacuo. The migration product was purified by 
flash chromatography (Hexane/Ethyl Acetate = 90:10). 
1-(3,4-Dichlorophenyl)-3-(dimethoxymethyl)-2,3-dihydro-1H-indene (214) 
 
The spectroscopic data are in agreement with literature.[33] Yellow oil; 1H NMR (250 
MHz, CDCl3): δ = 2.09-2.17 (m, 1H, H-4), 2.54-2.64 (m, 1H, H-4), 3.34 (s, 3H, H-1), 
3.43 (s, 3H, 2nd OMe), 3.48-3.60 (m, 1H, H-3), 4.35 (d, J = 6.9 Hz, 1H, H-2), 4.40 (t, J 
= 7.8 Hz, 1H, H-5), 6.94-6.99 (m, 2H, Ar-H), 7.17-7.29 (m, 3H, Ar-H), 7.33-7.36 (m, 
1H, Ar-H), 7.43-7.47 (m, 1H, Ar-H) ppm; ee: 9%, determined by HPLC analysis: 
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Daicel Chiralcel ODH column (25 cm), hexanes/i-PrOH = 99.9/0.1, 0.5 mL/min, 211 
nm; tr (minor) = 17.2 min, tr (minor) = 18.6 min; [α]D20 = + 2.0 (c = 0.98, CHCl3). 
Reduction reaction for compound 254a' 
To the solution of 254a' (0.04g, 0.098 mmol) in MeOH (3.0 mL), added NaBH4 
(0.007g, 0.196 mmol) at 0 ºC and stirred at room temperature for 30 min. The reaction 
was quenched with water and extracted with CH2Cl2 (3 x 5.0 mL) to give the reduced 
product 259 in 98% yield (0.039g, 0.0975mmol).  
3,3-Bis(2,2,2-trifluoroethoxy)1,2-diphenyl-propan-1-ol (259) 
               
Colourless oil; 1H NMR (400 MHz, CDCl3): δ = 2.02 (d, J = 4.4 Hz, 1H, major), 2.68 
(d, J = 3.1 Hz, 1H, minor), 3.12 (dd, J = 4.4, 7.5 Hz, 1H, major), 3.29 (dd, J = 5.7, 8.5 
Hz, 1H, minor), 3.52-3.61 (m, 1H, major), 3.68-3.79 (m, 1H, major), 3.95-4.05 (m, 2H, 
major), 5.09 (dd, J = 3.1, 8.5 Hz, 1H, minor), 5.23 (d, J = 7.5 Hz, 1H, major), 5.26 (t, J 
= 4.4 Hz, 1H, major), 5.33 (d, J = 5.7 Hz, 1H, minor), 7.04-7.25 (m, 10H, major), 7.15-
7.17 (m, 6H, minor) ppm; 13C NMR (100 MHz, CDCl3): δ = 56.4 (minor), 56.5 (major), 
61.9 (q, J = 35.1 Hz, major), 64.6 (q, J = 34.8 Hz, major), 73.5 (major), 75.3 (minor), 
103.5 (major), 104.6 (minor), 123.5 (q, J = 277.8 Hz, major), 123.6 (q, J = 278.2 Hz, 
major), 126.0 (2C, major), 126.7 (minor), 127.3 (minor), 127.5 (major), 127.6 (minor), 
127.65 (major), 127.7 (minor), 127.8 (minor), 128.0 (minor), 128.09 (2C, major), 128.1 
(2C, major), 129.8 (minor), 130.2 (2C, major), 134.0 (major), 135.2 (minor), 141.4 
(minor), 141.7 (major) ppm; IR (NaCl): 669,700, 968, 1010, 1085, 1165, 1280, 1456, 
2341, 2360, 1852, 2942, 2954 cm1; HRMS: [M+Na+] calcd. for C19H18F6O3•Na+: 
431.1058; found: 431.1053. 
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1,2-Diphenylethan-1-one (261) 
 
Compound 261 was synthesized from the reactions in Table 5.7. The data is in 
agreement with the literature.[35] 
Colourless oil; 1H NMR (250 MHz, CDCl3): δ = 4.32 (s, 2H, H-2), 7.29-7.59 (m, 8H, 
Ar-H), 8.03-8.06 (m, 2H, Ar-H), ppm. 
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6.7   Appendix 
X-Ray crystallographic data of 157 (CCDC 824540) 
 
 
 
Audit creation method            SHELXL-97 
Chemical formula moiety          C19 H20 N2 O3 S 
Chemical formula sum              C19 H20 N2 O3 S 
Chemical formula weight          356.43 
Chemical absolute configuration   ad 
celllength_c                    13.8565(3) 
 cell angle alpha                 90.00 
 cell angle beta                  90.00 
 cell angle gamma                 90.00 
 cell volume                      1719.40(6) 
 cell formula units Z             4 
 cell measurement temperature     150(2) 
 cell measurement reflns used     3711 
 cell measurement theta min       2.98 
 cell measurement theta max       28.69 
 exptl crystal description        Block 
 exptl crystal color             Colorless 
 exptl crystal size max           0.35 
 exptl crystal size mid           0.35 
 exptl crystal size min           0.35 
 exptl crystal density diffrn     1.377 
 exptl absorpt coefficient mu     0.209 
 exptl absorpt correction T min   0.9303 
 exptl absorpt correction T max   0.9303 
 diffrn ambient temperature       150(2) 
 diffrn radiation wavelength      0.71073 
 diffrn radiation monochromator   graphite 
 symmetry cell setting            'Orthorhombic' 
diffrn reflns number             9385 
diffrn reflns limit h max        14 
diffrn reflns limit k min        -11 
diffrn reflns limit k max        15 
diffrn reflns limit l max        18 
diffrn reflns theta min          2.98 
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diffrn reflns theta max          28.69 
reflns number total              4352 
reflns number gt                 3711 
 
refine ls matrix type            full 
refine ls weighting scheme       calc 
refine ls weighting details 
atom sites solution primary      direct 
atom sites solution secondary    difmap 
atom sites solution hydrogens    geom 
refine ls hydrogen treatment     constr 
refine ls extinction method      SHELXL 
refine ls extinction coef        0.065(5) 
refine ls extinction expression 
refine ls abs structure details 
'Flack H D (1983), Acta Cryst. A39, 876-881' 
refine ls abs structure Flack    -0.11(11) 
refine ls number reflns          4352 
refine ls number parameters      228 
refine ls number restraints      0 
refine ls R factor all           0.0739 
refine ls R factor gt            0.0592 
refine ls wR factor ref          0.1589 
refine ls wR factor gt           0.1429 
refine ls goodness of fit ref    1.143 
refine ls restrained S all       1.143 
 
X-Ray crystallographic data of 254a' 
 
 
  
 audit creation method            SHELXL-97 
 chemical name systematic 
 chemical formula sum           C19 H16 F6 O3 
 chemical formula weight          406.32 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'C'  'C'   0.0033   0.0016 
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'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'H'  'H'   0.0000   0.0000 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'F'  'F'   0.0171   0.0103 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'O'  'O'   0.0106   0.0060 
symmetry cell setting            Triclinic 
symmetry space group name H-M    P1 
cell length a                    5.8865(3) 
cell length b                    12.0427(7) 
cell length c                    19.4755(9) 
cell angle alpha                 81.241(3) 
cell angle beta                  85.465(3) 
cell angle gamma                 92.051(2) 
cell volume                      1358.63(12) 
cell formula units Z             3 
cell measurement temperature     150(2) 
exptl crystal size max           0.35 
exptl crystal size mid           0.06 
exptl crystal size min           0.04 
exptl crystal density diffrn     1.490 
exptl crystal density method     'not measured' 
exptl crystal F 000              624 
exptl absorpt coefficient mu     0.140 
exptl absorpt correction T min   0.9526 
exptl absorpt correction T max   0.9944 
diffrn ambient temperature       150(2) 
diffrn radiation wavelength      0.71073 
diffrn radiation type            MoK\a 
diffrn radiation source          'fine-focus sealed tube' 
diffrn radiation monochromator   graphite 
diffrn reflns number             5481 
diffrn reflns av R equivalents   0.0000 
diffrn reflns av sigmaI/netI     0.0607 
diffrn reflns limit h min        -5 
diffrn reflns limit h max        5 
diffrn reflns limit k min        -11 
diffrn reflns limit k max        12 
diffrn reflns limit l min        -19 
diffrn reflns limit l max        19 
diffrn reflns theta min          1.06 
diffrn reflns theta max          20.83 
reflns number total              5481 
reflns number gt                 4751 
reflns threshold expression      >2\s(I) 
computing structure refinement   'SHELXL-97 (Sheldrick, 2008)' 
 
 refine special details  
 
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and goodness 
of fit S are based on F^2^, conventional R-factors R are based on F, with F set to zero 
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for negative F^2^. The threshold expression of F^2^ > 2\s(F^2^) is used only for 
calculating R-factors(gt) etc. and is not relevant to the choice of reflections for 
refinement.  R-factors based on F^2^ are statistically about twice as large as those based 
on F, and R-factors based on ALL data will be even larger. 
refine ls structure factor coef  Fsqd 
refine ls matrix type            fullcycle 
refine ls weighting scheme       calc 
refine ls weighting details 
'calc w=1/[\s^2^(Fo^2^)+(0.1885P)^2^+0.7038P] where P=(Fo^2^+2Fc^2^)/3' 
atom sites solution primary      direct 
atom sites solution secondary    difmap 
atom sites solution hydrogens    geom 
refine ls hydrogen treatment     mixed 
refine ls extinction method      none 
refine ls abs structure details 
'Flack H D (1983), Acta Cryst. A39, 876-881' 
refine ls abs structure Flack    0.0(14) 
refine ls number reflns          5481 
refine ls number parameters      757 
refine ls number restraints      9 
refine ls R factor all           0.1026 
refine ls R factor gt            0.0889 
refine ls wR factor ref          0.2433 
refine ls wR factor gt           0.2225 
refine ls goodness of fit ref    1.077 
refine ls restrained S all       1.078 
refine ls shift/su max           0.009 
refine ls shift/su mean          0.002 
 
Atomic coordinates and  equivalent isotropic displacement parameters 
C1 C -0.0910(14) 0.1452(7) 0.2938(4) 0.0207(19) Uani 1 1 d   
C2 C -0.2935(16) 0.1129(7) 0.3312(5) 0.032(2) Uani 1 1 d   
H2 H -0.4118 0.0776 0.3106 0.038 Uiso 1 1 calc R    
C3 C -0.3262(16) 0.1316(8) 0.3998(5) 0.034(2) Uani 1 1 d   
H3 H -0.4655 0.1077 0.4269 0.041 Uiso 1 1 calc R    
C4 C -0.1540(18) 0.1852(8) 0.4281(5) 0.037(2) Uani 1 1 d   
H4 H -0.1782 0.2003 0.4745 0.044 Uiso 1 1 calc R    
C5 C 0.0468(15) 0.2167(7) 0.3918(5) 0.029(2) Uani 1 1 d   
H5 H 0.1647 0.2514 0.4129 0.034 Uiso 1 1 calc R    
C6 C 0.0823(16) 0.1979(7) 0.3220(4) 0.030(2) Uani 1 1 d   
H6 H 0.2225 0.2211 0.2952 0.036 Uiso 1 1 calc R    
C7 C -0.0365(16) 0.1231(7) 0.2179(4) 0.0218(19) Uani 1 1 d   
C8 C -0.2318(13) 0.0804(7) 0.1791(4) 0.022(2) Uani 1 1 d   
H8 H -0.3771 0.1124 0.1954 0.027 Uiso 1 1 calc R    
C9 C -0.2546(14) -0.0477(7) 0.1973(4) 0.025(2) Uani 1 1 d   
C10 C -0.4499(16) -0.1010(8) 0.2306(4) 0.030(2) Uani 1 1 d   
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H10 H -0.5744 -0.0576 0.2426 0.036 Uiso 1 1 calc R    
C11 C -0.4708(15) -0.2180(8) 0.2476(5) 0.032(2) Uani 1 1 d   
H11 H -0.6058 -0.2539 0.2724 0.039 Uiso 1 1 calc R    
C12 C -0.2938(17) -0.2801(8) 0.2281(5) 0.036(2) Uani 1 1 d   
H12 H -0.3105 -0.3599 0.2373 0.043 Uiso 1 1 calc R    
C13 C -0.0902(17) -0.2296(7) 0.1951(5) 0.033(2) Uani 1 1 d   
H13 H 0.0327 -0.2735 0.1825 0.040 Uiso 1 1 calc R    
C14 C -0.0711(15) -0.1101(8) 0.1807(5) 0.030(2) Uani 1 1 d   
H14 H 0.0680 -0.0731 0.1596 0.036 Uiso 1 1 calc R    
C15 C -0.1803(17) 0.1219(7) 0.1024(5) 0.034(2) Uani 1 1 d   
H15 H -0.0106 0.1239 0.0931 0.041 Uiso 1 1 calc R    
C16 C -0.1867(17) 0.2977(8) 0.0249(4) 0.039(2) Uani 1 1 d   
H16A H -0.3189 0.3405 0.0095 0.046 Uiso 1 1 calc R    
H16B H -0.1498 0.2458 -0.0088 0.046 Uiso 1 1 calc R    
C17 C 0.0101(17) 0.3761(9) 0.0255(5) 0.042(3) Uani 1 1 d   
C18 C -0.5097(16) 0.0417(9) 0.0644(4) 0.039(2) Uani 1 1 d   
H18A H -0.5758 0.1013 0.0885 0.046 Uiso 1 1 calc R    
H18B H -0.5586 -0.0322 0.0923 0.046 Uiso 1 1 calc R    
C19 C -0.5908(16) 0.0493(9) -0.0072(5) 0.040(3) Uani 1 1 d   
C20 C 0.4048(14) 0.4635(7) 0.3256(4) 0.024(2) Uani 1 1 d   
C21 C 0.2243(15) 0.4959(7) 0.2865(4) 0.029(2) Uani 1 1 d   
H21 H 0.0988 0.5309 0.3065 0.034 Uiso 1 1 calc R    
C22 C 0.2284(15) 0.4767(7) 0.2183(4) 0.029(2) Uani 1 1 d   
H22 H 0.1066 0.5010 0.1913 0.034 Uiso 1 1 calc R    
C23 C 0.4007(18) 0.4244(8) 0.1891(6) 0.041(3) Uani 1 1 d   
H23 H 0.3984 0.4108 0.1423 0.050 Uiso 1 1 calc R    
C24 C 0.5839(16) 0.3902(7) 0.2279(5) 0.033(2) Uani 1 1 d   
H24 H 0.7057 0.3525 0.2081 0.039 Uiso 1 1 calc R    
C25 C 0.5843(16) 0.4123(7) 0.2958(5) 0.031(2) Uani 1 1 d   
H25 H 0.7100 0.3919 0.3219 0.037 Uiso 1 1 calc R    
C26 C 0.4130(16) 0.4876(7) 0.3980(5) 0.029(2) Uani 1 1 d   
C27 C 0.2062(14) 0.5233(7) 0.4378(4) 0.025(2) Uani 1 1 d   
H27 H 0.0660 0.4885 0.4224 0.030 Uiso 1 1 calc R    
C28 C 0.1969(14) 0.6512(7) 0.4230(4) 0.026(2) Uani 1 1 d   
C29 C 0.3706(15) 0.7183(7) 0.4419(5) 0.032(2) Uani 1 1 d   
H29 H 0.4972 0.6855 0.4631 0.038 Uiso 1 1 calc R    
C30 C 0.3555(16) 0.8361(8) 0.4289(5) 0.041(3) Uani 1 1 d   
H30 H 0.4761 0.8829 0.4401 0.050 Uiso 1 1 calc R    
C31 C 0.1656(17) 0.8857(9) 0.3998(5) 0.045(3) Uani 1 1 d   
H31 H 0.1516 0.9648 0.3945 0.054 Uiso 1 1 calc R    
C32 C -0.0005(16) 0.8170(7) 0.3789(4) 0.031(2) Uani 1 1 d   
H32 H -0.1238 0.8491 0.3555 0.037 Uiso 1 1 calc R    
C33 C 0.0137(15) 0.6988(7) 0.3925(5) 0.033(2) Uani 1 1 d   
H33 H -0.1048 0.6518 0.3803 0.040 Uiso 1 1 calc R    
C34 C 0.223(2) 0.4800(8) 0.5163(5) 0.043(3) Uani 1 1 d   
H34 H 0.3883 0.4843 0.5243 0.052 Uiso 1 1 calc R    
C35 C 0.185(3) 0.3052(10) 0.5912(6) 0.075(4) Uani 1 1 d   
H35A H 0.2516 0.3575 0.6196 0.090 Uiso 1 1 calc R    
H35B H 0.0331 0.2778 0.6142 0.090 Uiso 1 1 calc R    
C36 C 0.320(3) 0.2162(12) 0.5907(7) 0.074(4) Uani 1 1 d   
155 
 
C37 C -0.107(2) 0.5361(12) 0.5570(6) 0.081(5) Uani 1 1 d   
H37A H -0.1527 0.4695 0.5363 0.097 Uiso 1 1 calc R    
H37B H -0.1488 0.6048 0.5268 0.097 Uiso 1 1 calc R    
C38 C -0.229(2) 0.5289(12) 0.6377(6) 0.053(3) Uani 1 1 d   
C39 C 0.3844(13) 0.5013(7) 0.8149(4) 0.021(2) Uani 1 1 d   
C40 C 0.2215(15) 0.4363(8) 0.7892(5) 0.033(2) Uani 1 1 d   
H40 H 0.0837 0.4681 0.7755 0.040 Uiso 1 1 calc R    
C41 C 0.2593(16) 0.3244(8) 0.7836(5) 0.036(2) Uani 1 1 d   
H41 H 0.1510 0.2811 0.7638 0.043 Uiso 1 1 calc R    
C42 C 0.4515(16) 0.2774(8) 0.8063(4) 0.034(2) Uani 1 1 d   
H42 H 0.4715 0.2000 0.8045 0.041 Uiso 1 1 calc R    
C43 C 0.6186(17) 0.3391(8) 0.8320(5) 0.039(2) Uani 1 1 d   
H43 H 0.7539 0.3054 0.8465 0.046 Uiso 1 1 calc R    
C44 C 0.5833(15) 0.4545(7) 0.8362(5) 0.029(2) Uani 1 1 d   
H44 H 0.6956 0.4990 0.8536 0.035 Uiso 1 1 calc R    
C45 C 0.3336(16) 0.6235(7) 0.8199(4) 0.028(2) Uani 1 1 d   
C46 C 0.5189(14) 0.6997(7) 0.8381(4) 0.025(2) Uani 1 1 d   
H46 H 0.6708 0.6704 0.8254 0.030 Uiso 1 1 calc R    
C47 C 0.4915(15) 0.7019(7) 0.9154(5) 0.033(2) Uani 1 1 d   
C48 C 0.6622(17) 0.6648(9) 0.9572(5) 0.044(3) Uani 1 1 d   
H48 H 0.7981 0.6385 0.9369 0.053 Uiso 1 1 calc R    
C49 C 0.6350(19) 0.6658(9) 1.0298(5) 0.045(3) Uani 1 1 d   
H49 H 0.7528 0.6418 1.0585 0.054 Uiso 1 1 calc R    
C50 C 0.4415(19) 0.7010(9) 1.0574(6) 0.049(3) Uani 1 1 d   
H50 H 0.4252 0.7009 1.1063 0.059 Uiso 1 1 calc R    
C51 C 0.2644(18) 0.7373(9) 1.0195(5) 0.043(2) Uani 1 1 d   
H51 H 0.1276 0.7605 1.0411 0.051 Uiso 1 1 calc R    
C52 C 0.2959(17) 0.7385(8) 0.9451(5) 0.043(3) Uani 1 1 d   
H52 H 0.1795 0.7651 0.9166 0.052 Uiso 1 1 calc R    
C53 C 0.4933(15) 0.8143(7) 0.7926(5) 0.031(2) Uani 1 1 d   
H53 H 0.3271 0.8287 0.7920 0.038 Uiso 1 1 calc R    
C54 C 0.522(2) 0.8923(10) 0.6735(5) 0.059(3) Uani 1 1 d   
H54A H 0.5364 0.9651 0.6908 0.071 Uiso 1 1 calc R    
H54B H 0.3629 0.8806 0.6622 0.071 Uiso 1 1 calc R    
C55 C 0.683(2) 0.8934(10) 0.6096(6) 0.064(3) Uani 1 1 d   
C56 C 0.8426(15) 0.8998(7) 0.8208(6) 0.040(3) Uani 1 1 d   
H56A H 0.9087 0.8536 0.7870 0.048 Uiso 1 1 calc R    
H56B H 0.8738 0.8649 0.8683 0.048 Uiso 1 1 calc R    
C57 C 0.9452(16) 1.0177(7) 0.8048(5) 0.039(2) Uani 1 1 d U    
F1 F 0.2002(10) 0.3236(5) 0.0427(4) 0.0620(17) Uani 1 1 d   
F2 F -0.0257(11) 0.4468(5) 0.0710(3) 0.0605(17) Uani 1 1 d   
F3 F 0.0606(12) 0.4388(5) -0.0368(3) 0.0643(18) Uani 1 1 d   
F4 F -0.5736(15) 0.1579(6) -0.0391(4) 0.089(2) Uani 1 1 d   
F5 F -0.4910(12) -0.0125(7) -0.0482(3) 0.078(2) Uani 1 1 d   
F6 F -0.8131(10) 0.0201(6) -0.0013(3) 0.0663(19) Uani 1 1 d   
F7 F 0.5475(17) 0.2716(9) 0.5655(4) 0.114(3) Uani 1 1 d   
F8 F 0.3001(15) 0.1488(5) 0.5459(3) 0.080(2) Uani 1 1 d   
F9 F 0.3652(14) 0.1560(5) 0.6510(3) 0.075(2) Uani 1 1 d   
F10 F -0.1973(13) 0.4258(6) 0.6685(3) 0.078(2) Uani 1 1 d   
F11 F -0.4460(12) 0.5435(7) 0.6348(3) 0.077(2) Uani 1 1 d   
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F12 F -0.1557(11) 0.5956(7) 0.6779(4) 0.074(2) Uani 1 1 d   
F13 F 0.9043 0.8994 0.6225 0.105 Uani 1 1 d   
F14 F 0.6387 0.9772 0.5603 0.097 Uani 1 1 d   
F15 F 0.6596 0.7994 0.5826 0.119 Uani 1 1 d   
F16 F 1.1673 1.0218 0.8029 0.076 Uani 1 1 d   
F17 F 0.8639 1.0846 0.8466 0.072 Uani 1 1 d   
F18 F 0.8995 1.0697 0.7417 0.098 Uani 1 1 d   
O1 O 0.1545(11) 0.1328(5) 0.1921(3) 0.0352(15) Uani 1 1 d   
O2 O -0.2443(11) 0.2351(5) 0.0916(3) 0.0401(16) Uani 1 1 d   
O3 O -0.2694 0.0549 0.0577 0.042 Uani 1 1 d   
O4 O 0.5960(12) 0.4791(5) 0.4245(3) 0.0385(16) Uani 1 1 d   
O5 O 0.1559(14) 0.3650(5) 0.5250(3) 0.053(2) Uani 1 1 d   
O6 O 0.1096(15) 0.5389(6) 0.5643(4) 0.063(2) Uani 1 1 d   
O7 O 0.1458(12) 0.6524(5) 0.8113(4) 0.0448(17) Uani 1 1 d   
O8 O 0.5786(12) 0.8029(5) 0.7256(3) 0.0391(16) Uani 1 1 d   
O9 O 0.6052(10) 0.9064(4) 0.8159(3) 0.0303(14) Uani 1 1 d   
 
Anisotropic displacement parameters 
C1 0.021(5) 0.015(5) 0.024(5) -0.004(4) 0.011(4) 0.002(4) 
C2 0.043(6) 0.019(5) 0.037(6) -0.014(4) -0.002(5) 0.004(4) 
C3 0.033(6) 0.035(6) 0.030(6) 0.002(5) 0.007(4) -0.006(4) 
C4 0.060(7) 0.025(5) 0.026(5) -0.011(4) 0.006(5) 0.005(5) 
C5 0.034(6) 0.024(5) 0.031(5) -0.016(4) 0.002(4) 0.003(4) 
C6 0.039(6) 0.021(5) 0.026(5) 0.011(4) -0.002(4) -0.003(4) 
C7 0.027(6) 0.012(5) 0.027(5) -0.003(4) -0.003(4) 0.001(4) 
C8 0.022(5) 0.021(5) 0.019(5) 0.011(4) -0.001(4) 0.001(4) 
C9 0.022(5) 0.029(5) 0.024(5) -0.005(4) 0.004(4) 0.006(4) 
C10 0.041(6) 0.029(6) 0.024(5) -0.011(4) -0.011(4) 0.007(4) 
C11 0.031(6) 0.032(7) 0.031(5) 0.004(4) -0.006(4) -0.015(5) 
C12 0.053(7) 0.029(6) 0.028(5) -0.006(4) -0.011(5) 0.014(5) 
C13 0.044(6) 0.021(6) 0.034(5) -0.005(4) -0.002(5) -0.006(4) 
C14 0.022(5) 0.033(6) 0.032(5) 0.003(4) 0.005(4) -0.006(4) 
C15 0.055(6) 0.014(5) 0.040(6) -0.017(4) -0.021(5) 0.008(4) 
C16 0.059(7) 0.029(6) 0.020(5) 0.017(4) 0.004(4) -0.001(5) 
C17 0.041(7) 0.057(7) 0.023(6) 0.008(5) 0.004(4) -0.009(6) 
C18 0.040(6) 0.053(7) 0.019(5) 0.003(4) 0.007(4) 0.002(5) 
C19 0.031(6) 0.047(7) 0.041(6) -0.012(6) 0.004(5) -0.009(5) 
C20 0.018(5) 0.023(5) 0.032(5) -0.007(4) 0.002(4) 0.006(4) 
C21 0.032(5) 0.031(5) 0.021(5) -0.002(4) -0.002(4) -0.006(4) 
C22 0.039(6) 0.020(5) 0.022(5) 0.010(4) -0.006(4) -0.004(4) 
C23 0.062(7) 0.024(6) 0.041(6) -0.012(5) -0.010(6) 0.009(5) 
C24 0.044(6) 0.012(5) 0.042(6) -0.013(4) 0.016(5) 0.001(4) 
C25 0.036(6) 0.024(5) 0.032(6) 0.000(4) -0.009(4) -0.008(4) 
C26 0.034(6) 0.014(5) 0.041(6) 0.003(4) -0.026(5) -0.003(4) 
C27 0.024(5) 0.028(5) 0.023(5) -0.002(4) 0.004(4) 0.014(4) 
C28 0.026(5) 0.027(5) 0.021(5) 0.003(4) 0.000(4) -0.001(4) 
C29 0.031(5) 0.026(6) 0.037(6) -0.003(4) 0.000(4) 0.002(4) 
C30 0.042(6) 0.031(6) 0.048(6) 0.000(5) -0.002(5) -0.011(5) 
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C31 0.050(7) 0.038(6) 0.046(6) 0.000(5) 0.001(5) 0.012(6) 
C32 0.044(6) 0.023(6) 0.024(5) 0.010(4) -0.009(4) 0.010(4) 
C33 0.036(6) 0.026(6) 0.039(6) -0.009(4) -0.003(5) 0.006(4) 
C34 0.078(7) 0.021(6) 0.031(6) -0.010(5) 0.014(5) 0.017(5) 
C35 0.134(12) 0.034(7) 0.053(8) 0.009(6) -0.006(7) 0.028(8) 
C36 0.111(12) 0.064(10) 0.047(8) -0.006(8) 0.002(7) 0.026(9) 
C37 0.070(9) 0.092(10) 0.065(8) 0.048(7) -0.048(7) -0.063(7) 
C38 0.037(8) 0.081(10) 0.031(6) 0.022(7) 0.006(5) -0.001(6) 
C39 0.025(5) 0.023(5) 0.014(4) -0.003(4) 0.000(4) -0.005(4) 
C40 0.030(5) 0.030(6) 0.038(5) 0.005(4) -0.010(4) 0.002(4) 
C41 0.035(6) 0.036(6) 0.042(6) -0.022(5) -0.007(4) 0.004(5) 
C42 0.044(6) 0.034(6) 0.024(5) -0.009(4) 0.000(4) -0.009(5) 
C43 0.046(6) 0.025(6) 0.042(6) 0.003(5) -0.005(5) 0.008(5) 
C44 0.030(5) 0.016(5) 0.040(5) -0.006(4) -0.002(4) -0.002(4) 
C45 0.025(6) 0.031(6) 0.031(5) -0.003(4) -0.019(4) 0.003(4) 
C46 0.028(5) 0.024(5) 0.022(5) 0.006(4) -0.010(4) 0.001(4) 
C47 0.024(5) 0.020(5) 0.053(6) -0.004(4) -0.007(5) -0.006(4) 
C48 0.038(6) 0.050(7) 0.047(7) -0.011(5) -0.007(5) 0.003(5) 
C49 0.053(7) 0.049(7) 0.033(6) -0.001(5) -0.013(5) 0.000(5) 
C50 0.054(8) 0.051(7) 0.038(6) -0.002(5) 0.002(6) -0.003(6) 
C51 0.051(7) 0.049(7) 0.031(6) -0.016(5) -0.004(5) 0.001(5) 
C52 0.043(7) 0.037(6) 0.046(7) 0.006(5) -0.002(5) 0.006(5) 
C53 0.032(5) 0.026(6) 0.039(6) -0.010(4) -0.004(4) 0.012(4) 
C54 0.081(8) 0.062(8) 0.036(6) -0.003(6) -0.010(6) 0.029(6) 
C55 0.099(9) 0.052(8) 0.041(7) 0.002(6) -0.010(6) 0.019(6) 
C56 0.038(6) 0.004(5) 0.079(7) -0.001(4) -0.016(5) 0.006(4) 
C57 0.046(5) 0.005(4) 0.067(6) -0.011(4) -0.001(4) 0.002(4) 
F1 0.046(4) 0.059(4) 0.077(4) -0.001(3) 0.002(3) 0.004(3) 
F2 0.098(5) 0.030(3) 0.054(4) -0.010(3) -0.002(3) -0.007(3) 
F3 0.099(5) 0.049(4) 0.035(4) 0.011(3) 0.012(3) -0.016(3) 
F4 0.141(7) 0.066(5) 0.057(4) 0.012(4) -0.043(4) -0.002(4) 
F5 0.084(5) 0.102(6) 0.052(4) -0.041(4) 0.026(4) -0.010(4) 
F6 0.045(4) 0.114(6) 0.048(4) -0.041(4) -0.005(3) -0.001(3) 
F7 0.115(7) 0.143(8) 0.078(6) 0.004(5) 0.003(5) 0.043(6) 
F8 0.165(7) 0.035(4) 0.046(4) -0.018(3) -0.014(4) 0.034(4) 
F9 0.143(6) 0.051(4) 0.031(3) 0.010(3) -0.012(4) 0.044(4) 
F10 0.113(6) 0.074(5) 0.034(3) 0.017(4) 0.014(3) -0.010(4) 
F11 0.060(5) 0.131(7) 0.038(4) -0.009(4) 0.000(3) 0.009(4) 
F12 0.060(4) 0.089(5) 0.069(5) 0.008(4) -0.020(4) 0.001(4) 
F13 0.100 0.144 0.054 0.029 0.004 -0.007 
F14 0.177 0.066 0.037 0.027 0.006 0.037 
F15 0.253 0.074 0.038 -0.015 -0.015 0.071 
F16 0.030 0.031 0.167 -0.020 0.000 -0.010 
F17 0.064 0.031 0.120 -0.020 0.014 -0.012 
F18 0.109 0.072 0.098 0.015 0.001 -0.045 
O1 0.022(4) 0.046(4) 0.038(4) -0.012(3) 0.008(3) -0.002(3) 
O2 0.063(4) 0.026(4) 0.026(4) 0.009(3) 0.004(3) 0.009(3) 
O3 0.062 0.040 0.023 -0.004 0.001 0.003 
O4 0.049(4) 0.032(4) 0.035(4) -0.006(3) -0.009(3) -0.001(3) 
O5 0.117(6) 0.016(4) 0.024(4) 0.007(3) -0.015(4) 0.007(4) 
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O6 0.078(6) 0.048(5) 0.059(5) 0.008(4) -0.018(4) 0.000(4) 
O7 0.043(5) 0.029(4) 0.066(5) -0.014(3) -0.019(3) 0.003(3) 
O8 0.073(5) 0.017(3) 0.026(4) 0.002(3) 0.001(3) 0.015(3) 
O9 0.039(4) 0.002(3) 0.050(4) -0.006(3) -0.002(3) 0.001(2) 
 
 Geom special details 
All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated 
using the full covariance matrix.  The cell s.u.'s are taken into account individually in 
the estimation of s.u.'s in distances, angles and torsion angles; correlations between 
s.u.'s in cell parameters are only used when they are defined by crystal symmetry.  An 
approximate (isotropic) 
 treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes. 
   geom bond atom site label 1 
  geom bond atom site label 2 
  geom bond distance 
  geom bond site symmetry 2 
  geom bond publ flag 
C1 C2 1.358(12)    
C1 C6 1.376(12)    
C1 C7 1.552(12)    
C2 C3 1.388(13)    
C2 H2 0.9500    
C3 C4 1.377(13)    
C3 H3 0.9500    
C4 C5 1.339(13)    
C4 H4 0.9500    
C5 C6 1.411(13)    
C5 H5 0.9500    
C6 H6 0.9500    
C7 O1 1.189(10)    
C7 C8 1.540(12)    
C8 C15 1.503(12)    
C8 C9 1.528(12)    
C8 H8 1.0000    
C9 C10 1.363(13)    
C9 C14 1.383(12)    
C10 C11 1.396(12)    
C10 H10 0.9500    
C11 C12 1.367(13)    
C11 H11 0.9500    
C12 C13 1.388(14)    
C12 H12 0.9500    
C13 C14 1.422(13)    
C13 H13 0.9500    
C20 C26 1.486(13)    
C21 C22 1.380(12)    
C21 H21 0.9500    
C22 C23 1.347(13)    
C22 H22 0.9500    
C23 C24 1.404(14)    
C23 H23 0.9500    
C24 C25 1.387(13)    
C24 H24 0.9500    
C25 H25 0.9500    
C26 O4 1.232(10)    
C26 C27 1.503(13)    
C27 C28 1.527(12)    
C27 C34 1.549(13)    
C27 H27 1.0000    
C28 C33 1.374(12)    
C28 C29 1.387(12)    
C29 C30 1.410(13)    
C29 H29 0.9500    
C30 C31 1.405(14)    
C30 H30 0.9500    
C31 C32 1.383(14)    
C31 H31 0.9500    
C32 C33 1.414(12)    
C32 H32 0.9500    
C33 H33 0.9500    
C34 O6 1.400(12)    
C40 H40 0.9500    
C41 C42 1.358(13)    
C41 H41 0.9500    
C42 C43 1.382(13)    
C42 H42 0.9500    
C43 C44 1.426(12)    
C43 H43 0.9500    
C44 H44 0.9500    
C45 O7 1.188(10)    
C45 C46 1.498(12)    
C46 C47 1.507(13)    
C46 C53 1.542(12)    
C46 H46 1.0000    
C47 C52 1.365(13)    
C47 C48 1.387(13)    
C48 C49 1.412(14)    
C48 H48 0.9500    
C49 C50 1.331(14)    
C49 H49 0.9500    
C50 C51 1.371(14)    
C50 H50 0.9500    
C51 C52 1.444(14)    
C51 H51 0.9500    
C52 H52 0.9500    
C53 O8 1.389(11)    
C53 O9 1.420(10)    
C53 H53 1.0000    
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C14 H14 0.9500    
C15 O3 1.394(8)    
C15 O2 1.417(10)    
C15 H15 1.0000    
C16 O2 1.409(11)    
C16 C17 1.470(14)    
C16 H16A 0.9900    
C16 H16B 0.9900    
C17 F2 1.329(12)    
C17 F3 1.334(11)    
C17 F1 1.345(11)    
C18 O3 1.411(9)    
C18 C19 1.501(14)    
C18 H18A 0.9900    
C18 H18B 0.9900    
C19 F5 1.294(12)    
C19 F6 1.334(11)    
C19 F4 1.357(12)    
C20 C25 1.376(12)    
C20 C21 1.390(12)    
C34 O5 1.407(12)    
C34 H34 1.0000    
C35 C36 1.356(17)    
C35 O5 1.403(13)    
C35 H35A 0.9900    
C35 H35B 0.9900    
C36 F8 1.288(14)    
C36 F9 1.335(14)    
C36 F7 1.489(18)    
C37 O6 1.292(13)    
C37 C38 1.665(18)    
C37 H37A 0.9900    
C37 H37B 0.9900    
C38 F12 1.289(14)    
C38 F11 1.303(12)    
C38 F10 1.319(13)    
C39 C44 1.383(12)    
C39 C40 1.387(12)    
C39 C45 1.528(12)    
C40 C41 1.392(13)    
C54 O8 1.430(12)    
C54 C55 1.498(17)    
C54 H54A 0.9900    
C54 H54B 0.9900    
C55 F15 1.326(12)    
C55 F14 1.330(11)    
C55 F13 1.349(13)    
C56 O9 1.413(10)    
C56 C57 1.500(13)    
C56 H56A 0.9900    
C56 H56B 0.9900    
C57 F16 1.304(9)    
C57 F17 1.306(9)    
C57 F18 1.343(10)    
 
 
  geom angle atom site label 1 
  geom angle atom site label 2 
  geom angle atom site label 3 
  geom angle 
  geom angle site symmetry 1 
  geom angle site symmetry 3 
  geom angle publ flag 
 
C2 C1 C6 121.5(8)       
C2 C1 C7 122.9(7)       
C6 C1 C7 115.5(7)       
C1 C2 C3 119.5(8)       
C1 C2 H2 120.2       
C3 C2 H2 120.2       
C4 C3 C2 119.1(8)       
C4 C3 H3 120.4       
C2 C3 H3 120.4       
C5 C4 C3 121.7(8)       
C5 C4 H4 119.1       
C3 C4 H4 119.1       
C4 C5 C6 119.7(8)       
C4 C5 H5 120.2       
C6 C5 H5 120.2       
C1 C6 C5 118.4(8)       
C1 C6 H6 120.8       
C25 C20 C21 119.3(8)       
C25 C20 C26 119.3(7)       
C21 C20 C26 121.4(8)       
C22 C21 C20 119.6(8)       
C22 C21 H21 120.2       
C20 C21 H21 120.2       
C23 C22 C21 121.6(8)       
C23 C22 H22 119.2       
C21 C22 H22 119.2       
C22 C23 C24 119.7(9)       
C22 C23 H23 120.2       
C24 C23 H23 120.2       
C25 C24 C23 119.0(8)       
C25 C24 H24 120.5       
C23 C24 H24 120.5       
C20 C25 C24 120.8(8)       
C20 C25 H25 119.6       
C44 C39 C45 122.1(7)       
C40 C39 C45 117.9(7)       
C39 C40 C41 120.2(8)       
C39 C40 H40 119.9       
C41 C40 H40 119.9       
C42 C41 C40 119.8(8)       
C42 C41 H41 120.1       
C40 C41 H41 120.1       
C41 C42 C43 121.9(9)       
C41 C42 H42 119.1       
C43 C42 H42 119.1       
C42 C43 C44 118.4(9)       
C42 C43 H43 120.8       
C44 C43 H43 120.8       
C39 C44 C43 119.6(8)       
C39 C44 H44 120.2       
C43 C44 H44 120.2       
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C5 C6 H6 120.8       
O1 C7 C8 120.9(7)       
O1 C7 C1 120.4(7)       
C8 C7 C1 118.6(7)       
C15 C8 C9 113.6(7)       
C15 C8 C7 108.3(7)       
C9 C8 C7 108.3(6)       
C15 C8 H8 108.8       
C9 C8 H8 108.8       
C7 C8 H8 108.8       
C10 C9 C14 119.7(8)       
C10 C9 C8 121.3(7)       
C14 C9 C8 119.0(7)       
C9 C10 C11 121.4(8)       
C9 C10 H10 119.3       
C11 C10 H10 119.3       
C12 C11 C10 118.9(8)       
C12 C11 H11 120.5       
C10 C11 H11 120.5       
C11 C12 C13 121.7(9)       
C11 C12 H12 119.2       
C13 C12 H12 119.2       
C12 C13 C14 118.0(8)       
C12 C13 H13 121.0       
C14 C13 H13 121.0       
C9 C14 C13 120.1(8)       
C9 C14 H14 119.9       
C13 C14 H14 119.9       
O3 C15 O2 114.7(6)       
O3 C15 C8 115.9(7)       
O2 C15 C8 106.0(7)       
O3 C15 H15 106.5       
O2 C15 H15 106.5       
C8 C15 H15 106.5       
O2 C16 C17 111.0(8)       
O2 C16 H16A 109.4       
C17 C16 H16A 109.4       
O2 C16 H16B 109.4       
C17 C16 H16B 109.4       
H16A C16 H16B 108.0       
F2 C17 F3 106.8(8)       
F2 C17 F1 105.8(8)       
F3 C17 F1 106.8(8)       
F2 C17 C16 112.6(8)       
F3 C17 C16 111.4(8)       
F1 C17 C16 112.9(9)       
O3 C18 C19 108.3(7)       
O3 C18 H18A 110.0       
C19 C18 H18A 110.0       
O3 C18 H18B 110.0       
C24 C25 H25 119.6       
O4 C26 C20 118.1(8)       
O4 C26 C27 120.5(8)       
C20 C26 C27 121.5(7)       
C26 C27 C28 109.4(7)       
C26 C27 C34 107.9(7)       
C28 C27 C34 111.9(7)       
C26 C27 H27 109.2       
C28 C27 H27 109.2       
C34 C27 H27 109.2       
C33 C28 C29 120.6(8)       
C33 C28 C27 119.6(7)       
C29 C28 C27 119.8(7)       
C28 C29 C30 118.7(8)       
C28 C29 H29 120.7       
C30 C29 H29 120.7       
C31 C30 C29 121.3(8)       
C31 C30 H30 119.3       
C29 C30 H30 119.3       
C32 C31 C30 118.7(9)       
C32 C31 H31 120.7       
C30 C31 H31 120.7       
C31 C32 C33 119.8(8)       
C31 C32 H32 120.1       
C33 C32 H32 120.1       
C28 C33 C32 120.8(8)       
C28 C33 H33 119.6       
C32 C33 H33 119.6       
O6 C34 O5 114.0(8)       
O6 C34 C27 117.4(8)       
O5 C34 C27 104.9(7)       
O6 C34 H34 106.6       
O5 C34 H34 106.6       
C27 C34 H34 106.6       
C36 C35 O5 114.7(11)       
C36 C35 H35A 108.6       
O5 C35 H35A 108.6       
C36 C35 H35B 108.6       
O5 C35 H35B 108.6       
H35A C35 H35B 107.6       
F8 C36 F9 108.3(11)       
F8 C36 C35 120.8(12)       
F9 C36 C35 119.5(11)       
F8 C36 F7 100.2(10)       
F9 C36 F7 101.2(11)       
C35 C36 F7 102.4(12)       
O6 C37 C38 104.3(9)       
O6 C37 H37A 110.9       
C38 C37 H37A 110.9       
O6 C37 H37B 110.9       
O7 C45 C46 123.1(8)       
O7 C45 C39 118.0(7)       
C46 C45 C39 118.8(7)       
C45 C46 C47 108.7(7)       
C45 C46 C53 105.3(6)       
C47 C46 C53 114.4(7)       
C45 C46 H46 109.4       
C47 C46 H46 109.4       
C53 C46 H46 109.4       
C52 C47 C48 119.5(9)       
C52 C47 C46 120.1(8)       
C48 C47 C46 120.4(8)       
C47 C48 C49 120.3(10)       
C47 C48 H48 119.8       
C49 C48 H48 119.8       
C50 C49 C48 118.8(9)       
C50 C49 H49 120.6       
C48 C49 H49 120.6       
C49 C50 C51 124.1(10)       
C49 C50 H50 118.0       
C51 C50 H50 118.0       
C50 C51 C52 116.7(9)       
C50 C51 H51 121.7       
C52 C51 H51 121.7       
C47 C52 C51 120.6(9)       
C47 C52 H52 119.7       
C51 C52 H52 119.7       
O8 C53 O9 111.1(7)       
O8 C53 C46 106.0(6)       
O9 C53 C46 114.2(7)       
O8 C53 H53 108.5       
O9 C53 H53 108.5       
C46 C53 H53 108.5       
O8 C54 C55 108.5(8)       
O8 C54 H54A 110.0       
C55 C54 H54A 110.0       
O8 C54 H54B 110.0       
C55 C54 H54B 110.0       
H54A C54 H54B 108.4       
F15 C55 F14 106.5(8)       
F15 C55 F13 104.3(8)       
F14 C55 F13 110.5(9)       
F15 C55 C54 111.8(10)       
F14 C55 C54 110.3(9)       
F13 C55 C54 113.2(9)       
O9 C56 C57 107.2(6)       
O9 C56 H56A 110.3       
C57 C56 H56A 110.3       
O9 C56 H56B 110.3       
C57 C56 H56B 110.3       
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C19 C18 H18B 110.0       
H18A C18 H18B 108.4       
F5 C19 F6 107.1(8)       
F5 C19 F4 108.9(9)       
F6 C19 F4 105.4(8)       
F5 C19 C18 116.4(9)       
F6 C19 C18 108.8(8)       
F4 C19 C18 109.7(8)       
 
C38 C37 H37B 110.9       
H37A C37 H37B 108.9       
F12 C38 F11 106.8(10)       
F12 C38 F10 106.4(9)       
F11 C38 F10 109.7(10)       
F12 C38 C37 119.8(10)       
F11 C38 C37 108.9(9)       
F10 C38 C37 105.0(10)       
C44 C39 C40 120.0(7)       
 
H56A C56 H56B 108.5       
F16 C57 F17 109.4(6)       
F16 C57 F18 104.6(7)       
F17 C57 F18 102.9(6)       
F16 C57 C56 112.9(7)       
F17 C57 C56 114.0(8)       
F18 C57 C56 112.2(7)       
C16 O2 C15 117.0(7)       
C15 O3 C18 114.3(6)       
C35 O5 C34 114.6(8)       
C37 O6 C34 109.8(10)       
C53 O8 C54 113.5(7)       
C56 O9 C53 116.3(6)       
 
diffrn measured fraction theta max    0.998 
 diffrn reflns theta full              20.83 
 diffrn measured fraction theta full   0.998 
 refine diff density max    0.725 
 refine diff density min   -0.337 
 refine diff density rms    0.122 
 
X-ray Crystallographic data for 254c (CCDC-929704) 
  
O
O
O
Cl
CF3
CF3
254c
 
 
  
 audit creation method            SHELXL-97 
 chemical formula moiety           C19 H15 Cl F6 O3 
 chemical formula sum        C19 H15 Cl F6 O3 
 chemical formula weight          440.76 
 atom type scat source 'C'  'C'   0.0033   0.0016 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'H'  'H'   0.0000   0.0000 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'Cl'  'Cl'   0.1484   0.1585 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'F'  'F'   0.0171   0.0103 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'O'  'O'   0.0106   0.0060 
162 
 
 symmetry cell setting            Monoclinic 
 cell length a                    5.8641(3) 
 cell length b                    33.384(2) 
 cell angle alpha                 90.00 
 cell angle beta                  90.00 
 cell angle gamma                 90.00 
 cell volume                      3855.5(4) 
 cell formula units Z             8 
 cell measurement temperature     293(2) 
 cell measurement reflns used     3462 
 cell measurement theta min       2.44 
 cell measurement theta max       23.63 
 exptl crystal description        needle 
 exptl crystal colour             colourless 
 exptl crystal size max           0.50 
 exptl crystal size mid           0.10 
 exptl crystal size min           0.03 
 exptl crystal density meas        
 exptl crystal density diffrn     1.519 
 exptl crystal F 000              1792 
 exptl absorpt coefficient mu     0.272 
 exptl absorpt correction T min   0.8759 
 exptl absorpt correction T max   0.9919 
 diffrn ambient temperature       293(2) 
 diffrn radiation wavelength      0.71073 
 diffrn radiation source          'fine-focus sealed tube' 
 diffrn radiation monochromator   graphite 
diffrn reflns number             12356 
diffrn reflns av R equivalents   0.0677 
diffrn reflns av sigmaI/netI     0.0898 
diffrn reflns limit h min        -6 
diffrn reflns limit h max        5 
diffrn reflns limit k min        -31 
diffrn reflns limit k max        37 
diffrn reflns limit l min        -21 
diffrn reflns limit l max        21 
diffrn reflns theta min          2.44 
diffrn reflns theta max          23.63 
reflns number total              5271 
reflns number gt                 3462 
 
refine ls matrix type            full 
refine ls weighting scheme       calc 
refine ls weighting details 
atom sites solution primary      direct 
atom sites solution secondary    difmap 
atom sites solution hydrogens    geom 
refine ls hydrogen treatment     constr 
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refine ls extinction method      none 
refine ls extinction coef          
refine ls abs structure details 
refine ls abs structure Flack    0.17(16) 
refine ls number reflns          5271 
refine ls number parameters      578 
refine ls number restraints      255 
refine ls R factor all           0.1430 
refine ls R factor gt            0.0876 
refine ls wR factor ref          0.1955 
refine ls wR factor gt           0.1696 
refine ls goodness of fit ref    1.088 
refine ls restrained S all       1.101 
refine ls shift/su max           0.013 
refine ls shift/su mean          0.001 
 
X-Ray crystallographic data of 254d (CCDC-929705) 
 
 audit creation method            SHELXL-97 
 chemical formula sum         C19 H15 Br F6 O3 
 chemical formula weight          485.22 
 atom type scat source 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'C'  'C'   0.0181   0.0091 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'H'  'H'   0.0000   0.0000 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'Br'  'Br'  -0.6763   1.2805 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'F'  'F'   0.0727   0.0534 
'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'   'O'  'O'   0.0492   0.0322 
 symmetry cell setting            Orthorhombic 
 symmetry space group name H-M    P212121 
cell length a                    33.8830(10) 
cell length b                    19.5966(8) 
cell length c                    5.8985(3) 
cell angle alpha                 90.00 
cell angle beta                  90.00 
cell angle gamma                 90.00 
cell volume                      3916.6(3) 
cell formula units Z             8 
cell measurement temperature     150(2) 
exptl crystal size max           0.50 
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exptl crystal size mid           0.04 
exptl crystal size min           0.02 
exptl crystal density diffrn     1.646 
exptl crystal F 000              1936 
exptl absorpt coefficient mu     3.558 
exptl absorpt correction T min   0.2693 
exptl absorpt correction T max   0.9322 
exptl special details 
diffrn ambient temperature       150(2) 
diffrn radiation wavelength      1.54180 
diffrn radiation type            CuK\a 
diffrn radiation source          'fine-focus sealed tube' 
diffrn radiation monochromator   graphite 
diffrn reflns number             10177 
diffrn reflns av R equivalents   0.0576 
diffrn reflns av sigmaI/netI     0.0681 
diffrn reflns limit h min        -42 
diffrn reflns limit h max        25 
diffrn reflns limit k min        -15 
diffrn reflns limit k max        23 
diffrn reflns limit l min        -4 
diffrn reflns limit l max        7 
diffrn reflns theta min          3.45 
diffrn reflns theta max          73.71 
reflns number total              6567 
reflns number gt                 5554 
reflns threshold expression      >2\s(I) 
 
refine ls matrix type            full 
refine ls weighting scheme       calc 
refine ls weighting details 
atom sites solution primary      direct 
atom sites solution secondary    difmap 
atom sites solution hydrogens    geom 
refine ls hydrogen treatment     mixed 
refine ls extinction method      none 
'Flack H D (1983), Acta Cryst. A39, 876-881' 
refine ls abs structure Flack    0.00(4) 
refine ls number reflns          6567 
refine ls number parameters      523 
refine ls number restraints      2 
refine ls R factor all           0.0918 
refine ls R factor gt            0.0810 
refine ls wR factor ref          0.2212 
refine ls wR factor gt           0.2107 
refine ls goodness of fit ref    1.027 
refine ls restrained S all       1.029 
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Stereoselective Synthesis
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Highly Stereoselective Metal-Free Oxyaminations Using Chiral
Hypervalent Iodine Reagents**
Umar Farid and Thomas Wirth*
Hypervalent iodine reagents are frequently used and have
found wide applications in synthesis.[1,2] They are used in
a wide range of transformations as environmentally friendly,
mild and highly selective oxidants because they avoid the
issues of toxicity or the complicated ligands of many
transition-metal-based systems. They can also be employed
as electrophilic reagents for the functionalization of alkenes
in halolactonizations[3] and dioxytosylations,[4] for the oxida-
tive dearomatization of phenols,[5] and the a-functionalization
of ketones.[6,7] In this context, the use of chiral hypervalent
iodine reagents for asymmetric transformations has emerged
as an interesting area of research in recent years.[8] Only
recently the catalytic use of iodine compounds in synthesis has
been developed.[9] We reported the first catalytic use of
enantiomerically pure iodoarenes in asymmetric reactions,[10]
which opened the possibility to employ a wide range of such
compounds with various structural features as catalysts.[11]
The 1,2-difunctionalization of alkenes is a very important
transformation as is illustrated by the occurrence of the 1,2-
amino alcohol moiety in a huge range of bioactive com-
pounds, natural products, and chiral reagents for stereoselec-
tive synthesis. Transition-metal-catalyzed oxidative amination
reactions are established methods for the synthesis of new
carbon–nitrogen and carbon–oxygen bonds through the
functionalization of alkenes.[12] The osmium-based catalytic
aminohydroxylation is an early efficient route developed by
Sharpless et al. ,[13] but other metal catalysts, such as palladium
and platinum, have also been used for intramolecular
aminations.[14] The use of bifunctional nucleophiles together
with hypervalent iodine reagents in additions to alkenes can
lead to versatile building blocks as shown in the amino-
hydroxylations of alkenes.[15]
Herein we describe the first efficient stereoselective
oxyaminations using chiral hypervalent iodine compounds.
For these reactions we have investigated sulfonyl-substituted
homoallylic urea derivatives of type 1 (Scheme 1). After the
activation of the double bond with the hypervalent iodine
reagent, the first nucleophile reacts to give intermediate 2.
The hypervalent iodine moiety is then attached to an sp3-
hybridized carbon atom and is therefore an excellent leaving
group, several orders of magnitude more reactive than
triflates or tosylates.[16] The subsequent substitution reaction
directly yields bicyclic compounds 3. It has already been
shown that, depending on the reaction conditions, such
cyclizations can lead either to isoureas 3a or to the formation
of diamination products 3b (Scheme 1).[15c,17]
Initial cyclizations of substrate 4 were performed by
modifying literature procedures.[15c] [Bis(trifluoroacetoxy)io-
do]benzene led to the reaction products 5a and 5b in low
yields in a very slow reaction (Table 1, entry 1). Also the
addition of catalytic amounts of diphenyl diselenide, a catalyst
which was successful in a series of other cyclization–elimi-
nation sequences,[18] did not provide a substantial improve-
ment as reaction time is still long (entry 2). The addition of
tert-butyldimethylsilyl triflate (TBDMSOTf, Table 1,
entries 3 and 4) or trimethylsilyl triflate (TMSOTf) to
(diacetoxyiodo)benzene generates in situ, as evidenced by
NMR spectroscopic investigations (see the Supporting Infor-
Scheme 1. Cyclization of urea bisnucleophiles with alkenes using
hypervalent iodine reagents (Ar-IL2) for the synthesis of isoureas 3a
(path a) or of cyclic ureas 3b (path b).
Table 1: Different hypervalent iodine reagents for the cyclization of 4.
Entry Reagents Solvent, Yield [%]
Conditions 5a 5b
1 PhI(OCOCF3)2 CH2Cl2, RT, 120 h 26 28
2 PhI(OCOCF3)2,
5 mol% (PhSe)2
CH2Cl2, RT, 72 h 62 6
3 PhI(OAc)2,
TBDMSOTf
CH2Cl2, 78 to
RT, 8 h
48 20
4 PhI(OCOCF3)2,
TBDMSOTf
CH2Cl2, 78 to
RT, 3 h
50 22
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mation), the more reactive PhI(OTf)2.
[19] This step leads to
a mixture of 5a and 5b (ratio approx. 2:1) in a much faster
reaction with improved combined yields of 72% (Table 1,
entry 4).
Lactate-based hypervalent iodine compounds have been
synthesized by Fujita et al.[20] and reagent 6a has been
introduced by Ishihara et al. for a highly enantioselective
spirolactonizations.[21] As the products 5a and 5b contain
stereogenic centers, substrate 4 was cyclized using the differ-
ent chiral hypervalent iodine reagents 6 (Figure 1). Under
various reaction conditions, only isourea compound 5a was
obtained with all reagents 6 and the cyclic urea derivative 5b
could not be detected.
As shown in Table 2, the hypervalent iodine reagent 6a
has been investigated together with different acids for its
activation (Table 2, entries 1–3). The highest selectivities are
obtained with trimethylsilyl triflate (TMSOTf) leading to the
reaction product 5a with an enantiomeric excess of 61% ee
(Table 2, entry 3).[22] Slightly higher reaction temperatures led
to lower selectivities (Table 2, entry 4), as did other solvents
(Table 2, entries 5 and 6). The hypervalent iodine compounds
6b and 6d, which are also derived from lactic acid, were less
efficient in the stereoselective cyclization of 4 (Table 2,
entries 7 and 8). In these experiments, stoichiometric amounts
of the hypervalent iodine reagents 6 are being used. About
80–85% of the reduced aryl iodides are recovered after the
reaction without loss of optical purity and can be reused by
oxidation. Previous research by our group using selenium
electrophiles revealed that styrene derivatives are potential
substrates for cyclizations with high selectivities.[23] We there-
fore prepared and investigated compound 7 in stereoselective
cyclizations leading to isourea 8 containing a stereogenic
tetrasubstituted carbon atom.
All the chiral hypervalent iodine reagents 6 shown in
Figure 1 have been used for the cyclization of compound 7
(Table 3, entries 1–5). Highest selectivities have been
obtained with reagent 6a, probably because of its ability to
coordinate through the amide nitrogen atoms to the iodine
atom.[21] Also reagent 6e, containing lactic acid and mandelic
acid moieties, led to a good selectivity for product 8 (Table 3,
entry 5). The addition of trifluoroethanol, which can strongly
influence reactions with hypervalent iodine compounds,[24]
did not have a pronounced effect in this case (Table 3,
entry 6). The use of other solvent mixtures increased selec-
tivities and yields. Experiments with 7 containing small
amounts of para-toluenesulfonamide (TsNH2) as a result of
the preparation procedure gave variable results. Addition of
TsNH2 to the reagent 6a together with an excess of TMSOTf,
led to reproducible results and to synthetically very attractive
selectivities, especially if 6a is allowed to react first with
TMSOTf (Table 3, entries 9 and 10).
Figure 1. Enantiomerically pure lactate- and mandelate-derived hyper-
valent iodine reagents 6.
Table 2: Conditions for the stereoselective cyclization to 5a.
Entry Reagents[a] Solvent Yield
[%]
ee
[%]
1 6a, TBDMSOTf CH2Cl2 50 40
2 6a, TfOH CH2Cl2 58 40
3 6a, TMSOTf CH2Cl2 48 61
4 6a, TMSOTf CH2Cl2 61 57
[b]
5 6a, TMSOTf toluene 0 –
6 6a, TMSOTf THF 34 10
7 6b, TMSOTf CH2Cl2 30 12
8 6d, TMSOTf CH2Cl2 50 0
[a] Reaction temperature 78 8C, reaction time 14 h. [b] Reaction
temperature 78 8C to room temperature.
Table 3: Stereoselective cyclization of 7 to isourea derivative 8.
Entry Reagents[a] Solvent Yield
[%]
ee
[%][b]
1 6a,
1.5 equiv TMSOTf
CH2Cl2 40 78
2 6b,
1.5 equiv TMSOTf
CH2Cl2 35 69
3 6c,
1.5 equiv TMSOTf
CH2Cl2 34 50
4 6d,
1.5 equiv TMSOTf
CH2Cl2 20 50
5 6e,
1.5 equiv TMSOTf
CH2Cl2 40 75
6 6a,
1.5 equiv TMSOTf
CH2Cl2/CF3CH2OH (1:1) 43 81
7[c,d] 6a,
2 equiv TMSOTf
CH2Cl2/Et2O (3:1) 48 88
8[c] 6a,
2 equiv TMSOTf,
0.5 equiv TsNH2
CH2Cl2/Et2O (1:3) 76 90
9[c,e] 6a,
2 equiv TMSOTf,
0.5 equiv TsNH2
CH2Cl2/Et2O (1:3) 60–71 92–96
10[c,e,f ] 6a,
3 equiv TMSOTf,
0.5 equiv TsNH2
CH2Cl2:Et2O (1:3) – >99
[a] Reaction temperature 78 8C, reaction time 14–18 h. [b] The major
enantiomer has S configuration. [c] Reaction time 3 h. [d] Reaction
temperature 100 8C. [e] Addition of 7 after reaction of 6a with TMSOTf.
[f ] Reaction performed on analytical scale.
Angewandte
Chemie
3463Angew. Chem. Int. Ed. 2012, 51, 3462 –3465  2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org
Owing to large signal broadening and decomposition
above 40 8C, the structure of 6a after the addition of
TMSOTf and TsNH2 could not be examined by NMR
spectroscopy. Compound 8 was obtained enantiomerically
pure (> 99% ee) on an analytical-scale reaction (Table 3,
entry 10), however, the selectivity dropped slightly on larger
scale (Table 3, entry 9). The absolute configuration of the
major isomer of 8 was found to be S by anomalous dispersion
scattering by X-ray crystallography[25] and the refined Flack
parameter[26] was 0.11(11). This allowed the rapid synthesis of
(S)-2-phenylprolinol [(S)-10] by acidic cleavage of the tosy-
lated derivative 8 to give the isourea compound 9 and
subsequent basic cleavage to form the amino alcohol 10.[15c]
As a result of the tetrasubstituted carbon atom in 8, all one-
step deprotection attempts were unsuccessful. Despite the
importance of proline-based catalysts in organocatalysis, 2-
phenylprolinol 10 has not yet been prepared enantiomerically
pure because a-aryl proline derivatives are very difficult to
synthesize in optically pure form.[27]
This method was then also applied to substrates 11 and 13
demonstrating that other compounds are also accessible in
good enantioselectivities (Scheme 2). Products 12a and 12b
are formed as single diastereomers as judged from their NMR
spectra but with low selectivities. Electron-withdrawing sub-
stituents on the aryl moiety in 13a (R=F) led to the expected
amino oxygenated product 14a, whereas the electron-rich
derivative 13b (R=OMe) undergoes, after cyclization,
further oxidation and rearrangement, probably through
a reaction between the hypervalent iodine reagent and the
methoxy-substituted aryl moiety.
Apart from the N-tosylated urea derivatives shown above,
substrates with other substituents on the nitrogen atom were
investigated. The cyclization of tosylamide derivative 15 did
result in the formation of achiral six-membered ring systems
with elimination whereas the direction of elimination was found
to be dependent on the Lewis acid used in the reaction (Table 4,
entries 1 and 2). The addition of TBDMSOTf led to the
elimination product 16 while with BF3·OEt2 enamine 17 was
isolated. The cyclization of tosylamide 18 also resulted in a 6-
endo cyclization product with the acetate added as an external
nucleophile. In this reaction the use of 6a as chiral reagent led
to an enantiomeric excess of only 27% in product 19 (Table 4,
entry 3). Similar reactions have already been described using
gold catalysis.[28] The variation of the tosyl substituent on the
urea moiety leads to altered nucleophilicities of the nitrogen
moiety. A phenyl (Table 4, entries 4 and 5) or trifluoromethyl-
phenyl substituent (entries 6 and 7) resulted in substrates with
generally lower reactivity as seen by the lower yields in these
reactions. Also the solvents used in the reactions had to be
adjusted to ensure the solubility of the starting materials. With
substrate 20 the use of PhI(OTf)2 as the achiral reagent led to
the expected isourea derivative 21, whereas the chiral reagent
6a yielded the cyclic urea 22 as the product of a diamination
reaction. Good enantioselectivity (79% ee) was obtained in
product 26 (Table 4, Entry 7) and the absolute configuration
was assigned in analogy to the results shown above.
The addition of nitrogen nucleophiles to alkenes using
hypervalent iodine reagents is known and we have inves-
Scheme 2. Application of the hypervalent-iodine-mediated oxyamina-
tion of alkenes: Synthesis of (S)-2-phenylprolinol 10 and other oxy-
aminations.
Table 4: Other substrates in stereoselective cyclization reactions using
6a and TMSOTf.
Entry Substrate Product Yield
[%]
ee
[%][b]
1 48[a] –
2 42[b] –
3 54 27
4 31[c] 0
5 15[d] 42
6 45 39
7 30 79
[a] PhI(OAc)2, TBDMSOTf, AcOH. [b] PhI(OAc)2, BF3·OEt2, AcOH.
[c] PhI(OAc)2, TMSOTf. [d] solvent: CH3CN, no reaction occurred in
CH2Cl2.
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tigated aziridinations in detail, but stoichiometric amounts of
the reagents were always necessary.[29] The requirement for
a catalytic reaction is an oxidant that can convert iodoarenes
into the iodine(III) reagents but that does not oxidize the
alkene substrates. We are still investigating if such an oxidant
exists for the aminohydroxylation described herein which
would allow a catalytic asymmetric, metal-free aminohydrox-
ylation.
These results demonstrate the large potential of chiral
hypervalent iodine reagents in oxyaminations in place of
metal-based methods together with a rapid access to unusual
amino acid derivatives.
Experimental Section
General procedure for cyclizations: TMSOTf was added slowly to
a solution of the urea-tethered alkene (1 equiv) and the hypervalent
iodine compound 6 (1.2 equiv) in the solvent/solvent mixture (2 mL/
0.1 mmol alkene) at 78 8C. The dry ice/acetone bath was removed
and the reaction was allowed to warm to room temperature. The
reaction was stirred overnight. The reaction was quenched with
saturated aqueous NaHCO3 (2 mL/0.1 mmol alkene), and the layers
were separated. The aqueous layer was extracted with CH2Cl2 (2 
5 mL/0.1 mmol alkene) and combined with the organic layer, dried
over MgSO4, filtered and concentrated in vacuo. The products were
purified by chromatography (silica gel, ethyl acetate/hexane 3:5).
Product yields are given in Tables 1–4 and Scheme 2. Typically, 80–
85% of the reduced aryl iodide are isolated without loss of optical
purity.
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Organic molecules bearing hypervalent iodine moieties have
fascinated chemists over the years. Mild reaction conditions
and environmentally friendly behavior through replacement
of toxic heavy metals have led to their recent renaissance in
organic synthesis.[1] Their use not only as selective oxidants[2]
but also as enantiomerically pure reagents[3] make them
versatile reagents for many organic transformations, such as
the oxidation of sulfides to sulfoxides,[4] the a-oxygenation[5]
and a-arylation of carbonyl compounds,[6] the dearomatiza-
tion of phenols,[7] and the dioxygenation,[8] diamination,[9]
aminohydroxylation,[10] and aminofluorination[11] of alkenes.
The nature of hypervalent iodine(III) compounds to react as
electrophiles and then act as excellent leaving groups make
them highly suitable reagents for generating cationic inter-
mediates, which can either directly react with nucleophiles or
lead to rearranged products[12] under ring expansion,[13] ring
contraction,[14] or aryl migration.[8d,15] Similar rearrangements
have been performed with much more toxic thallium
reagents.[16]
We recently reported a novel oxidative rearrangement of
aryl substituted unsaturated carboxylic acids for the facile
access of furanones.[17] Calculations were conducted to inves-
tigate the interplay of various cationic intermediates. Other
studies have also confirmed the involvement of aryl moieties
in cationic intermediates of rearrangement reactions.[18] The
use of chiral hypervalent iodine reagents in asymmetric
rearrangement reactions seems to be a very promising area of
research and, to our knowledge, no reactions of this type have
been reported to date. Herein, we describe the first stereo-
selective rearrangements of aryl substituted alkenes with high
enantioselectivites mediated by chiral hypervalent iodine
reagents. We have investigated chalcones of type 1, which are
easily accessible through an aldol condensation between
methyl ketones RCOMe and aryl aldehydes ArCHO. Oxida-
tive rearrangements of such compounds to a-arylated car-
bonyl compounds have been known for some time.[19] The
reaction of aryl-substituted alkenes 1 with electrophilic chiral
iodine reagents results in the formation of phenyliodinated
intermediates 2, which can be stabilized by the formation of
phenonium ions[20] followed by the reaction with a second
alcohol nucleophile to give the 1,2-migration products 3
(Scheme 1).
Initially the reaction of (E)-1,3-diphenyl prop-2-en-1-one
1a with only (diacetoxyiodo)benzene [PhI(OAc)2] was inves-
tigated, but its reactivity with 1a is too low and no conversion
was observed (Table 1, entry 1). As already described,[19] an
activation of the hypervalent iodine(III) reagent is necessary,
and addition of 50% aqueous H2SO4 as a Brønsted acid to the
reaction mixture[21] resulted in the rearranged product in 64%
yield. When using [bis(trifluoroacetoxy)iodo]benzene as an
iodine(III) source, the yield increased to 82% (Table 1,
entries 2 and 3).
Scheme 1. Rearrangement of 1 to 3 via phenyliodinated intermediate 2
using hypervalent iodine reagents Ar*IL2.
Table 1: Different hypervalent iodine reagents for the migration of 1a.
Entry Reagents Reaction 3a
Conditions[a] Yield [%] ee [%][b]
1 1.05 equiv PhI(OAc)2 RT, 12 h 0 –
2 1.05 equiv PhI(OAc)2
1.4 equiv 50% H2SO4
RT, 3 h 64 –
3 1.05 equiv PhI(OCOCF3)2
1.4 equiv 50% H2SO4
RT, 3 h 82 –
4 1.2 equiv PhI(OAc)2
1.4 equiv TBDMSOTf
0 8C to RT,
14 h
37 –
5 1.15 equiv 4a
1.4 equiv 50% H2SO4
RT, 2 h 4 17
6 1.15 equiv 4b
1.4 equiv 50% H2SO4
RT, 20 h 5 5
7 1.5 equiv 4a
3 equiv TBDMSOTf
78 8C, 12 h – –
8 1.5 equiv 4a
3 equiv TBDMSOTf
78 8C to RT,
12 h
50 0
[a] Solvent: MeOH. [b] Determined by HPLC on chiral stationary phase.
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As a new stereogenic center is established in the product,
lactic acid based chiral hypervalent iodine compounds,
synthesized initially by Fujita et al.[8f,h,22] and further explored
by various research groups[7d,9, 10] in asymmetric reactions,
were investigated. The reagents 4a and 4b (Figure 1) are
diacetoxyiodo arenes and not reactive enough to induce the
rearrangement (see also Table 1, entry 1), but after addition
of sulfuric acid the reaction proceeded slowly and the
rearranged product was obtained in low yields and with
poor enantioselectivities (Table 1, entries 5 and 6). Inspired
by the successful activation of hypervalent iodine compounds
with Lewis acids in asymmetric functionalizations of alke-
nes,[8h,10] a similar approach was investigated in these migra-
tion reactions. Unfortunately, there was either no reaction at
low temperatures or only racemic product was obtained by
using tert-butyldimethylsilyl triflate (TBDMSOTf) in MeOH
(Table 1, entries 7 and 8).
Previous investigations also indicated that the solvent
composition is crucial in stereoselective reactions with iodine-
(III) reagents.[10] Mixtures of methanol and dichloromethane
did not improve the enantiomeric excess in 3a (Table 2,
entry 1). However, when the initial synthesis of the highly
electrophilic hypervalent iodine reagent Ar*I(OTf)2 by prior
mixing of the chiral hypervalent diacetoxyiodo derivative
Ar*I(OAc)2 with TBDMSOTf in dichloromethane at 78 8C
as evidenced by NMR studies[10,23] is followed by addition of
methanol along with starting material 1a, the product 3a was
obtained with improved enantioselectivities (Table 2,
entry 2). When the reaction temperature was kept at
15 8C, the enantioselectivity rose to a promising level of
86% (Table 2, entry 3). Also other Lewis acids have been
utilized in the migration reaction in combination with differ-
ent solvents and chiral hypervalent iodine reagents, as shown
by entries 4–8 in Table 2.
When triflic acid was used together with hypervalent
iodine reagent 4b in a 1:1 mixture of dichloromethane and
2,2,2-trifluoroethanol, a mixture of the dimethoxy acetal 3a
(95% ee) and the bis(trifluoroethoxy)acetal 3a’ (99% ee) was
obtained (Table 2, entry 9). A close monitoring of the
reaction by 1H NMR revealed only a 28% conversion into
the product 3a by employing triflic acid as Lewis acid and
dichloromethane and methanol (8 equiv) as solvents (see the
Supporting Information). The enantiomeric excess was found
to be constant over the course of the reaction (ca. 85% ee),
indicating no further interaction of the chiral reagent with the
product. This reaction and all the results described in Table 2
have been carried out on a sub-millimolar scale without
isolation of the reaction products.
When the reaction was performed without the addition of
methanol using only a 1:1 mixture of dichloromethane and
2,2,2-trifluoroethanol with triflic acid as Lewis acid, a higher
yield (66%) of the product 3a with moderate selectivity
(69% ee) was obtained. By using TMSOTf as the Lewis acid
for iodine(III) activation, the asymmetric induction was
found to be excellent, giving the product in 97% ee
(Table 3, entry 2). When TMSOTf is used as the activating
Lewis acid, the same significant increase in selectivity is
observed with the 4-fluorophenyl substituted chalcone 1b
(Table 3, entries 3 and 4). These reaction conditions were then
applied to a wide range of substrates. Electronically with-
drawing substituents on the aryl moiety at position 4 led to the
expected rearranged products 3 with high selectivities, but the
yields decrease with an increase in the Hammett value[25] of
the halide substituents from sp= 0.06 (F) to sp= 0.23 (Br)
(Table 3, entries 4 to 6). With the 4-nitro substituted chalcone
1e (sp= 0.78), the starting material was completely recovered
and no rearrangement took place (Table 3, entry 7). The
absolute configuration of the major isomer of 3c and 3d was
found to be R by anomalous dispersion scattering, and the
refined Flack parameters[26] were 0.17(16) and 0.00(4),
respectively, as determined by X-ray crystallography.[27]
When compounds 1 with electron-donating substituents
on the aryl moiety were subjected to the rearrangement
reaction conditions, products 3 were obtained in high yields
and selectivities (Table 3, entries 9 and 10). Unfortunately,
compounds 1 with a 4-tert-butyl (1h) and a 3-methyl
substituent (1 i) resulted in products 3h and 3 i with only
moderate selectivities (Table 3, entries 11 and 12). Compound
1j with a 4-methoxy substituent only led to complete
decomposition under different reaction conditions (Table 3,
entry 13). From these results it is obvious that both steric and
electronic parameters from substituents in the para position
are strongly influencing the yield and selectivity of the
reaction.
Heteroaromatic compound 1k as well as other unsatu-
rated carbonyl compounds such as the cinnamyl ester 1 l and
the methyl-substituted ketones 1m also underwent the
rearrangement reaction with high selectivities, but only gave
the reaction products 3 in low yields (Table 3, entries 14–16).
Figure 1. Lactate-based chiral hypervalent iodine reagents 4a and 4b.
Table 2: Conditions for the stereoselective rearrangement of 1a to 3a.
Entry Reagents[a] Solvent 3a
ee [%]
1 4b, TBDMSOTf[b] CH2Cl2/MeOH (1:1) 12
2 4b, TBDMSOTf[b] CH2Cl2, 10 equiv MeOH 43
3 4b, TBDMSOTf CH2Cl2, 8 equiv MeOH 86
4 4b, BF3·OEt2 CH2Cl2, 8 equiv MeOH 24
5 4b, TMSOTf CH2Cl2, 8 equiv MeOH 88
6 4a, TMSOTf CH2Cl2, 8 equiv MeOH 12
7 4b, BF2OTf·OEt2
[c] CH2Cl2, 8 equiv MeOH 89
8 4b, TfOH CH2Cl2, 8 equiv MeOH 91
9 4b, TfOH CH2Cl2/2,2,2-trifluoroethanol
(1:1), 8 equiv MeOH
95[d]
99[e]
10 4b, TfOH CH3CN, 8 equiv MeOH 92
[a] 1.5 equiv 4, 3 equiv Lewis acid, reaction temperature 78 8C to
15 8C, reaction time 14 h. [b] Reaction temperature 78 8C to RT,
reaction time 14 h. [c] Prepared by a 1:1 mixture of TMSOTf and
BF3·OEt2.
[24] [d] 3a. [e] 3a’: Bis-2,2,2-trifluoroethoxy acetal.
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In these experiments, an excess of the hypervalent iodine
reagent 4b (1.5 equiv) is being used. About 80–85% of the
reduced aryl iodide can be recovered after the reaction
without loss of optical purity and can be reoxidized.
A recent publication showed the potential of an aryl
ketone to migrate in boron trifluoride catalyzed epoxide
opening reactions.[28] To confirm that the reaction mechanism
proceeds with aryl ring migration, the deuterium-labeled
compound 1n was treated with PhI(OAc)2 together with
TfOH. The phenyl ring migrated product 3n was obtained
exclusively alongside unreacted starting material. The prod-
uct 3n’, which would result from an aryl ketone
migration, was not observed in this reaction.We also
investigated compound 1o in an attempt to generate
quaternary carbon centers in this process. No
reaction was observed in attempted stereoselective
rearrangement with 4b, but the reaction proceeded
by using (diacetoxyiodo)benzene and TMSOTf as
activating reagent to give the expected rearranged
product 3o in 48% yield. Photoisomerization of
(E)-1a[29] led to an inseparable mixture of (E)-1a
and (Z)-1a (4:10), which was subjected to the
rearrangement conditions using reagent 4b. Product
3a’ was obtained in 31% yield and with 55% ee ; the
recovered starting material 1a showed an altered E/
Z ratio of about 10:2. This indicates that (Z)-1a
reacts much faster than (E)-1a, but the enantiomer-
ic excess obtained in the product 3a’ is lower.
Compound 3a’ was reduced with sodium bor-
ohydride to obtain the corresponding alcohol 4 with
good diastereoselectivity (Scheme 2). Products of
type 4 are versatile building blocks for further
manipulations. Moreover, this asymmetric method
allowed the synthesis of fluorinated acetals, which
have many applications in biological chemistry and
industry.[30]
Ring contraction reactions of tetralone deriva-
tives have also been performed using this method.[14]
When compound 6a was subjected to the rearrangement
reaction conditions, rearranged product 7a was obtained in
59% ee. The selectivity was improved at lower temperature to
70% ee but with decreased yields. Further functionalization
of compound 7a can lead to the synthesis of compounds of
biological importance.[31] Unfortunately, substrate 6b gave
a very low selectivity in product 7b when methanol was used
as nucleophile. The use of 2,2,2-trifluoroethanol in this ring-
contraction reaction resulted in a complex mixture of
products (Scheme 3).
In conclusion, we have developed an efficient and highly
stereoselective method for the a-arylation of a wide range of
Table 3: Other substrates for the stereoselective rearrangement.[a]
Entry Substrate R Ar Product Yield [%] ee [%]
1 1a Ph Ph 3a’ 66[b] 69
2 1a Ph Ph 3a’ 59 97
3 1b Ph 4-F-C6H4 3b 60
[b] 69
4 1b Ph 4-F-C6H4 3b 50 94
5 1c Ph 4-Cl-C6H4 (R)-3c 38 92
6 1d Ph 4-Br-C6H4 (R)-3d 17 91
7 1e Ph 4-NO2-C6H4 3e 0
[c] –
8 1 f Ph 4-Me-C6H4 3 f 92
[b] 66
9 1 f Ph 4-Me-C6H4 3 f 80 86
10 1g Ph 4-iPr-C6H4 3g 68 89
11 1h Ph 4-tBu-C6H4 3h 65 52
12 1 i Ph 3-Me-C6H4 3 i 42 53
13 1 j Ph 4-OMe-C6H4 3 j 0
[c] –
14 1k 2-furyl Ph 3k 8 83
15 1 l OMe Ph 3 l 12 96
16 1m Me Ph 3m 10 –[d]
[a] Reaction conditions: CH2Cl2/CF3CH2OH (1:1), 1.5 equiv 4b, 3 equiv TMSOTf,
40 8C, 1 h; then15 8C, 14 h. [b] Lewis acid: TfOH. [c] Hypervalent iodine reagent:
PhI(OAc)2, reaction temperature: 0 8C. [d] The enantiomers were inseparable on
a HPLC column.
Scheme 2. Isotope labeling and generation of quarternary centers.
Reaction conditions: a) 1.5 equiv PhI(OAc)2, 3 equiv TfOH, CH2Cl2/
CF3CH2OH (1:1), 40 8C, 1 h; then 0 8C, 3 h. b) 1.5 equiv PhI(OAc)2,
3 equiv TMSOTf, CH2Cl2/CF3CH2OH (1:1), 40 8C, 1 h; then 15 8C,
14 h. c) 2 equiv NaBH4, MeOH, 0 8C, 30 min.
Scheme 3. Ring-contraction reactions of tetralone derivatives 6. Reac-
tion conditions: a) 78 8C: 1.5 equiv 4b, 3 equiv TfOH, CH2Cl2/
CF3CH2OH (4:1), 14 h; 100 8C: 1.5 equiv 4b, 3 equiv TMSOTf,
CH2Cl2/CF3CH2OH/Et2O (3:1:4), 3 h. b) 1.5 equiv 4b, 3 equiv TfOH,
8 equiv MeOH, CH2Cl2, 78 8C, 14 h.
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carbonyl compounds by an oxidative rearrangement proce-
dure. These results are noteworthy as they are the first
examples of chiral hypervalent iodine(III) reagents in highly
stereoselective rearrangement reactions. Further investiga-
tions for developing a catalytic reaction and for the synthesis
of enantiomerically enriched building blocks using this
approach are currently in progress.
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